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Introduction
Hysterectomy is the most frequently performed major gynaecologic surgical procedure, with 
millions of procedures performed annually throughout the world (1). Approximately 90% of 
hysterectomies are performed for benign conditions, such as fibroids causing abnormal uterine 
bleeding (2). Hysterectomy can be performed by a vaginal, abdominal or laparoscopic approach. 
Vaginal hysterectomy is generally regarded as the first choice, although there is an overlap in 
indications for either approach. The decision is made in the light of the relative benefits and hazards 
of each approach (3). In health care, three levels of decision-making are generally distinguished: 
decisions on resource utilisation, decisions for groups of patients and decisions for individual 
patients (4). In the comparison of approaches to hysterectomy, the most important issues on these 
three levels need to be considered. 
Significant blood loss, infections and injuries to adjacent organs are of concern in 
hysterectomy, and their rates of occurrence differ with various approaches to hysterectomy 
and surgical experience level (3). Ureteric injuries, for example, have been reported in 2.2% of 
laparoscopic hysterectomies and bladder injuries in 2.0% of laparoscopic hysterectomies during 
the learning curve (5), which is widely perceived as an unacceptable high rate. These rates decrease 
to 0.5% and 0.8% respectively after completion of a learning curve of 30 procedures, which is 
then comparable to the rates in abdominal hysterectomy. 
In general, it is presumed that a quicker recovery is followed by the laparoscopic approach as 
compared with open surgery. However, post-operative recovery is ill defined. Although recovery 
is associated with the duration of hospital stay and the time taken to return to normal activities, 
their assessment provides no more than indirect measures of recovery. Local habits and social 
security matters have a major influence on the available time to recover, which disqualifies the 
assessment of duration of hospital stay and absence from work as objective recovery tools. 
Consequently, more reliable and valid instruments are needed to assess recovery. 
An international consensus, based on available evidence on recovery following colonic 
surgery, has resulted in a post-operative recovery enhancement protocol (6). This protocol lists 
21 elements on preoperative, intraoperative and post-operative patient care. The application of 
a similar protocol in patients undergoing colonic surgery has resulted in a reduction in hospital 
stay by over 50% (7), which has been considered as a major progress. However, the term recovery 
was used synonymous here with reduction of hospital stay, and it is not known whether the 
patients experienced the reduction in hospital stay as advantageous to their recovery. This 
example illustrates the importance of patients’ judgement, when measuring a subjective matter, 
such as recovery.
As a consequence, more emphasis has been put on patient reported recovery instruments 
such as questionnaires in recent years (8). Both questionnaires assessing generic health-related 
quality of life or questionnaires assessing recovery specific quality of life are now available for 
this purpose. With regards to satisfactory measurement properties, these instruments offer a 
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less biased outcome measure with high relevance to the patient. These measurement properties 
include satisfactory validity and reproducibility, which ensure that the instrument measures what 
it is supposed to measure in a reproducible manner (9). 
Laparoscopic surgery is likely to be associated with higher costs as compared with open 
surgery, due to longer operation times and the additional costs of the laparoscopic basic 
equipment and disposable materials. Whether reduced expenses associated with the recovery 
process and especially the absence from work, compensate these costs, remains unclear. Adequate 
recovery measurement tools will be helpful in future research on cost-effectiveness of surgical 
techniques, where the additional costs associated with a certain difference in recovery score can 
be established. 
The choice of a laparoscopic approach instead of laparotomy, as well as the avoidance 
of complications are obvious elements in the improvement of recovery. These two issues 
are diametrically opposed in laparoscopic versus abdominal hysterectomy. In laparoscopic 
hysterectomy an extensive abdominal incision is avoided, but at the same time the operation 
bears an increased risk of major complications, such as injury to ureter and bladder (3), especially 
during the learning curve (5). These opposing effects are an important subject of discussion in 
the present thesis, where an evaluation of patients’ preferences is included.
In addition to complication rates and the speed of recovery, long-term effects, such as effects 
on pelvic organ function, are likewise important in the choice for an approach to hysterectomy. 
Although hysterectomy for benign disease does not seem to have a major impact on pelvic floor 
function, it is not known until now, whether one of the approaches to hysterectomy is superior 
in that respect (10).  
Thesis "On the measurement of recovery following hysterectomy"
This thesis studies the differences in various approaches to hysterectomy with emphasis on 
postoperative recovery. The available evidence on complications, costs and quality of life following 
hysterectomy is summarised and the results of a randomised controlled trial on laparoscopic versus 
abdominal hysterectomy are presented, in which quality of life and pelvic organ function are main 
outcome measures. In addition, a literature review on recovery specific instruments and their 
measurement properties is presented and the measurement properties of two recovery specific 
instruments and one generic health-related instrument are assessed in patients who underwent 
hysterectomy. Women’s preferences are studied in patients and nurses to whom the benefits and 
disadvantages of laparoscopic and abdominal hysterectomy had been explained in a standardised 
manner.
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The aims of this thesis are:
•   to provide an overview on complications, recovery, quality of life, pelvic organ function, and 
costs associated with hysterectomy (Chapters 2 and 3).
•   to compare laparoscopic and abdominal hysterectomy with regards to quality of life (Chapter 4) 
and pelvic organ function (Chapter 5). 
•   to provide an overview on available post-operative recovery instruments and their measurement 
properties (Chapter 6).
•   to assess the relative measurement properties of two Dutch recovery instruments: Recovery 
index-10 and Quality of recovery-40, and a generic health-related instrument: RAND-36, in 
patients undergoing hysterectomy (Chapter 7).
•   to assess women’s preferences for laparoscopic or abdominal hysterectomy (Chapter 8)
 
10
Chapter 1
References
 1] Garry R. Health economics of hysterectomy. Best Pract Res Clin Obstet Gynaecol 2005; 19(3):451-465.
 2] Flory N, Bissonnette F, Binik YM. Psychosocial effects of hysterectomy: literature review. J Psychosom Res 2005; 
59(3):117-129.
 3] Johnson N, Barlow D, Lethaby A, Tavender E, Curr E, Garry R. Surgical approach to hysterectomy for benign 
gynaecological disease. Cochrane Database Syst Rev 2006; (2):CD003677.
 4] Sutherland HJ, Till JE. Quality of life assessments and levels of decision making: differentiating objectives. Qual Life 
Res. 1993; 2(4):297-303.
 5] Makinen J, Johansson J, Tomas C, Tomas E, Heinonen PK, Laatikainen T et al. Morbidity of 10 110 hysterectomies 
by type of approach. Hum Reprod 2001; 16(7):1473-1478.
 6] Fearon KC, Ljungqvist O, Von Meyenfeldt M, Revhaug A, Dejong CH, Lassen K, Nygren J, Hausel J, Soop M, 
Andersen J, Kehlet H. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing 
colonic resection. Clin Nutr. 2005; 24(3):466-77.
 7] Anderson AD, McNaught CE, MacFie J, Tring I, Barker P, Mitchell CJ. Randomized clinical trial of multimodal 
optimization and standard perioperative surgical care. Br J Surg. 2003; 90(12):1497-504.
 8] Korolija D, Sauerland S, Wood-Dauphinee S, Abbou CC, Eypasch E, Caballero MG et al. Evaluation of quality 
of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg 
Endosc 2004; 18(6):879-897.
 9] Streiner DL, Norman GR. Health Measurement scales, a practical guide to their development and use. Third edition. 
Oxford University Press, 2003.
 10] Thakar R, Sultan AH. Hysterectomy and pelvic organ dysfunction. Best Pract Res Clin Obstet Gynaecol 2005; 
19(3):403-418.
11
Introduction
12
Chapter 1
 Comparison of hysterectomy techniques 
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Introduction
The first descrixption of the removal of gangrenous and inverted uteri goes back to the third 
century A.D. (1). However, it was not until 1813 when a German surgeon Conrad Langenbeck 
described the first intentional complete vaginal hysterectomy in which the patient survived. 
In those days the operative mortality rate was close to 90%. The first reports of abdominal 
hysterectomies were accidental hysterectomies at the time of ovariectomy, mostly with 
conservation of the cervix. The first abdominal hysterectomy where the patient survived was 
reported by an American surgeon Walter Burnham in the American Lancet in 1854 (2). Another 
American surgeon Harry Reich has reported the first laparoscopic assisted vaginal hysterectomy 
in 1989 (3).
Hysterectomy is now the most frequently performed major gynaecologic operation, with 
millions of procedures annually performed throughout the world (4). Abdominal hysterectomy 
has traditionally been the surgical approach for gynaecological malignancy, in cases where pelvic 
pathology such as endometriosis or adhesions is suspected and in the presence of a large uterus. 
Abdominal hysterectomy remains the ‘fallback option’ if the uterus cannot be removed by another 
approach. The vaginal approach was originally used for prolapse, but has become more widely 
used for abnormal uterine bleeding when the uterus is of fairly normal size with or without a 
small degree of descent. Compared to abdominal hysterectomy, successful vaginal hysterectomy 
is considered as less invasive and can be performed under spinal anaesthesia, whereas abdominal 
and laparoscopic hysterectomy will mostly require general anaesthesia. 
In women with an enlarged uterus, where vaginal hysterectomy is not feasible, laparotomy can 
be avoided by performing a laparoscopic hysterectomy. If oophorectomy is needed, a laparoscopic 
approach may also be preferred over the vaginal approach. Laparoscopic hysterectomy usually refers 
to a hysterectomy where at least part of the operation is undertaken laparoscopically. Laparoscopic 
hysterectomy (LH) is further classified in three categories: laparoscopic assisted vaginal hysterectomy 
(LAVH), where vaginal hysterectomy is assisted by prior laparoscopy and the laparoscopic procedure 
does not include the occlusion of the uterine arteries; laparoscopic hysterectomy (LH(a)), where 
the laparoscopic part of the hysterectomy includes the occlusion of the uterine arteries and total 
laparoscopic hysterectomy (TLH), where the vaginal part of the operation is restricted to the 
removal of the laparoscopically freed uterus and all other operative manipulations, including vaginal 
14
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Table 1. Categories of laparoscopic hysterectomy (5).
Category Laparoscopic content
LAVH  Laparoscopic content does not involve division of the uterine vessels, which is performed 
vaginally
LH(a)  Laparoscopic content includes ligation of the uterine vessels, where there is a vaginal 
component in the procedure
TLH  Entire operation is performed laparoscopically, including suturing vaginal vault.
vault closure, are undertaken laparoscopically (5). This classification causes some confusion, as the 
term ‘laparoscopic hysterectomy’ is used for the overall laparoscopic hysterectomy (LH), as well as 
for LH(a), which refers to one of the three categories. 
A total hysterectomy is the removal of the entire uterus and cervix. When the cervix is 
preserved, this is known as a subtotal hysterectomy. Other terms used for subtotal hysterectomy 
are supra-cervical and supra-vaginal hysterectomy. The procedure may be advantageous in case 
of dense pelvic adhesions or emergency obstetric hysterectomy for atonic bleeding.
Outcomes of hysterectomy
In common with the overall hysterectomy rate, the proportion of hysterectomies currently 
being performed by different approaches varies markedly across countries, within countries and 
even between individual surgeons working within the same unit. Each gynaecologist will have 
different indications for the approach to hysterectomy for benign disease, based largely on their 
own array of surgical skills and patient characteristics such as uterine size and descent, extra uterine 
pelvic pathology, previous pelvic surgery and other features such as obesity, nulliparity and the 
need for oophorectomy. Even though vaginal hysterectomy has been widely considered to be the 
operation of choice for abnormal uterine bleeding, the VALUE study has shown that in 1995 in 
the UK, 67% of the hysterectomies performed for this indication were abdominal hysterectomies 
(6). Previous caesarean section is often considered as a contraindication for vaginal hysterectomy. 
However, this is not supported by evidence, as the retrospective trials available have not reported 
a clinically relevant increase in complication rate in hysterectomy patients following caesarean 
section (7-10). Encouraging vaginal surgery amongst gynaecologists has been shown to be an 
effective method of increasing vaginal hysterectomy rates. Finland had a vaginal hysterectomy 
rate as low as 7% in the 1980’s. Following annual meetings on gynaecological surgery where 
vaginal and laparoscopic surgery was encouraged, the vaginal hysterectomy rate increased to 
39% in 2004 (11). 
Following the introduction of laparoscopic hysterectomy in 1989, research on hysterectomy 
received a new impetus. A systematic review summarizes the results of all randomized controlled 
trials on the subject, assessing the potential role of the three approaches to hysterectomy for benign 
indications (12). The meta-analysis provided adequate estimates on blood loss, operation times, 
complication rates and return to normal activities. However, estimates on post hysterectomy 
quality of life, pelvic organ function and psychosocial effects could still not be given due to lacking 
and heterogeneous data. Both LAVH and LH(a) are frequently evaluated in trials, whereas TLH 
is only studied in two randomized controlled trials. 
Although much has been written in the scientific literature about various outcomes of 
hysterectomy, not discussion has been had over what outcomes are of key importance. Surgeons 
wish to minimise operative complications, health care managers wish to minimise costs, but 
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what do patients want? Complications are often uncommon and existing studies do not 
capture each one of them individually powerfully. So researchers tend to pool them together 
into composite outcomes, an approach that is not scientifically sound.  More importantly, when 
comparing different types of hysterectomies, laparotomy cannot be a complication of abdominal 
hysterectomy leading asymmetry in comparison. We have proposed that quality of life is likely to 
be the most key outcome as it captures the benefit the patient experiences from treatment and 
takes into account the effects of complications on patients’ lives (13). The choice should therefore 
weigh this outcome when decision making.
In the following section the comparable oucomes of approaches to hysterectomy are described, 
mainly based on the results as achieved in the meta-analysis (12). Available quantitative data from 
the meta-analysis can be found in table 2.
Operating time
Operating time was longer for laparoscopic as compared to either abdominal or vaginal 
hysterectomy. However, LAVH had a significantly shorter operating time than both abdominal 
hysterectomy and LH(a), thus suggesting that the operating time is governed by the proportion 
of the surgery performed laparoscopically. The greater proportion performed laparoscopically, 
the lengthier the operation (12).
Haemorrhage
Although there was no significant difference in the need for blood transfusions between 
laparoscopic hysterectomy and abdominal hysterectomy, laparoscopic hysterectomy was 
associated with significantly less blood loss and a smaller drop in haemoglobin. The need 
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Table 2. Differences between approaches to hysterectomy (12).
 AH vs VH LH vs AH  LH vs VH
Operating time (min) NR 10.6 (7.4;13.8) 41.5 (33.7;49.4)
Blood loss (ml) NR -45.3 (-72.7;-17.9) 9.7 (-50.2;69.7)
Drop in haemoglobin (g/l) NR -0.6 (-0.8;-0.3) 0.2 (-0.3;0.6)
Infection unspecified  0.4 (0.2;0.8)* 0.7 (0.5;0.9)* 0.8 (0.5;1.3)*
Wound infections NR 0.3 (0.1;0.9)* 3.1 (0.1;77.8)*
Urinary tract injury NR 3.0 (1.3;6.9)* 1.0 (0.4;2.8)*
Hospital stay (days) 1.0 (0.7;1.2) -2.0 (-2.2;-1.9)  0.3 (-0.1;0.8)
Return to normal activities 12.3 (4.8;19.9) -13.6 (-15.4;-11.8) -1.1 (-4.2;2.1)
(days)
AH = abdominal hysterectomy, LH = laparoscopic hysterectomy, VH = vaginal hysterectomy, NR = not reported.
Data presented as weighted mean difference (95% confidence interval) or *odds ratio (95% confidence interval). 
for blood transfusion, the mean blood loss and haemoglobin drop for comparisons between 
abdominal and vaginal hysterectomy, as well as between laparoscopic and vaginal hysterectomy 
were not significantly different (12).
Infections
There was significantly less infectious morbidity for vaginal hysterectomy as compared to 
abdominal hysterectomy. For laparoscopic hysterectomy versus abdominal hysterectomy, there 
were significantly fewer wound infections as well as other infectious morbidity. No significant 
differences were found between vaginal and laparoscopic hysterectomy. Thus, avoidance of 
abdominal hysterectomy appears to be important in the avoidance of postoperative infectious 
morbidity (12). 
Urinary tract injury
A study amongst 37,295 women undergoing hysterectomy in the UK has shown that bladder 
injury was the most frequent visceral injury, with an incidence of one in 200 hysterectomies (14). 
Although no significant difference between the three different approaches has been found, the 
occurrence of ureteric injury remains the major concern in relation to the laparoscopic approach. 
Meta-analysis has shown that in laparoscopic hysterectomy the risk of urinary tract injury was 
2.6 fold increased as compared to abdominal hysterectomy (12). Moreover, there was a tendency 
to increased ureteric injury, which occurred in 1 in 78 women having laparoscopic hysterectomy 
and 1 in 492 women having abdominal hysterectomy. Although it could be speculated that 
laparoscopic uterine artery ligation is the manoeuvre most likely to increase the risk of ureteric 
injury, this was not confirmed by evidence, as no statistically significant difference has been found 
in urinary tract injury for LH(a) versus LAVH.
Unintended laparotomy
As the abdominal approach is the ‘fallback option’ in case of difficult and complicated 
hysterectomies, unintended laparotomies or conversions are inherent to the laparoscopic 
and vaginal approach.  Sometimes these conversions are prudent rather than the result of a 
complication. As calculated from randomised controlled trials, conversions occurred in 8.7% of 
laparoscopic hysterectomy patients and 2.6% of vaginal hysterectomy patients. The possibility 
of the need for conversion should be discussed with the patient prior to surgery (12).
Other complications
There were no significant differences in the occurrence of bowel injury between any of 
the approaches to hysterectomy, with an overall incidence of 0.2%. The same holds true for 
the occurrence of thrombo-embolic events, number of severe bleedings, blood transfusions 
and pelvic haematoma as well as for vaginal cuff infections, urinary tract infections and chest 
infections as separate entities (12).
17
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Although it has been suggested that LAVH does little more than to combine the complications 
of laparoscopic surgery with those of vaginal surgery (15), this has not been supported by 
evidence. The concepts that laparoscopic hysterectomy allows identification of pelvic disease 
such as adhesions and endometriosis and that the meticulous haemostasis achievable with ‘final-
look’ laparoscopy might reduce pelvic haematomas or vaginal cuff infections (16) have not been 
borne out by improved outcomes following laparoscopic versus abdominal hysterectomy in the 
meta-analysis of randomised trials (12).
Pain, hospital stay and return to normal activities 
Avoidance of abdominal hysterectomy appears to be important to minimise postoperative 
pain. Recovery from surgery favoured vaginal hysterectomy and laparoscopic hysterectomy as 
compared to abdominal hysterectomy in terms of shorter hospital stay and return to normal 
activities. There were no significant differences in hospital stay and return to normal activities 
between laparoscopic hysterectomy and vaginal hysterectomy or between LH(a) and LAVH. Thus, 
the speed of postoperative recovery seems to be determined by the avoidance of an abdominal 
procedure; abdominal hysterectomy is associated with lengthier recovery as compared to the 
other approaches to hysterectomy (12). 
Psychosocial effects and quality of life
A further report of the systematic review of randomised trials of surgical approach to 
hysterectomy arbitrarily identified three primary outcomes: time to return to normal activities, 
major operative complication and major lasting problem (17). As long term outcomes were not 
reported in any of the 27 randomised trials included in this review, no information was available 
for the latter outcome. Indeed, approximately 90% of hysterectomies are performed for benign 
indications, which are rarely life-threatening (18). Thus there is a strong argument that psychosocial 
effects and changes in quality of life should be considered as the outcomes of paramount importance 
in the comparison of techniques. Surprisingly, few studies assessing laparoscopic techniques address 
these issues. The available evidence does not support any broad adverse effects of hysterectomy on 
psychosocial functioning (19). As far as quality of life is concerned, there are various reports on the 
enhancement after hysterectomy (20). Randomised controlled trials using validated quality of life 
methods, have shown that the enhancement of quality of life is equal or greater in vaginal as well 
as laparoscopic hysterectomy when compared to abdominal hysterectomy (15;20-24), whereas no 
differences have been found amongst vaginal and laparoscopic hysterectomy (15;23). 
Pelvic organ dysfunction 
In the early 1980’s advantages as far as postoperative urinary incontinence and sexuality were 
concerned, were claimed from a prospective observational study on subtotal hysterectomy and 
total abdominal hysterectomy (25;26). This has now been challenged by meta-analysis of three 
randomised controlled trials, where no advantages of subtotal hysterectomy were found (27).
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In the short term there does not seem to be a negative effect from non-radical hysterectomy on the 
incidence of urinary, bowel and sexual dysfunctions (28). An improvement of urinary incontinence 
and sexual problems has even been found and de novo problems were rare. The roles of the different 
approaches still needs further establishment, but thus far there is no evidence of superiority of one of 
the approaches. No prospective long term data are available up to date, though large epidemiologic 
studies have shown an increased risk of urinary incontinence in post hysterectomy women (29). 
Recource use in hysterectomy relative to outcome 
There are several types of economic analysis available for the evaluation of health care 
technology (30). Costs or resource use for different treatment options can be compared without 
considering a (potential) difference in treatment outcome. In cost-effectiveness analysis however, 
costs are related to the effect of a particular treatment. A difference in effectiveness between 
two strategies is expected and the analysis aims to express additional costs of the additional 
health gain. Alternatives to cost-effectiveness analysis are cost-utility analysis and cost-benefit 
analysis. In cost-utility analysis, the outcome of medical interventions is expressed in utilities, 
for example life years that are adjusted for the quality of life of these years. In cost-benefit 
analysis, not only the costs, but also the potential benefits of interventions are expressed in 
financial terms. Since there is no uniform extrapolation of women having had hysterectomy into 
financial terms, cost-benefit analysis is only rarely applied. Where the difference in effectiveness 
or quality of life has not been assessed, and the analysis is limited to the difference in costs, 
assuming a similar medical outcome, the analysis is a cost-minimisation analysis. 
When hysterectomy is compared to other interventions, such as ablation or a levonorgestrel 
intra-uterine device (IUD), a difference in effect on menorrhagia is expected, which makes a 
cost-effectiveness analysis appropriate. When comparing various approaches to hysterectomy, 
a difference in recovery can be expressed in quality adjusted life years (QALYs), making cost-
utility analysis possible. 
PubMed searches for economic analyses were performed using the key words ‘cost$, 
combined with menorrhagia, uterine bleeding, hysterectomy, endometrial ablation, (fibroid 
or myom$ and emboli$) and myomectomy. Data on economic analyses from reviews and 
randomized controlled trials on comparisons of approaches to hysterectomy and comparisons 
of hysterectomy to other treatments were extracted.
Hysterectomy versus medical treatment as well as endometrial ablation has been subject to 
randomised studies comparing the costs or resource use (31-37). Formal cost-utility analysis 
has been performed for hysterectomy as compared to the levonorgestrel-IUD (38) and for 
laparoscopic hysterectomy as compared to both vaginal and abdominal hysterectomy (23). 
The applicability of randomised studies on the economic impact of different treatment 
options for abnormal uterine bleeding is limited as endometrial ablation and hysterectomy are not 
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options for women wishing to retain their fertility, and as hormonal treatment is inappropriate 
for women wishing to become pregnant. Furthermore, a sufficiently long follow-up period is 
required to include all costs of re-treatments in the group where a less effective strategy has 
initially been applied. These costs will increase over time, whereas hysterectomy is more expensive 
on the short term, but has a long-lasting effect.
Resource use in different approaches to hysterectomy
Operating time, hospital stay and return to normal activities are obviously the most important 
factors in potential differences in resource use amongst approaches to hysterectomy. As derived from 
randomised controlled studies summarised in the meta-analysis (12), in laparoscopic hysterectomy 
the difference in operating time was 11 minutes as compared to abdominal hysterectomy and 42 
minutes as compared to vaginal hysterectomy, both detrimetal to laparoscopic hysterectomy. On 
the other hand, hospital stay was two days longer in abdominal hysterectomy as compared to 
laparoscopic hysterectomy and one day longer in abdominal hysterectomy as compared to vaginal 
hysterectomy. Furthermore, in abdominal hysterectomy the difference in time taken until return to 
normal activities was 14 days as compared to laparoscopic hysterectomy and 12 days as compared 
to vaginal hysterectomy. There were no statistically significant difference amongst laparoscopic 
hysterectomy and vaginal hysterectomy as far as hospital stay and return to normal activities were 
concerned.  
Six randomised controlled trials (21-23;39-41) have compared the resource use in laparoscopic 
versus abdominal hysterectomy, from which one performed a formal cost-utility analysis (23). 
None of the studies has found a significant difference in overall costs. However, hospital costs 
were significantly higher for the laparoscopic approach in two of these studies (21;22), caused by 
the longer operation times and higher costs of disposables in laparoscopic hysterectomy. When 
including society costs due to productivity loss, this difference was wiped out (21). Until now 
the resource use for basic equipment in laparoscopic hysterectomy, which is extremely variable, 
has not been taken into account. The least expensive will be a simple uterine manipulator and 
reusable bipolar coagulation forceps and scissors, although many surgeons regard an optimal 
vaginal delineator as an essential safety feature in total laparoscopic hysterectomy. However many 
varieties of more expensive equipment are now available for therapeutic laparoscopy. These costs 
should be carefully recorded in future studies to get a more thorough picture of comparable costs 
of laparoscopic and abdominal hysterectomy.
Resource use in hysterectomy as compared to alternative treatments 
Medical treatment
Both endometrial ablation and hysterectomy have shown to be more effective in the resolution 
of abnormal uterine bleeding and the enhancement of quality of life, as compared to medical 
treatment (31;32). However, at the end of a two year follow-up period, the total resource use 
was significantly higher (51%) in women randomised to hysterectomy as compared to women 
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randomised to expanded medical treatment, i.e. combinations of prostaglandin synthetase 
inhibitors, tranexamic acid and hormonal treatment. Fifty-three percent of the women in the 
medical treatment group had undergone hysterectomy as a subsequent treatment within these 
two years. 
Furthermore, in a randomized controlled trial comparing the levonorgestrel-IUD with 
hysterectomy, 42% of the women in the levonorgestrel-IUD eventually underwent hysterectomy 
in the five years follow-up period. Nonetheless, a cost-utility analysis at one-year follow-up and a 
cost comparison at five years follow-up both favoured the levonorgestrel-IUD group. Five years 
after randomization the resource use was 65% higher in the hysterectomy group (33;38). 
Endometrial ablation
In three randomized controlled trials costs were calculated for endometrial ablation versus 
hysterectomy (34-37) and all have shown that the costs were lower in the endometrial ablation 
group. However, with longer-term follow-up periods this difference had narrowed due to the 
costs of further treatments in the endometrial ablation groups (37).
Myomectomy
Myomectomy is associated with a high recurrence rate. Following hysteroscopic myomectomy, 
25% of the women had needed additional surgical treatment at the end of an eight year follow-
up period (42). Comparable data have been reported following laparoscopic and abdominal 
myomectomy (43;44). Myomectomy may however bring relief to women suffering abnormal 
uterine bleeding due to myoma and wishing to preserve the uterus (45). Short-term costs of 
abdominal myomectomy will be comparable to those of hysterectomy, which makes cost-
effectiveness of abdominal myomectomy less likely, although no studies are available to date. 
Uterine artery embolization
In two randomised controlled trials uterine artery embolization was compared to 
hysterectomy, but costs were not considered as clinical endpoints (46;47). In a prospective 
observational study comparing hysterectomy to uterine artery embolization, women above 
the age of 40 were followed until menopause (48). This study suggested that the costs in the 
embolization group were lower.
Cost-utility analysis in hysterectomy
The first analysis in gynaecologic surgery on resource use in relation to outcome was published 
by Grover et al. in 1996 (49). They have reported positive cost-effectiveness of concomitant 
elective hysterectomy at the time of adnexectomy in women beyond 45 years of age. 
In the cost-utility analysis published in 2004 by Sculpher et al., the costs for laparoscopic 
hysterectomy as compared to vaginal and abdominal hysterectomy were calculated in a secondary 
analysis of the eVALuate study data (23). One quality adjusted life year when performing a 
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laparoscopic hysterectomy instead of abdominal hysterectomy would cost the British National 
Health System (NHS) £26 571 ($46 893; €37 813). Provided that the outcome, including operation 
time, would not change when exchanging disposables for reusable instruments, these costs would 
decrease 2.5 fold. In the parallel trial on laparoscopic versus vaginal hysterectomy, it was shown 
that laparoscopic hysterectomy was not cost-effective (23). No other randomized studies have been 
performed on the financial implications of abdominal versus vaginal hysterectomy. However, as 
vaginal hysterectomy is associated with a shorter operation time and hospital stay, it is expected 
to be less expensive.
One randomised controlled study has reported a similar resource use over a two year period 
after subtotal abdominal hysterectomy as compared to total abdominal hysterectomy (50). 
Furthermore, the conclusion from a study on cost-effectiveness of the application of pre-operative 
GnRH agonists in women with fibroids undergoing hysterectomy was that the benefits do not 
justify the costs (51). A cost-effectiveness analysis of oophorectomy at the time of hysterectomy 
has not yet been undertaken.
As has already been remarked in the section on resource use, a cost-utility analysis at one-year 
follow-up favoured the levonorgestrel-IUD as compared to hysterectomy (38). 
Other considerations on hysterectomy
Learning curve
Mäkinen et al. have reported a prospective study on the learning curve in 10,110 hysterectomies 
for benign indications of which 5,875 were abdominal, 1,801 were vaginal and 2,434 were 
laparoscopic hysterectomies (52). As far as injuries to adjacent organs were concerned, the 
surgeons’ experience significantly correlated inversely with the occurrence of urinary tract injuries 
in laparoscopic hysterectomy and the occurrence of bowel injuries in vaginal hysterectomy. Still, 
randomised controlled trials frequently do not report the experience of the surgeon(s), which 
hampers interpretation of the results. However, in the two largest trials incorporated in the 
meta-analysis on hysterectomy, thus having the highest impact on the outcome, surgeons had 
performed at least 25 respectively 50 interventions by either approach (15;22). 
All gynaecologists tend to become thoroughly trained in abdominal hysterectomy techniques, 
but there is huge variation in their learning curve position in relation to vaginal and laparoscopic 
hysterectomy techniques (53). Total laparoscopic hysterectomy requires the highest degree of 
surgical skill and currently only a very small proportion of newly trained gynaecologists will be 
able to perform this type of surgery. However, some gynaecologists who have not received specific 
training have acquired the skills to perform laparoscopic hysterectomy. One important benefit 
of introduction of laparoscopic hysterectomy into gynaecologic training has been to increase 
surgeons’ confidence and skills with vaginal and overall laparoscopic surgery. 
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Conclusions 
In conclusion, when technically feasible, vaginal hysterectomy should be performed in 
preference to laparoscopic and abdominal hysterectomy. There are no significant disadvantages 
of vaginal hysterectomy compared to any other surgical approach to hysterectomy, provided it can 
be accomplished safely.  Compared to the abdominal approach, successful vaginal hysterectomy 
has a shorter operation time, is less painful and there are fewer febrile episodes postoperatively 
and it is associated with earlier discharge from hospital and return to normal activities. Where 
vaginal hysterectomy is not feasible, laparoscopic hysterectomy offers some benefits of avoiding 
abdominal hysterectomy, including less operative blood-loss, less pain and less infectious 
morbidity, as well as a shorter hospital stay and more rapid return to normal activities. These 
advantages are offset by longer operating time and more urinary tract injuries. No advantages of 
laparoscopic hysterectomy over vaginal hysterectomy could be found, whereas the disadvantages 
are a longer operating time, greater use of pain medication and higher cost. 
In women undergoing hysterectomy, vaginal hysterectomy is cost-effective compared to 
laparoscopic hysterectomy and is likely to be cost-effective compared to abdominal hysterectomy. 
The difference in cost-effectiveness between laparoscopic and abdominal hysterectomy is more 
balanced, especially when avoiding the use of disposable instruments.  
Cost-effectiveness of the levonorgestrel-IUD over hysterectomy has been reported in women 
suffering menorrhagia. Although other medical treatments are less expensive, cost-effectiveness 
is less likely, due to their lower effectiveness. The costs of endometrial ablation and uterine artery 
embolization are lower as compared to hysterectomy, although the difference decreases over time 
due to the higher costs of re-treatments in the non-hysterectomy groups. 
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Abstract
The objective of this study was to investigate the randomized studies reporting on quality of life 
after laparoscopic hysterectomy as compared to abdominal hysterectomy.
A systematic qualitative review was performed on published studies identified by the databases 
PubMed and EMBASE, as well as cross-references. Randomized clinical trials on laparoscopic 
versus abdominal hysterectomy were assessed for the methods in which studies reported on 
postoperative health or quality of life as an outcome measure. Study results were described 
qualitatively. Thirty papers, published between 1994 and 2004 were identified. Only seven studies, 
incorporating data on 1,450 patients, reported on postoperative health or quality of life. Four of 
these studies used eight different validated quality of life questionnaires. Two of these four studies 
reported significant differences between the treatment groups, with better quality of life in the 
first six weeks after laparoscopic hysterectomy when compared to the abdominal approach.
Although the main reason for performing a laparoscopic hysterectomy instead of an abdominal 
hysterectomy is the improvement of quality of life, only few studies have used this as an outcome 
measure. The data available show that the laparoscopic hysterectomy performs equally or better 
in terms of postoperative health and quality of life in the first weeks after surgery. In the decision 
for an approach to hysterectomy, the advantage of better quality of life should be offset against 
the increased risk of complications in laparoscopic hysterectomy.
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Introduction
For decades, abdominal hysterectomy has been the standard method for removal of the uterus 
for benign gynaecological disease, in cases where vaginal surgery was not possible. It is a safe and 
effective treatment, but has the disadvantage of morbidity, hospitalization and costs. Laparoscopic 
hysterectomy was introduced in 1989 as an alternative for hysterectomy by laparotomy (1). 
The laparoscopic approach aims to reach equal medical effectiveness for quicker recovery. As a 
consequence, studies evaluating laparoscopic hysterectomy should take into account measures for 
recovery as one of the key clinical outcomes. Recovery is frequently reported on in terms of pain 
scores, duration of hospital stay and return to normal activities or work. Although postoperative pain 
is an outcome of clinical interest, the duration of hospital stay or return to work is dependent on local 
culture and social security support and hence they cannot be used as rigorous scientific outcomes. A 
meta-analysis of the three approaches to hysterectomy has previously used three primary outcomes: 
time taken to return to normal activities, major adverse surgical complications and major long-term 
complications. Quantitative estimates of the effects on quality of life were not provided (2;3).
Quality of life instruments aim to measure the impact of surgery on the patient’s life. They 
indirectly evaluate postoperative recovery by proxy, since there are at present no generally accepted 
postoperative recovery specific quality of life instruments. The purpose of the present study was 
to review randomized clinical trials comparing abdominal and laparoscopic hysterectomy on the 
approaches in which they have reported on postoperative health and quality of life. In view of the 
expected clinical and statistical heterogeneity with this outcome, our report will be qualitative 
rather than quantitative.
Materials and methods
A systematic literature search was performed, using both PubMed between January 1966 
and January 2006 and EMBASE between January 1980 and January 2006. Keywords used were 
‘randomized’ or ‘randomised’ and ‘laparosc*’ or ‘abdominal’ and ´hysterectomy’. Cross-references 
of the selected studies were checked to identify other studies. The studies had to be randomized 
clinical trials comparing laparoscopic and abdominal hysterectomy in humans. Both studies on 
benign and malignant disease were included. 
All studies were scored methodologically. This was done independently by two of the authors 
(KBK and BWJM). In each study inclusion and exclusion criteria, method of randomization, 
type of surgery and outcome measures were documented. Depending on the extent of the 
laparoscopic and the vaginal part of the procedure, we categorized the laparoscopic hysterectomies 
as laparoscopically assisted vaginal hysterectomy (LAVH), laparoscopic hysterectomy (LH(a)), 
total laparoscopic hysterectomy (TLH) and laparoscopic subtotal hysterectomy (LSH). The 
LAVH was defined as procedures where the laparoscopic component of the surgery extended 
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only down to the level above the uterine arterial pedicles, whereas LH(a) were cases where the 
laparoscopic dissection was performed to the level at least below the uterine arterial pedicles. In 
the TLH there was no vaginal component of the procedure other then removal of the uterus. The 
LSH were cases of subtotal hysterectomy (i.e. cervix retained), which were performed entirely 
laparoscopically (4). 
We checked whether there was concealment before randomization, and whether the study was 
performed according to the ’intention-to-treat’ principle. We evaluated the primary outcome of 
the studies. For this purpose, trials having peri- and postoperative course, data of the surgical 
procedures, complications and morbidity, pain and medication use or duration of hospital stay as 
primary outcome, were categorized as reporting on short-term medical outcomes. We then evaluated 
on whether these studies reported on postoperative health or quality of life as an outcome measure. 
We recorded the methods used for measurement of postoperative health and quality of life. We 
also collected information on the prior validation of the instruments used, the postoperative time 
interval at which these instruments were used, the response rate, the completeness of reporting 
of the results of the quality of life instruments and conclusions generated.  
Results
The PubMed-search revealed 670 studies, of which 29 fulfilled the inclusion criteria for this 
systematic review. The EMBASE search revealed 579 studies, of which 24 fulfilled the inclusion 
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Table 1. Characteristics of eight randomized studies reporting on postoperative health and quality of life.
First author  Year  Country Number   Inclusion criteria * Randomisation Concealment Blinding Intention to  Power Baseline  AH LH
   of centers     treat analysis analysis characteristics  
Raju (25) 1994 UK 1 B, uterine size < 14 wks Y Y NR NR Y Y TAH + BSO LAVH+BSO
Ellstrom (9) 1998 Sweden NR B, VH not suitable Y NR NR NR Y Y TAH LH(a)
Falcone (11) 1999 USA 1 B, uterine fundus > 2 cm below umbilicus Y Y N Y Y Y AH*** LH(a)
Lumsden (18) 2000 UK 3 B, uterine size > 14 wks or BSO Y Y NR Y Y Y TAH*** LAVH, LH(a) 
Schutz (28) 2002 Germany 1 Estimated uterine size**   > 200 g Y Y NR NR Y Y TAH LAVH, LH(a)
Ellstrom (10) 2003 Sweden 1 B, VH not suitable NR NR NR N Y Y TAH LH(a)
Garry (13), Sculpher (29) 2004 UK, South Africa 30 B, uterine size < 12 wks Y Y NR Y Y Y AH*** LAVH, LH(a), TLH, LSH
NR = not reported VH = vaginal hysterectomy LAVH = laparoscopically assisted vaginal hysterectomy
Y = yes LH = laparoscopic hysterectomy LH(a) = laparoscopic hysterectomy 
N = no AH = abdominal hysterectomy TLH = total laparoscopic hysterectomy 
B = benign disease TAH = total abdominal hysterectomy LSH = laparoscopic subtotal hysterectomy 
BSO = bilateral salpingo-oophorectomy 
  * denotes inclusion criteria for indication and uterine size 
 ** denotes sonographically estimated uterine weight 
***  denotes no description of technique
criteria. Out of these 24 studies, one paper had not been detected in the PubMed-search (5). 
Checking of cross-references did not reveal further studies. Thus, 30 papers on randomized 
controlled trials comparing laparoscopic and abdominal hysterectomy were included in our study 
(5-34).  The papers were published between 1994 and 2004 and reported on 3,016 women, of 
whom 876 women were included in the eVALuate trial which is the largest study on the topic 
(13;29). In 22 studies the primary outcome was a short-term medical measure. Other primary 
outcomes were costs (n=3) (9;21;29), tissue trauma or laboratory results (n=3) (6;7;34) and 
survival (n=1) (32). Only one study had disease specific quality of life as primary outcome (10). 
Eight further studies reported on postoperative health and quality of life as a secondary 
outcome (9;11;13;18;21;25;28;29). One of these studies was presented as an abstract (21). As 
confirmed by the author, the abstract dealt with the same patients and methods as a later published 
paper (9) and for this reason only the latter paper was taken into account in our study. Two papers 
reported on different quality of life outcomes in the same patient group of 876 patients (13;29). 
These two papers were considered as a single study. Thus, seven randomized controlled trials 
comparing laparoscopic hysterectomy to abdominal hysterectomy studied postoperative health or 
quality of life. They reported on 1,450 patients, of which 874 were randomized to the laparoscopic 
procedure and 576 to the abdominal procedure. Nineteen patients (LH n=9, AH n=10) were 
recruited into two studies by Ellstrom et al., which reported on different clinical outcomes i.e. 
cost analysis and quality of life (9) versus psychological wellbeing and sexuality (10). 
All patients were operated for benign disease. Further study characteristics and results of quality 
of life analysis are shown in Tables 1 and 2. In six studies (9;11;13;18;25;28), the randomization 
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Table 1. Characteristics of eight randomized studies reporting on postoperative health and quality of life.
First author  Year  Country Number   Inclusion criteria * Randomisation Concealment Blinding Intention to  Power Baseline  AH LH
   of centers     treat analysis analysis characteristics  
Raju (25) 1994 UK 1 B, uterine size < 14 wks Y Y NR NR Y Y TAH + BSO LAVH+BSO
Ellstrom (9) 1998 Sweden NR B, VH not suitable Y NR NR NR Y Y TAH LH(a)
Falcone (11) 1999 USA 1 B, uterine fundus > 2 cm below umbilicus Y Y N Y Y Y AH*** LH(a)
Lumsden (18) 2000 UK 3 B, uterine size > 14 wks or BSO Y Y NR Y Y Y TAH*** LAVH, LH(a) 
Schutz (28) 2002 Germany 1 Estimated uterine size**   > 200 g Y Y NR NR Y Y TAH LAVH, LH(a)
Ellstrom (10) 2003 Sweden 1 B, VH not suitable NR NR NR N Y Y TAH LH(a)
Garry (13), Sculpher (29) 2004 UK, South Africa 30 B, uterine size < 12 wks Y Y NR Y Y Y AH*** LAVH, LH(a), TLH, LSH
NR = not reported VH = vaginal hysterectomy LAVH = laparoscopically assisted vaginal hysterectomy
Y = yes LH = laparoscopic hysterectomy LH(a) = laparoscopic hysterectomy 
N = no AH = abdominal hysterectomy TLH = total laparoscopic hysterectomy 
B = benign disease TAH = total abdominal hysterectomy LSH = laparoscopic subtotal hysterectomy 
BSO = bilateral salpingo-oophorectomy 
  * denotes inclusion criteria for indication and uterine size 
 ** denotes sonographically estimated uterine weight 
***  denotes no description of technique
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Table 2. Data on the instruments used and the results of quality of life assessment.
First author  Number    QoL   Prior   Measurement  Response  Completeness    Study
 of instrument instrument interval rate of reporting group
 patients used validation   of QoL results favoured
Raju (25) LH n=40 Questioning  N 6 weeks 100% NR LH
 AH n=40      
Ellstrom (9)  LH n=38 * SF 36 health survey Y 1,3,12 weeks NR Y  LH
 AH n=38 *      
Falcone (11) LH n=24 Daily diary N 6 weeks NR N LH
 AH n=24      
Lumsden (18) LH n=100 Achievement  N 4 weeks 87% N Equal
 AH n=100 of milestones     
  VAS Euroqol 5D Y Baseline 95% Y Equal 
    1 month 78%  
    6 month 64%  
    12 month 47%  
Schutz (28) LH n=28 18 items   N 12 month NR N LH
 AH n=20 questionnaire       
Ellstrom (10) LH n=36 Psychological General  Y Baseline NR Y Equal  
 AH n=38 Well-Being Index  1 year   
 LH n=29 Mc Coy Scale Y Baseline NR N Equal
 AH n=33   1 year   
Garry (13) LH n=584 SF 12 health survey Y Baseline 76% Y LH
 AH n=292   6 weeks 50%  
    4 month 50%  
    12 month 50%  
  Body Image Scale Y Baseline 92% Y LH
    6 weeks 60%  
    4 month 55%  
    12 month 60%  
  Sexual activity  Y Baseline NR N LH
  questionnaire  6 weeks   
    4 month   
    12 month   
Sculpher (29) LH n=573 Euroqol 5D   Y Baseline NR Y Equal
 AH n=286 and QALYs  6 weeks     
    4 month   
    12 month   
N = no LH = laparoscopic hysterectomy QALYs = quality adjusted life years
Y = yes AH = abdominal hysterectomy 
NR = not reported QoL = Quality of Life  
*denotes undefined subgroup of trial population.
procedure was described adequately. However, in one of these studies only an undefined subset 
of 76 out of the 143 randomized patients was asked to fill out the SF 36 health survey without 
baseline measurement (9). Five (11;13;18;25;28) out of the six studies that described the 
randomization process reported adequate concealment by using a third party, sealed envelopes 
or telephone inquiry. None of the studies reported that they were set-up in a blinded fashion. 
Three studies were analyzed according the intention-to-treat principle (11;13;18). Two studies 
(25;28) did not provide information on the intention to treat analysis in spite of conversions from 
laparoscopic to abdominal hysterectomy in one of the studies (25). This leaves it unclear whether 
the patients with conversions were analyzed in the laparoscopic or abdominal hysterectomy group. 
Furthermore, one study neither provided information on intention to treat nor information on 
conversions (9). One study clearly did not follow the intention-to-treat principle (10). All studies 
presented a power analysis and patients’ baseline characteristics.
Different approaches to laparoscopic surgery were used, ranging from LAVH to TLH and 
LSH. Although three studies used more then one laparoscopic approach, the quality of life 
data were not presented per subgroup (18;28;13). In four studies (9;10;25;28) the abdominal 
procedure was only described briefly whereas the other three studies (11;13;18) did not provide 
any information on the surgical technique.
The following eight validated quality of life questionnaires were used: the SF 36 health 
survey (9), the Euroqol Visual Analogue Scale (18), the Psychological General Well-Being Index 
(10), the Mc Coy Scale (10), the SF 12 health survey (13), the Body Image Scale (13), Sexual 
Activity Questionnaire (13) and the Euroqol 5D (29). The SF-36 and SF-12 health surveys are 
generic health related quality of life questionnaires measuring perceived health status in eight 
dimensions which are grouped into two components: the physical and mental health summary 
measure. The EuroQol 5D is another generic health related quality of life instrument with the 
potential to calculate quality adjusted life years, which can be used in economic evaluation. The 
EuroQol Visual Analogue Scale is a separately validated part of the EuroQol 5D and measures 
health status in one question, which is answered on a zero to 100 visual analogue scale. The 
Psychological General Well-Being Index was developed to measure self-perceived psychological 
well-being (anxiety, depression, positive well-being, vitality, self-control and general health) in 
the general population. The Body Image Scale is a questionnaire addressing satisfaction with 
bodily appearance and changes that may have resulted from disease or treatment. The McCoy 
Scale and Sexual Activity Questionnaire assess sexual functioning in terms of activity, pleasure 
and discomfort. 
One study had a follow-up period of twelve weeks postoperatively (9), whereas the others 
included a measurement at one year postoperatively (10;13;18;29). Only two out of the four 
studies that used validated quality of life measurement resulted in significant differences between 
the treatment groups and showed better quality of life after laparoscopic hysterectomy in the 
early postoperative period, i.e. in the first six weeks (9;13). The first of these two studies, was by 
Ellstrom et al. on the SF 36 health survey. The study was powered to look for significant differences 
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in quality of life, and in two out of eight dimensions one week postoperatively and in four out 
of eight dimensions three weeks postoperatively the laparoscopic hysterectomy was favourable 
(9). However, the results were analyzed by unadjusted multiple testing for eight dimensions and 
three time points, which involves the risk of overestimation of the effects due to an increased 
type I error (9). The second study was the eVALuate study by Garry et al., in which laparoscopic 
hysterectomy was favourable at six weeks after surgery on all three questionnaires used (i.e. the 
Physical Component Summary of the SF 12 health survey, the Body Image Scale and the Sexual 
Activity Questionnaire), whereas no differences were found at one year after surgery (13). In 
this study the sample size calculation was based on the detection of differences in complications 
and not on differences in quality of life (13). This resulted in a large study population, where a 
clinically non-relevant difference in the secondary outcome became statistically significant. The 
follow up period was longer than six weeks in all studies, but no statistically significant differences 
between study groups were found beyond this time point. 
Four studies (11;18;25;28), especially the older studies, made use of non-validated 
measurement methods to evaluate postoperative health and quality of life, of which one 
study used both a validated and a non-validated method (18). These studies failed to describe 
the methods used (11;18;25) or did not adequately present the results (28), thus hampering 
interpretation of the data. Nonetheless, three out of four studies concluded that laparoscopic 
hysterectomy was more favourable over abdominal hysterectomy (11;25;28).
Comment
This systematic review summarized the available evidence comparing the quality of life 
after hysterectomy by the laparoscopic and abdominal approach. Although we found 30 papers 
describing randomized trials on this topic, only seven studies reported on the assessment of 
some form of quality of life. The few data available indicate that the laparoscopic procedure 
performs better or equally as far as quality of life is concerned. In the two studies where significant 
differences between study groups were found, this was on the short term, i.e. in the first six weeks 
after surgery.
Either in their introduction or discussion sections of the manuscripts, the postoperative 
recovery was stated to be quicker after laparoscopic hysterectomy in 24 studies. However, most 
of them failed to measure quality of life and postoperative health in an adequate way or failed to 
make use of validated instruments. As a consequence the systematic review and meta-analysis 
on this subject only reported on complication rates and return to normal activities, but not on 
the primary aim of laparoscopic surgery, i.e. whether quality of life in the short and long term 
was better following laparoscopic surgery (2). 
The same shortcoming came across in meta-analyses comparing other gynaecologic 
laparoscopic procedures, such as tubal sterilization, benign ovarian tumours, tubal ectopic 
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pregnancy and colposuspension, where data on quality of life where likewise lacking (35-38). 
Another issue of concern was the lack of uniformity on the use of the validated quality of 
life instruments amongst the few randomized trials that employed such outcome assessment. 
There is a necessity to standardize the quality of life instruments, which are suitable to measure 
postoperative recovery for studies comparing laparoscopic with conventional open surgery or 
other new surgical techniques. As postoperative differences in quality of life, disappeared in the 
longer term, a standard sequence of postoperative time intervals at which such instruments 
should be used would be helpful.
Laparoscopic hysterectomy is associated with quicker postoperative recovery and decrease 
of operative blood loss and febrile morbidity at the expense of an increased risk of urinary tract 
injuries (3). Whether these advantages can compensate for the extra risk of urinary tract injuries 
is an important issue. Data on quality of life can show the impact of surgery and complications 
on patient’s lives and thus be a leading argument in the discussion about the best way to perform 
a hysterectomy. The effect of the uterine size on postoperative quality of life in hysterectomy 
patients is not known until now. Due to the limited number of studies, we were not able to 
compare subgroups of patients with normal and enlarged uteri. However, the largest study 
in our review excluded patients with enlarged uteri, which might have influenced the better 
postoperative quality of life after laparoscopic hysterectomy in this study (13).
Although the main reason to perform laparoscopic surgery is the enhanced postoperative 
quality of life due to less physical impact, our present study shows that this outcome is usually 
not considered in randomized controlled trials on laparoscopic hysterectomy. Data from the few 
studies that report on quality of life, indicate that postoperative quality of life after laparoscopic 
hysterectomy as compared to abdominal hysterectomy is better or equal in the first six weeks 
after surgery and equal subsequently.  Women scheduled for hysterectomy, with a moderately 
enlarged and mobile uterus, should therefore be appropriately informed about the laparoscopic 
procedure and should have the opportunity to opt for this approach
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Abstract
Study objective
Minimal invasive surgery aims to achieve at least a similar clinical effectiveness with a quicker 
recovery. Although there have been numerous randomized clinical trials comparing laparoscopic 
hysterectomy with hysterectomy by laparotomy, only a few studies have compared quality of 
life after different types of hysterectomy. None of these studies evaluated total laparoscopic 
hysterectomy. In this paper we report on a randomized comparison of quality of life after total 
laparoscopic versus total abdominal hysterectomy. 
Design 
Randomized controlled trial (Canadian Task Force Classification I).
Setting
Single center teaching hospital in The Netherlands, experienced in gynecological minimal invasive 
surgery.
Methods
Patients scheduled for hysterectomy for a benign condition, in whom a vaginal hysterectomy 
was not possible and laparoscopic hysterectomy was feasible (mobile uterus not exceeding the 
size of 18 weeks’ gestation). 
Interventions
Abdominal versus laparoscopic hysterectomy.
Measurements and main results
Patients completed the Dutch version RAND-36 health survey pre-operatively as well as at five time 
points in the first 12 weeks after surgery. The primary outcome of the study was quality of life as 
measured by the RAND-36. A linear mixed model was used for statistical analysis while accounting 
for the baseline values. Secondary outcomes were hospital stay and complications. There were 88 
patients eligible, of whom 59 gave consent for randomization. Twenty-seven women were allocated to 
the laparoscopic arm and 32 to the abdominal arm. We found a significant treatment effect favoring 
laparoscopic hysterectomy in the RAND-36 scale for vitality. Laparoscopic hysterectomy performed 
better on all other scales of the RAND-36, but these differences were not statistically significant.
Conclusions
Laparoscopic hysterectomy results in more postoperative vitality when compared with abdominal 
hysterectomy. For this reason, all women with a benign condition requiring abdominal 
hysterectomy, in whom the laparoscopic approach is feasible, should have the chance to choose 
laparoscopic hysterectomy. 
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Introduction
Hysterectomy is the most frequently performed gynecologic operation. In case of hysterectomy 
for benign gynecological disease, vaginal hysterectomy should, whenever possible, be the first 
procedure of choice (1;2). In 1989 a laparoscopic approach to hysterectomy, as an alternative for 
abdominal hysterectomy was described by Reich (3). Laparoscopic hysterectomy (LH) is further 
divided in three categories: laparoscopic assisted vaginal hysterectomy (LAVH), in which vaginal 
hysterectomy is assisted by prior laparoscopy and the laparoscopic procedure does not include 
the occlusion of the uterine arteries; LH(a), laparoscopic hysterectomy, in which the laparoscopic 
part of the hysterectomy includes the occlusion of the uterine arteries; and total laparoscopic 
hysterectomy (TLH), in which the vaginal part of the operation is restricted to the removal of 
the laparoscopically freed uterus (4,5). 
In contrast to other implementations of laparoscopic interventions, laparoscopic hysterectomy 
is not well established (6). Laparoscopic hysterectomy has a longer learning curve, takes longer 
to perform and has a higher complication rate of urinary tract injury compared with abdominal 
hysterectomy, especially during the learning curve (7). On the other hand, there is less blood loss 
and febrile morbidity resulting in shorter hospital stay (2).
There have been 30 randomized trials published by now comparing laparoscopic and 
abdominal hysterectomy. However, in only five trials (8-12) were validated quality of life 
questionnaires used, of which two reported on the same patient group (10;12). Two trials (8;10) 
showed significantly better quality of life favoring laparoscopic hysterectomy, whereas the other 
three (9;11;12) did not show a difference. As different methods of quality of life assessment 
were used, the studies could not be pooled, as was demonstrated in a recent meta-analysis on 
the subject (2). In 2003, an expert committee on quality of life recommended use of the SF-36 
health survey in trials comparing post-hysterectomy health status (13). The RAND-36 health 
survey used in the present study is identical to the SF-36 health survey (14). Until now there has 
been only one randomized trial using this instrument and showing better quality of life after 
laparoscopy (8). However that study was performed without baseline measurement and in an 
undefined subset of the randomized patients after LH(a), not TLH. The eVALuate study, the most 
extensive study on quality of life after laparoscopic hysterectomy, had major complications as its 
primary outcome (10). Quality of life as measured by the SF 12 and Body Image Scale was studied 
as one of the secondary outcomes. The SF-12 yields less precise scores than does the SF-36, 
although this becomes less important in a large study as confidence intervals for group averages 
are largely determined by sample size (15). The eVALuate study showed better quality of life in 
the SF-12 Physical Component Summary at six weeks after surgery in the laparoscopic group. 
But still, the conclusion of the authors was that future studies on hysterectomy incorporating 
quality of life measurement were needed, especially those on TLH (16), which was confirmed 
in the meta-analysis on the subject (5). Furthermore, there are at present only few data on the 
surgical outcomes of TLH (5). 
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In the present paper, we present the results of a randomized controlled trial comparing TLH 
and total abdominal hysterectomy (TAH). We studied postoperative quality of life as measured 
by the RAND-36 health survey and the surgical outcomes of the two interventions. 
Methods 
Participants 
This randomized study was performed in the Máxima Medical Centre, a large teaching 
hospital with 865 beds in two locations in the south of The Netherlands, from August 2002 
through January 2005. The gynecologic department is experienced in minimal invasive surgery, 
and the first laparoscopic hysterectomy was performed in 1992. In the year 2000, before the 
inclusion started, the distribution of the three different approaches to hysterectomy in our 
clinic was 50% vaginal hysterectomy, 25% abdominal hysterectomy and 25% laparoscopic 
hysterectomy. 
For benign indications, a vaginal hysterectomy was performed when the size of the uterus 
did not exceed 12 weeks’ gestation with the cervix descending until at least halfway the vagina 
under cervical traction with a tenaculum forceps. In cases in which these conditions for vaginal 
hysterectomy were not met and the size of the uterus did not exceed  18 weeks’ gestation, patients 
were eligible for the study. Exclusion criteria were suspicion of malignancy, a previous lower 
midline incision, the need for simultaneous interventions like prolapse repair, and inability to 
speak Dutch. Written informed consent was required. We obtained approval for the study from 
the ethics committee of the Máxima Medical Center.
Surgical procedures 
All patients had general anesthesia and received preoperative antibiotic prophylaxis as well 
as anticoagulants during immobilization. Operations were either performed by gynecologists or 
residents in training supervised by gynecologists. The laparoscopic procedures were performed 
or supervised by three experienced gynecologists who were trained in Clermont-Ferrand, France 
and had performed at least 100 laparoscopic hysterectomies each before the start of the study. 
The laparoscopic procedures were intentionally TLH procedures. The performed procedures were 
subdivided in LAVH, LH(a) and TLH  as described above (2). In addition to the port for the 
camera at the umbilicus or 10 cm above, three trocars were inserted for instrumentation. The 
uterus was manipulated by the Karl Storz Clermont-Ferrand manipulator (Karl Storz, Tuttlingen, 
Germany). All vascular pedicles were secured by bipolar coagulation and divided with the use of 
scissors. Scissors in combination with monopolar coagulation was used to open the bladder flap. 
The bladder was dissected with scissors as well as bluntly from the cervix and upper part of the 
vagina. The cervix was separated from the vagina making use of a monopolar needle over a rotating 
vaginal blade. Laparoscopic extracorporeal knots (vicryl) were used to close the vagina. 
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The abdominal hysterectomies were performed or supervised by 10 different experienced 
gynecologists. A transverse incision was made, and hysterectomy was performed using the 
extrafascial technique by means of clamps and suture ligation. 
Quality of life
The primary outcome of this study was quality of life as measured by the Dutch version 
RAND-36 health survey until 12 weeks after surgery. The RAND-36 is a generic health related 
quality of life questionnaire, which is validated for the Dutch language. The questionnaire 
measures subjective health in eight scales, which range from 0-100. Thus the total score ranges 
from 0 to 800, where 0 is the poorest quality of life and 800 the best imaginable. Summated ratings 
and standardized scoring algorithms were used to assess the eight scales (17). Patients completed 
the baseline measurement after randomization. Postoperative measures were made at one, two, 
four, six and twelve weeks after surgery. Patients filled out the questionnaires without assistance 
of the researcher and returned the questionnaires by mail. 
Secondary outcomes
The peri- and postoperative course, including surgical details, complications and duration of 
hospital stay, were secondary outcome measures of the study. Data were collected prospectively 
by completion of a standardized case record form by the surgeon and researchers. The 
anesthesiology team recorded the amount of blood loss and operation times. Conversions 
from laparoscopy to laparotomy were not seen as a complication and were described separately. 
We defined complications as adverse effects during and after surgery. All complications were 
collected prospectively in the first six weeks after surgery and according to a predefined list in 
case record forms. Complications were recorded ad hoc beyond these six weeks, and there had to 
be a reasonable relationship to the hysterectomy. Data on visceral damage, re-operations, major 
and minor anesthesia problems and trombembolism were collected. Complications of bleeding 
were split up in four groups: hemorrhage requiring transfusion, blood loss greater than 1000 
mL without transfusion, major hematoma needing and major hematoma not needing surgery. 
We defined several categories of infections: urinary tract infections that had to be treated with 
antibiotics in hospital or by the general practitioner in the first six weeks; wound infections were 
infections with pus drainage; pelvic infections should have pus drainage or the combination 
of fever and ultrasound confirmation of an abscess; chest infections had to be confirmed by 
radiograph and there was a category of other infections (e.g. serious infection of the infusion 
site). Fever was defined as a temperature 38°C or higher on two time points at least 12 hours apart 
and had to occur beyond the first postoperative day to be regarded as a complication. Cervical 
stump problems were defined as unintended subtotal procedures. Wound dehiscence was defined 
as visceral herniation with and without restoration.
The postoperative care was administered according to local protocols, and the researchers did 
not interfere. The urinary catheter was removed on the morning after surgery. The hemoglobin 
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was measured prior to surgery and on day 1 after hysterectomy. Data on the use of medication 
in the first 3 postoperative days were collected from the nursing chart. Analgesics were given 
according to a standardized post-anesthesia protocol using a zero-to-10 visual analogue scale for 
pain, where patients were offered analgesics in case of a pain score at rest above three. Patients 
were discharged when they were free of fever; did not need systemic analgesics; had normal 
micturition and normal defecation; and were able to eat, drink and mobilize.
Sample size and randomization
Before the start of the study, the sample size was calculated for the quality of life as measured 
by the questionnaire RAND-36. A difference of 15 per scale (8) was considered as  clinically 
relevant. With a standard deviation of 20, a type I error of 0,05, and 80% power, 28 patients 
were needed per arm. 
After obtaining written informed consent, randomization took place by opening numbered, 
sealed opaque envelopes. For concealment an independent person had randomly assigned an equal 
number of 38 papers with either intervention to the envelopes. The closed envelopes were shuffled 
before numbering. The patients and medical team were not blinded to the intervention. 
Statistical methods
Analysis of the data was performed on intention-to-treat basis. Correlations among the 
patients’ baseline characteristics (age, body mass index (BMI), parity, American society of 
Anesthesiologists (ASA) score, and uterus weight) were calculated using Spearman’s correlation 
coefficient. Differences in medical outcome between the two treatment groups were tested for 
statistical significance using the t-test in case of normally distributed data, Mann Whitney U 
test in case of non-normally distributed data and the Fishers-exact test in case of two by two 
tables. The  means and standard deviations are presented in case of normally distributed data, 
the medians with the range in case of non-normally distributed data and absolute numbers with 
percentages in case of  dichotomous variables.
Cronbach’s alpha of each scale of the RAND-36 at baseline was calculated to assess the 
internal consistency. A linear mixed model was used to study the differences in recovery from 
two to twelve weeks after surgery between the two groups while accounting for the baseline 
values, for each of the scales of RAND-36, separately (18). The dependent variable was the 
scale of RAND-36. The independent class variables were patient and treatment (laparoscopic 
and abdominal hysterectomy, respectively) and the independent regression variables were the 
RAND-36 baseline level and time in weeks after surgery. Both the intercept and the regression in 
time of each patient were treated as random variables in the model. This way differences between 
treatments are estimated given the baseline value, while differences in recovery among patients 
are allowed. Initially interaction terms and quadratic terms in time were included in the linear 
part of the model; but as the inclusion did not significantly (Likelihood-Ratio test) improve the 
fit to the data, these terms were not included in the final model used (18). Note that, excluding 
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the interaction term of group with time, results in a parallel line model, (i.e. the increase per week 
is estimated to be identical in both groups). The estimated regression parameters with standard 
errors of each RAND-36 score are used to calculate the average level per week of the patients in 
each group. These levels with confidence bands are further presented in figures. 
The quality of life data were analyzed by SAS 10.0 software (SAS Institute, Inc., Chicago, IL), 
all other data in SPSS 13.0 software (SPSS, Inc., Chicago, IL), with p-values ≤ .05 considered 
statistically significant.
Results 
The study population
A flowchart of the study is shown in Figure 1. We randomized 59 women, of which 27 were 
allocated to the laparoscopic arm and 32 were allocated to the abdominal arm. One woman 
allocated to the laparoscopic procedure refused the laparoscopy after randomization and an 
abdominal hysterectomy was performed. Her data were analyzed in the laparoscopy group 
according to the intention to treat principle. Patient characteristics and surgical indications are 
shown in Table 1. A statistically significant correlation was found between BMI and ASA score 
in both groups (LH .46, AH .62). All other correlations in the patients’ characteristics were less 
than or equal to .34.
Quality of life
The overall return rate of the questionnaires was 91% in the laparoscopic group and 97% 
in the abdominal group. The Cronbach’s alpha for the eight scales, two summary measures and 
total RAND-36 score at baseline were all high, ranging from .74 to .93.
In Figure 2 the observed and estimated scores from two to twelve weeks after surgery, as 
well as the observed baseline and one-week scores of the total RAND-36 score are presented. 
In both groups, a linear increase from two until twelve weeks after surgery was revealed. The 
estimated increase of RAND-36 level (95% confidence interval) by treatment group, by unit 
increase in baseline score and per week after surgery on the eight RAND-36 scales and total 
score are shown in Table 2. The presented difference between the treatment groups is after 
correction for differences in baseline values between the groups. For all items, the regression 
lines for the laparoscopic group (continuous line) were on a higher level as compared with 
the abdominal group (broken line) for all RAND-36 scales, indicating better quality of life. 
However, when accounting for differences at baseline, this difference is statistically significant 
only in the scale vitality, where the estimated difference over time measures 12.0 units on a scale 
of 100, with a 95% confidence interval of 4.7 to 19.3 units. The scores on the vitality scale are 
presented in Figure 3. As the difference exists over a period of 10 weeks, this may be seen as a 
clinically relevant difference. In the scales physical functioning and bodily pain, as well as in the 
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RAND-36RAND-36
Baseline n = 27
 1 week n = 27
 2 weeks n = 26
 4 weeks n = 26
 6 weeks n = 25
12 weeks n = 22  
Abdominal
hysterectomy
(n = 32)
 Return to theatre 2          
Laparoscopic
hysterectomy
(n = 27)
Pre-operative conversion 1
Intra-operative conversion 2
Informed consent for randomisation
 (n = 59)
 Patients eligible
 (n = 88)
Baseline n = 32
 1 week n = 32
 2 weeks n = 32
 4 weeks n = 31
 6 weeks n = 30
12 weeks n = 30  
Figure 1. Flowchart of the trial population
Table 1. Patient characteristics and surgical indications by treatment group.
 LH (n=27) AH (n=32)
Age (yrs)  46.0 ± 7.3  45.2 ± 6.0 
BMI (kg/m2)  26.0 ± 4.5  26.5 ± 3.8 
Parity 1.8 ± 1.1  1.4 ± 1.1 
ASA score 1.4 ± 0.6  1.4 ± 0.6 
Uterine weight (g) 281 [62-1066] * 173 [40-468] *
Primary indication for surgery  
Bleeding disorders  21 (78%) ** 27 (84%) **
Dysmenorrhoea 4 (15%) ** 5 (16%) **
Other 2 (7%) ** 0 
AH = abdominal hysterectomy;  ASA = American society of Anesthesiologists;  
BMI = body mass index;  LH = laparoscopic hysterectomy.
Data shown as mean ± standard deviation, * median (range), ** absolute numbers (percentage).
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Table 2. Estimated increase of RAND-36 level (95%confidence interval) by treatment group, by unit increase in 
baseline score and per week, using a linear mixed model.
RAND-36 Difference * in favor  Baseline effect** Increase per week after 
 of LH  surgery in each group***
Physical functioning 7.8 (-0.3;15.9) 0.11 (-.07;.29) 4.1 (3.5;4.6)
Social functioning 7.0 (-1.8;15.7) 0.36 (.15;.57) 3.4 (2.7;4.1)
Role physical 1.7 (-7.7;11.1) 0.07 (-.04;.18) 4.6 (3.2;6.1)
Role emotional 1.5 (-13.4;16.5) 0.18 (.00;.36) 2.2 (1.1;3.4)
Mental health 3.6 (-2.8;9.9) 0.36 (.17;.56) 0.7 (0.3;1.2)
Vitality 12.0 (4.7;19.3) 0.27 (.10;.45) 2.1 (1.6;2.6)
Bodily pain 8.4 (-0.1;17.4) 0.39 (.18;.60) 3.4 (2.6;4.2)
General health 0.0 (-8.1;8.1) 0.49 (.27;.72) 0.23 (-.16;.62)
Total RAND-36  49.6 (-5.1 ; 104.2) 0.24 (0.05 ; 0.42) 20.8 (16.6 ; 24.9)
LH = Laparoscopic Hysterectomy; RAND-36 = RAND 36-Item Short Form Health Survey.
*Difference between groups after correction for baseline differences. **The baseline effect is the increase in postoperative 
score per unit increase at baseline.  *** Because the data fit very well to the parallel-line model the increase per week is 
estimated to be identical in both groups (see also figure 2 and 3).
Example: On average the estimated level of the total RAND-36 score in the laparoscopic hysterectomy group was 49.6 units 
higher as compared with the abdominal hysterectomy group, at each time point from two until twelve weeks after surgery. 
The estimated increase per unit higher level in the total RAND-36 score at baseline between two patients was 0.24, this is 
independent of both time point and treatment group. Furthermore, the estimated increase in the total RAND-36 score per 
week in both groups was 20.8 units. 
Table 3. Data on surgical procedures by treatment group.
 LH (n=27) AH (n=32) p
Laparoscopic procedures
LAVH 1 (4%)  –   –
LH(a) 2 (7%)  –   –
TLH 21 (78 %)  –   –
Preoperative conversion 1 (4%)  –   –
Intra operative conversion 2 (7%)  –   –
Resident 1st surgeon 11 (39%) 28 (88%)  < 0.01 
Readmissions 2 (7%) 2 (6%) 1. 0
Return to theatre 0  2 (6%) 0.50
Operation time (min) 121 ±36 * 78 ±27 * < 0.01 
Operation time incl. re-operations (min) 121 ± 36 * 90 ± 60 *  0.02
Blood loss (mL) 200 [0-650] ** 300 [100-1100] **  0.01
Patients receiving opoids  10 (37%) 22 (69%)  < 0.01
Patients receiving antiemetics  2 (7%) 8 (25%)   0.07
Hospitalization (days) 4 .2 ± 1,3 * 5 .4 ± 2,4 *  0.02
Hospitalization incl. readmissions (days) 4 [2-25] ** 5 [3-34] **  0.02
AH=abdominal hysterectomy; LH=laparoscopic hysterectomy; LAVH=laparoscopic assisted vaginal hysterectomy, in which vaginal 
hysterectomy is assisted by prior laparoscopy and the laparoscopic procedure does not include the occlusion of the uterine 
arteries; LH(a)=laparoscopic hysterectomy, in which the laparoscopic part of the hysterectomy includes the occlusion of the 
uterine arteries; TLH=total laparoscopic hysterectomy, in which the vaginal part of the operation is restricted to the removal 
of the laparoscopically freed uterus; – =not applicable.
Data shown as absolute numbers (percentage), *mean ± standard deviation, ** median [range]. p=p-value for difference 
between groups using Fisher’s exact test in cases of two-by-two tables, t-test in cases of normal distributed variables and 
Mann-Whitney test in cases of non-normal disrtibuted variables.
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Table 4. Number of complications by treatment group.
Complications LH (n=27) AH (n=32) p
Ureteric injury 1 (4%) 0 0.46
Bladder injury 1 (4%) 2 (6%) 1.0
Anesthesia problems 0 1 (3%) 1.0
Hemorrhage (with transfusion) 0 2 (6%) 0.50
Blood loss >1000 cc (no transfusion) 0 1 (3%) 1.0
Hematoma (needing surgery) 0 0 –
Hematoma (resorption) 0 5 (15%) 0.06
Pulmonary embolus 0 1 (3%) 1.0
Infection or fever  3 (11%) 7 (21%) 0.32
Cervical stump problems 0 1 (3%) 1.0
Others 1 (4%)  a 3 (9%)  b 0.62
Total complications  6 23  –
No of patients with complications 6 (22%) 17 (53%)  0.02  
AH = abdominal hysterectomy; LH = laparoscopic hysterectomy; -- = not applicable; a = local treatment of granulation tissue in 
the top of the vagina (n = 1); b = temporary lesion of the plexus lumbalis caused by an injury at the height of the m. psoas (n=1), 
dyspnoea and low oxygenation resolved with temporary oxygen therapy (n=1) and deterioration of colitis ulcerosa (n=1).
Data shown as absolute numbers (percentage). p=p-value for difference between groups using Fisher’s exact test.
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Figure 2. Observed total RAND-36 scores and estimated regression lines by treatment group, using a linear mixed 
model that accounts for the baseline value.
49
Quality of life after TLH vs TAH
total RAND-36 score the lower limit of the 95% confidence interval is near zero, which shows 
borderline significance.
Quality of life as measured by the RAND-36 decreased after surgery in both groups. The 
RAND-36 baseline levels differed significantly, but the one-week levels in both treatment groups 
were remarkably similar. In the laparoscopic group, the RAND-36 levels started to increase 
beyond the first week, whereas in the abdominal group they started to increase only beyond 
the second week. This suggests a greater impact of surgery on the patient’s quality of life in the 
abdominal group.
Secondary outcome - The surgical outcome
Data on the procedures are presented in Table 3. The two intraoperative conversions from 
laparoscopy to laparotomy were related to the size of the uterus in both patients. One of these 
patients suffered a urinary tract infection and no other complications occurred. In the abdominal 
group, one procedure was performed subtotal because of difficult access to the operation field. 
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Figure 3. Observed RAND-36 scores on the vitality scale and estimated regression lines by treatment group, using 
a linear mixed model that accounts for the baseline value.
Intraoperative complications in the laparoscopic hysterectomy group consisted of a bladder 
lesion due to severe endometriotic scarring, which was treated by laparoscopic suturing. In the 
abdominal hysterectomy group one severe allergic reaction of unknown origin occurred. In both 
groups, there was an equal drop in hemoglobin and hematocrit. Significantly fewer patients in 
the laparoscopic group needed opoids in the first two postoperative days as compared with the 
abdominal group (37 vs 69%, p≤.01). Furthermore, fewer patients needed antiemetics (resp. 
7% and 25%). On the third postoperative day none of the patients in either group needed any 
opoids or antiemetics. In the laparoscopic hysterectomy group, 59% of the patients versus 31% 
of the patients in the abdominal hysterectomy group were discharged on day two, three or four 
days after surgery (p=.03). Two patients in each treatment group were readmitted; these were 
the patients who had suffered urinary tract lesions.
The registration of complications is presented in Table 4. Within one-week postoperatively, 
one patient in the laparoscopic hysterectomy group presented with urinary loss through the 
vagina caused by a fistula of the right ureter. This was treated uneventfully with a double-J catheter 
for 4 weeks. Evaluation of the video of the procedure led to the conclusion that a coagulation 
lesion of the ureter must have occurred during bipolar coagulation of the uterine artery on the 
right side using the contra lateral (left) lateral port site. In the abdominal hysterectomy group 
two bladder fistulas occurred. One patient needed a relaparotomy, whereas the other needed two 
relaparotomies for repair. One patient in the laparoscopic group had a wound dehiscence of the 
10 mm lateral port site, which was not repaired at the end of follow up. Histological findings of 
the uterus showed myoma or adenomyosis in 89% of patients after laparoscopic hysterectomy 
versus 87% after abdominal hysterectomy.
Discussion
We conducted a randomized controlled trial to establish the difference in quality of life after 
TLH and TAH in the patients suitable for both types of hysterectomy. After baseline correction, 
we report a significant difference in postoperative vitality favoring laparoscopic hysterectomy. 
This difference between the treatment groups was present all along the recovery period until 
twelve weeks after surgery. The vitality scale is composed of questions on fatigue and loss of 
energy. These are important factors in the post-hysterectomy period, as fatigue is known to 
occur more frequently and persist twice as long as compared with pain (19;20). Borderline 
significant differences, also favoring laparoscopic hysterectomy, were found in the RAND-36 
scales of physical functioning and bodily pain, as well as in the total RAND-36 score. In agreement 
with previous reports, we found that the laparoscopic procedure took longer to perform, but was 
equal or favorable as compared with abdominal hysterectomy on all other parameters. 
The RAND-36 is the most suitable instrument to measure post-hysterectomy quality of life 
(21), and our data are directly comparable to RAND-36 and SF-36 data from other studies (17;22). 
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Ellstrom et al. (8) studied the SF-36 in patients who had undergone hysterectomy, but analyzed 
the results by multiple statistical testing for the eight scales and for the three postoperative time 
points. This involved the risk of overestimation of the effects due to an increased type I error. 
Furthermore, they did not take baseline values into account. The present study shows better 
quality of life after laparoscopic hysterectomy even after correction for baseline measurement 
and multiple measure moments. 
The vast majority of hysterectomy is performed for benign indications, which makes 
assessment of quality of life in research on hysterectomy an issue of utmost importance (20). 
It is surprising that so little studies on laparoscopic hysterectomy report on quality of life, as a 
better quality of life is the main reason for a laparoscopic approach. While our study was ongoing, 
the results of the eVALuate trial were published in 2004, and a meta-analysis on the subject was 
published in 2005 (2;10). As the eVALuate study was powered to find differences in complications, 
a large sample of over 800 women was studied. As a consequence, clinically irrelevant differences 
in the quality of life outcome became statistically significant. In the meta-analysis, the data on 
postoperative quality of life could not be presented due to missing and heterogeneous data. 
Thus our study can still fill the gap in published data on post-hysterectomy quality of life. The 
difference in quality of life all along a postoperative period of 10 weeks may be seen as a clinically 
relevant difference in a reasonable sample. 
A disadvantage of our study is that the patients, who were not blinded to the procedure, 
completed the baseline measurement after hearing the result of the randomization. At 
this time point we found a statistically significant lower RAND-36 score in the abdominal 
hysterectomy group as compared with the laparoscopic hysterectomy group. There were no 
further differences in baseline characteristics that could account for the difference, including 
pre-existing psychopathology. Furthermore, we asked the patients whether they disliked the idea 
of the operation and found an equal percentage doing so in both groups. This indicates that the 
difference is not due to disappointment or fear of the abdominal procedure, which would be a 
treatment effect (23).  To deal with the difference at baseline, we applied a statistical technique 
with a correction for the RAND-36 baseline level as described in the methods section. Still, we 
found a statistically significant treatment effect for patients with the same baseline levels in the 
different treatment groups. 
The percentage of operations performed by a resident in training was significantly higher 
in the abdominal hysterectomy group, which will be a reflection of daily clinical practice in 
teaching hospitals. Furthermore, we could confirm most data on surgical outcome from earlier 
studies. The hospital stay was significantly shorter in the laparoscopic group. Conversions were 
not regarded as complication, because they are inherent to laparoscopic surgery (24). We had a 
large number of complications in our study, both minor and major complications. Because our 
study was prospective, under-reporting is less likely than in retrospective studies. 
The finding that quality of life was better after laparoscopic hysterectomy goes hand in 
hand with a higher complication rate in laparoscopic hysterectomy. A meta-analysis reported a 
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significant 2.6-fold increased risk of urinary tract injury. Dependent on patient preference, this 
should be weighted against the improved quality of life in individual cases.
The lifetime risk of a woman to undergo hysterectomy ranges from 10% to 30% among 
different countries. The approach of hysterectomy is varying even more (1). This study suggests 
that in case of abdominal approach, patients may benefit from a total laparoscopic hysterectomy 
when feasible. 
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Abstract 
Study objective
To assess the incidence of urinary incontinence, bowel dysfunction and sexual problems following 
laparoscopic hysterectomy as compared with abdominal hysterectomy. 
Design
Randomized controlled trial (Canadian Task Force Classification I).
Setting
Single centre teaching hospital in The Netherlands, experienced in gynecological minimal access 
surgery.
Patients
Women with a benign or malignant condition scheduled for hysterectomy where vaginal 
hysterectomy was not feasible and laparoscopic hysterectomy was possible.
Interventions
Laparoscopic (n=38) and abdominal hysterectomy (n=38).
Measurements and main results
Patients were asked pre-operatively and three month after surgery whether they experienced 
urinary incontinence and completed the validated questionnaires Urogenital Distress Inventory 
(UDI), Incontinence Impact Questionnaire (IIQ), Defecatory Distress Inventory (DDI) and the 
Questionnaire for screening Sexual Dysfunctions (QSD) one year after surgery. The incidence of 
urinary incontinence at three month after surgery decreased equally in both groups as compared 
with baseline. De novo urinary incontinence and sexual problems were rare. One year after 
surgery, a significant treatment effect favoring laparoscopic hysterectomy was found in the UDI 
and IIQ, whereas no differences were found in the DDI and QSD. 
Conclusion
Laparoscopic hysterectomy is superior to abdominal hysterectomy with respect to postoperative 
symptoms of urinary dysfunction.
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Introduction
Pelvic organ dysfunctions, such as urinary incontinence, bowel dysfunction and sexual 
problems, are a major health care problem with a large impact on the patients’ quality of life 
(1). Because hysterectomy is the most frequently performed gynecologic operation, it is crucial 
to know the effects of various approaches to hysterectomy on pelvic organ function. Whether 
hysterectomy is a risk factor for pelvic organ dysfunction and particularly urinary incontinence 
has been a matter of debate (2-4). Large epidemiologic, cross sectional studies have shown an 
increased risk of urinary incontinence in women with previous hysterectomy (4). It is only since 
recently that data from large prospective studies have become available (3). They have shown 
that non-radical or simple hysterectomy, that is, hysterectomy performed for other reasons than 
cervical carcinoma, do not affect bowel function and sexual function. For urinary incontinence 
even a reduction was found (3-5). However, it is not known whether the route of hysterectomy 
is a factor in this. 
Laparoscopic hysterectomy has been introduced as an alternative to abdominal hysterectomy 
in patients where vaginal hysterectomy is not feasible. Although many randomized controlled trials 
comparing laparoscopic and abdominal hysterectomy have been published, none of the studies 
reported on urinary and bowel dysfunctions. Two studies, however, considered questionnaires 
on sexual function as an outcome measure (6;7). Whereas the eVALuate trial showed a significant 
favorable sexual activity habit score at six weeks after laparoscopic hysterectomy as compared 
with abdominal hysterectomy in the Sexual Activity Questionnaire (7), no differences were found 
in either the Mc Coy Scale (6) or the Sexual Activity Questionnaire (7) at one year after surgery. 
Two prospective observational studies on pelvic organ function following hysterectomy have 
included laparoscopic hysterectomy patients (8;9). Whereas one study did not find differences 
between the abdominal, vaginal and laparoscopic hysterectomy groups (9), the other reported 
laparoscopic hysterectomy patients to be at a twofold increased risk of reporting severe urinary 
incontinence five years after surgery when compared with patients undergoing abdominal and 
vaginal hysterectomy (8). Furthermore, there is one report on factors influencing postoperative 
urinary function following laparoscopic hysterectomy. In a study by Long et al. patients undergoing 
laparoscopic hysterectomy were randomized to concomitant vaginal cuff suspension versus 
no suspension (10). In this study clamping the uterosacral ligament complex and closing the 
vagina was always performed vaginally. The intervention of the trial was the anchorage of the 
ligament complex to the vaginal cuff versus no anchorage. A positive effect on incidence of urinary 
incontinence was seen in the group with this cuff suspension. 
The consequences for pelvic organ function of the different approaches to hysterectomy and 
especially laparoscopic hysterectomy are still under debate. In this article we present the results of 
a randomized controlled trial in which the effects of laparoscopic hysterectomy and abdominal 
hysterectomy on urinary function, bowel function and sexuality are compared. 
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Materials and methods: 
Setting and patients
This randomized study was performed in the Máxima Medical Centre from August 2002 
until January 2005. The local ethics committee approved the study. The Máxima Medical Centre 
is a large teaching hospital with 865 beds on two locations in the south of The Netherlands. The 
gynecologic department is experienced in minimally invasive surgery and the first laparoscopic 
hysterectomy was performed in 1992. Before the start of the study, the distribution of the three 
different approaches to hysterectomy in the department was 50% vaginal hysterectomies, 25% 
abdominal hysterectomies and 25% laparoscopic hysterectomies. 
The criteria for the different approaches to hysterectomy were as follows: a vaginal hysterectomy 
was performed for benign indications in case the size of the uterus was not exceeding 12 weeks’ 
gestation with the cervix descending until at least halfway the vagina under cervical traction with 
a tenaculum forceps. In case these conditions for vaginal hysterectomy were not met and, on the 
other hand, the uterus was not exceeding the size of 18 weeks’ gestation, patients were scheduled 
for laparoscopic hysterectomy. In case the uterus was above this size an abdominal hysterectomy 
was performed. In case of atypical hyperplasia or endometrial carcinoma, patients were counseled 
for a laparoscopic hysterectomy, unless there was suspicion of advanced endometrial carcinoma 
beyond stage I. 
All patients with benign and malignant disease, where vaginal hysterectomy was not possible 
and laparoscopic hysterectomy was feasible in terms of the criteria as mentioned above, were 
eligible for the study. Exclusion criteria were a previous lower midline incision, the need for 
simultaneous interventions such as anti incontinence procedures and prolapse repair and inability 
to understand Dutch. Written informed consent was obtained in every patient. No standardized 
information on pelvic floor alteration due to surgery was provided during consent for surgery. 
In case the issue was discussed pre-operatively, the patients were informed that no significant 
changes were to be expected.
The laparoscopic procedures were all intentionally total laparoscopic hysterectomies (TLH). 
The surgical technique has been described in detail before (11). The abdominal hysterectomies 
were performed through a transverse incision using the standard extrafascial technique. There 
was an equal dissection of pelvic tissues in the laparoscopic as compared with the open technique. 
No fixation of utero sacral ligaments or other form of vaginal cuff suspension was undertaken in 
either technique. Details on the procedures and short-term generic health related quality of life 
of the patients with benign indications for hysterectomy have been published previously (11).
Outcome measures
In this study we report on pelvic organ function as measured by the disease specific quality 
of life questionnaires Urogenital Distress Inventory (UDI), Incontinence Impact Questionnaire 
(IIQ), Defecatory Distress Inventory (DDI) and the Questionnaire for the screening of Sexual 
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Dysfunctions (QSD) one year after surgery, of which the UDI was regarded as the primary outcome 
measure. The questionnaires were previously validated for the Dutch language (1;12;13). 
The UDI consists of 11 items and five scales on bothersome urinary complaints. The IIQ 
consists of 13 items and measures the impact of urinary incontinence on quality of life in five 
scales. The DDI measures bothersome defecatory complaints, which consists of 10 items and 
four scales. The score on each scale of these questionnaires ranges from 0-100, where 0 indicates 
the best quality of life and 100 indicates the poorest quality of life. 
Sexually active women were asked to complete the QSD. The QSD consists of 36 items, but 
in our study only 12 questions (14) concerning bothersome problems with lubrication, orgasm, 
pain or unpleasant sensations in the genital area and arousal were analyzed. Symptoms were 
considered to be bothersome when scored I am bothered, I am much bothered or I am severely 
bothered (14;15). 
Furthermore, the women completed written questions on urinary incontinence and sexuality 
prior to surgery and 12 weeks post-operatively. Patients were asked whether they experienced 
urinary incontinence. In case urinary incontinence was present, they were asked whether this 
was related to physical effort such as coughing and sneezing (stress urinary incontinence) and/
or when feeling the urge to void (urge urinary incontinence). Patients experiencing stress and 
urge incontinence were categorized as mixed incontinent. Furthermore, the patients were asked 
whether they were satisfied with their sexuality. In case a question was not completed at both time 
points, the data were excluded. Twelve weeks after surgery, the women were asked whether their 
sexuality had changed since the hysterectomy and in case it had, whether this was in a positive 
or a negative sense. Patients filled out the questionnaires without assistance of the researcher 
and returned them by mail. 
Sample size and randomization
A difference of 15 units in each scale of the UDI, IIQ and DDI was considered as a clinical 
relevant difference (1;16). With standard deviation 20 units, a type I error of 0.05 and 90% power, 
38 patients were needed per arm.  The study was part of a study on generic health related quality 
of life after hysterectomy (11).
After obtaining written informed consent, randomization took place by opening numbered 
sealed opaque envelopes. It was not possible to blind the patients and medical team for the 
intervention. 
Statistical methods
Analysis of the data was performed on intention to treat basis. Means, standard deviations 
and 95% confidence intervals are presented in case of normally distributed data, medians and 
range or means and 25th and 75th percentile in case of non-normally distributed data and absolute 
numbers and percentages in case of  dichotomous variables. Differences between the treatment 
groups were tested for statistical significance using Mann Whitney test in case of non-normally 
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distributed data. Dichotomous data were analyzed by the Chi-square test (between groups) and 
the McNemar test (within groups).  Software package SPSS 13.0 (SPSS, Inc., Chicago, IL) was 
used for statistical analysis. P-values < 0.05 were considered statistically significant.
Results 
The study population
A flowchart of the study is shown in Figure 1. One hundred and twenty patients were eligible 
of which 76 gave informed consent for randomization. Thirty-eight patients were allocated to 
the laparoscopic arm and 38 to the abdominal arm. One woman allocated to the laparoscopic 
procedure refused the laparoscopy after randomization, and an abdominal hysterectomy was 
performed. Her data were analyzed in the laparoscopy group according to the intention to treat 
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RAND-36RAND-36
Abdominal
hysterectomy
(n = 38)
 Return to theatre 2          
Laparoscopic
hysterectomy
(n = 38)
Pre-operative conversion 1
Intra-operative conversion 3
Informed consent for randomisation
 (n = 76)
 Patients eligible
(n = 120)
Baseline n = 37
12 weeks n = 32
One year n = 35  
Baseline n = 38
12 weeks n = 36
One year n = 32  
Figure 1. Flowchart of the trial population.
principle. Patient characteristics and operation indications are shown in Table 1. Eleven patients 
in both groups (29%) had a fibroid uterus between 12 and 18 weeks’ gestation.
There were three intra-operative conversions from laparoscopy to laparotomy, which were 
related to difficult access due to the uterine size twice and due to obesity once. In the laparoscopic 
group one patient had a bladder injury, which was sutured laparoscopically and one patient had a 
ureteric injury, which was treated with a double J catheter for six weeks. In the abdominal group 
two patients had vesicovaginal fistula. Repeat laparotomies were needed for repair. Although three 
patients required postoperative radiotherapy in each group, none of the patients with endometrial 
carcinoma required further surgical staging.
Pelvic Organ function
The response rate of the questionnaires one year after surgery was 92% in the laparoscopic group 
and 84% in the abdominal group (p=.46). The data from the quality of life questionnaires UDI, 
IIQ and DDI one year after surgery are presented in Table 2. A significant treatment effect favoring 
LH was found in the UDI scales Overactive Bladder, Incontinence and Obstructive Micturition, as 
well as in the IIQ scales Mobility, Social Functioning, Embarrassment and Emotional Health. After 
exclusion of the two patients in the abdominal hysterectomy group with previous incontinence 
surgery, the difference was still significant in two scales of the UDI, i.e. Overactive Bladder (p=0.01) 
and Obstructive Micturition (p=0.02) and three scales of the IIQ, i.e. Mobility (p=0.05), Social 
Functioning (p=0.05) and Embarrassment (p=0.01). No differences were found in the various scales 
of the DDI. There was a significant treatment effect favoring LH in the UDI total score (p=0.02), 
but not in the IIQ or DDI total scores (p=0.14 and p=0.09 respectively). 
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Table 1. Patient characteristics and operation indications by treatment group.
 LH (n=38) AH (n=38)
Age (yr)  49.9 ± 9.1 (46.9;52.9)  48.1 ± 9.3 (45.1;51.2) 
BMI (kg/m 2)  26.9 ± 5.9 (25.0;28.9)  26.4 ± 3.8 (25.2;27.7) 
Parity 1.9 ± 1.1 (1.5;2.2)  1.6 ± 1.3 (1.2;2.0) 
ASA score 1.5 ± 0.6 (1.3;1.7)  1.5 ± 0.6 (1.3;1.7) 
Uterine weight (g) 187 [62-1066] * 168 [40-468] *
Urinary incontinence 16 (43%) ** 21 (58%) **
Previous incontinence surgery 0  2 (5%) **
Indication for surgery  
Benign disease 27 (71%) ** 32 (84%) **
Atypia /endometrial carcinoma (stage I) 11 (29%) ** 6 (16%) **
Postoperative radio therapy 3 (8%) ** 3 (8%) **
LH = Laparoscopic Hysterectomy,  AH = Abdominal Hysterectomy.
Data shown as mean ± standard deviation (95% confidence interval) in case of normally distributed data,  
 * median [range] in case of non-normally distributed data,  
** absolute numbers (percentage) in case of dichotomous variables. 
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Table 2. Urogenital Distress Inventory, Incontinence Impact Questionnaire and Defecatory Distress Inventory 
one year after laparoscopic and abdominal hysterectomy.
 
  LH (n=35) AH (n=32) P
UDI Overactive bladder 0 [0-11] 11 [0-33] 0.01
 Urinary incontinence  0 [0-17] 17 [0-33] 0.05
 Obstructive micturition  0 [0-0] 0 [0-17] 0.01
 Discomfort/pain  0 [0-17] 17 [0-33] 0.21
 Genital prolapse  0 [0-0] 0 [0-0] 0.30
IIQ Physical functioning 0 [0-0] 0 [0-0] 0.85
 Mobility 0 [0-6] 0 [0-22] 0.03
 Social functioning 0 [0-0] 0 [0-11] 0.03
 Embarrassment 0 [0-0] 0 [0-17] 0.00
 Emotional health 0 [0-0] 0 [0-22] 0.05
DDI Constipation 0 [0-0] 0 [0-0] 0.32
 Obstructed defecation 0 [0-8] 8 [0-15] 0.07
 Pain 0 [0-0] 0 [0-0] 0.63
 Incontinence  0 [0-0] 0 [0-0] 0.14
LH = Laparoscopic Hysterectomy, AH = Abdominal Hysterectomy, UDI = Urogenital Distress Inventory, IIQ = Incontinence Impact 
Questionnaire, DDI = Defecatory Distress Inventory, p = p-value for difference between groups using Mann Whitney test. Data 
presented as median [p25-p75].
Note: three patients in the LH group and two patients in the AH group were lost to follow up.
Table 3. Urinary incontinence at baseline and 12 weeks after laparoscopic and abdominal hysterectomy.
 
  LH (n=32) AH (n=36) p
Urinary Incontinence Baseline 16 (50%) 21 (58%) 0.49
 12 wks after surgery 9 (28%) 12 (33%) 0.64
 De novo complaints 0 3 (8%) 0.24
Stress Incontinence Baseline 8 (25%) 9 (25%) 1.0
 12 wks after surgery 7 (22%) 4 (11%) 0.33
 De novo complaints 0 0 –
Mixed Incontinence Baseline 7 (22%) 9 (25%) 0.76
 12 wks after surgery 2 (6%) 8 (22%) 0.09
 De novo complaints 0 3 (8%) 0.24
Urge Incontinence Baseline 1 (3%) 3 (8%) 0.62
 12 wks after surgery 0 0 –
 De novo complaints 0 0 –
LH = Laparoscopic Hysterectomy, AH = Abdominal Hysterectomy, p = p-value for difference between groups using Chi square 
test. Data presented as absolute numbers (percentage). 
Note: six patients in the LH group and two patients in the AH group were lost to follow up.
The incidence of urinary incontinence decreased in both treatment groups; in the laparoscopic 
hysterectomy group from 50% prior to surgery to 28% twelve weeks after surgery (p=0.02, 
McNemar test) and in the abdominal hysterectomy group from 58% to 33% respectively (p≤.01, 
McNemar test). There were no statistically significant differences between the treatment groups. 
The distribution amongst types of incontinence and the incidence of de novo incontinence by 
treatment group can be found in Table 3. 
Data of the QSD are shown in Table 4 and Table 5, where the data on satisfaction with 
sexuality before and 12 weeks after surgery are presented including data on a possible change 
since the hysterectomy. As far as sexuality was concerned, there were no statistically significant 
differences between the groups. De novo dissatisfaction with sexuality at 12 weeks after surgery 
appeared in two patients undergoing laparoscopic hysterectomy (7%) and in one patient 
undergoing abdominal hysterectomy (3%) (p=0.60). 
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Table 4. Questionnaire for Screening of Sexual Dysfunctions one year after laparoscopic and abdominal 
hysterectomy. 
 LH (n=23) AH (n=23) P
Any problem 11 (48%) 7 (30%) 0.37
Lubrication problem 5 (22 %) 4 (17 %) 1.0
Orgasm problem 7 (30 %) 3 (13 %) 0.28
Pain / unpleasant sensation 8 (35 %) 5 (22 %) 0.51
Arousal problem 7 (30 %) 3 (13 %) 0.28
LH = Laparoscopic Hysterectomy, AH = Abdominal Hysterectomy. p = p-value for difference between groups 
using Chi square test. Data presented as absolute number (percentage).
Note: only sexually active women completed the questionnaire.
Table 5. Sexuality at baseline and 12 weeks after laparoscopic and and abdominal hysterectomy.
 LH  AH P
Satisfied with sexuality (n=27) (n=30) 
Baseline 19 (70%) 20 (67%) 0.78
12 wks after surgery 23 (85%) 26 (87%) 1.0
De novo complaints 2 (7%) 1 (3%) 0.60
Change in sexuality (12 wks) (n=27) (n=32) 
No change 15 (56%) 17 (53%) 1.0
Improvement 10 (37%) 11 (34%) 1.0
Deterioration 2 (7%) 4 (13%) 0.68
LH = Laparoscopic Hysterectomy, AH = Abdominal Hysterectomy, p = p-value for difference between groups using Chi square 
test. Data presented as absolute numbers (percentage). 
Note: only sexually active women completed the questions.
Discussion
This randomized controlled study is to our knowledge the first that reports on urinary 
incontinence and other pelvic organ dysfunction after laparoscopic hysterectomy as compared 
with abdominal hysterectomy. Patients in whom a vaginal hysterectomy was not feasible, were 
suitable for both types of hysterectomy (maximum uterine size 18 weeks’) and had benign 
and malignant disease. There was a significant difference between the groups in favor of the 
laparoscopic hysterectomy, in three scales of the questionnaire UDI and four scales of the IIQ 
at one year after surgery. No differences in bowel function and sexual problems as measured by 
the questionnaires DDI and QSD were found at one year after surgery. Furthermore, we found 
an equal and statistically significant decrease in urinary incontinence at 12 weeks after surgery as 
compared with baseline in both groups. There were only few patients suffering de novo urinary 
incontinence and de novo dissatisfaction with sexuality in both groups. 
Our data on incidence of urinary incontinence before and after hysterectomy are comparable 
to those in other prospective non-comparative studies (3;4). This confirms, that on the short term 
there is a positive effect from hysterectomy on urinary function. However, the equal positive effect 
in both groups is in contrast with the increased risk of urinary incontinence after laparoscopic 
hysterectomy reported in a prospective cohort study by McPherson et al. (8). In a randomized 
controlled trial on the effects on urinary incontinence six months after laparoscopic hysterectomy 
of suspension of the utero-sacral ligament complex to the vaginal cuff, Long et al. found a positive 
effect from suspension (10). However, this treatment effect was largely caused by differences at 
baseline, whereas the postoperative incidences of urinary incontinence were remarkably similar in 
the two groups. The postoperative incidence of stress urinary incontinence following laparoscopic 
hysterectomy in the present study with no vaginal cuff suspension performed, was even less 
when compared with the incidence in the group with vaginal cuff suspension in the study by 
Long et al..
The fact that laparoscopic hysterectomy results in less tissue trauma is a possible explanation 
for the better urinary incontinence – specific quality of life reported one year after surgery. 
Several studies show a difference in inflammatory response and tissue trauma when comparing 
laparoscopic and abdominal hysterectomy (17-20). However, it is unknown whether this 
difference in overall tissue trauma is also valid for a difference in bladder trauma, because the 
wound area will account for the majority of the observed difference in tissue trauma between 
laparoscopy and open surgery. 
Bowel function is not influenced by non radical or simple abdominal hysterectomy or 
vaginal hysterectomy (3;21). Because we did not find differences in bowel function between 
the laparoscopic and abdominal hysterectomy, our data suggest that this holds true for the 
laparoscopic hysterectomy as well. 
We showed that satisfaction with sexuality improves and that de novo sexual problems are 
rare after laparoscopic and abdominal hysterectomy, as has been reported previously by others 
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for the abdominal and vaginal hysterectomy (3;15). Our data confirm previously published data 
on sexuality at one year after surgery (6;7) and showed no difference between the laparoscopic 
and abdominal hysterectomy group as far as satisfaction with sexuality and change in sexuality 
following hysterectomy was concerned. 
As the follow-up in our study is one year, the question whether these women are at an 
increased risk of suffering urinary incontinence at older age (>60 years) remains unanswered 
(2). Another limitation of our study is the lack of a baseline measurement of the quality of life 
questionnaires. However, this is overcome by the fact that the patients were randomized to the 
treatments and that there were no significant differences in the incidence of urinary incontinence 
and satisfaction with sexuality at baseline. Although the written questions on incidence of urinary 
incontinence and satisfaction with sexuality were not validated before the study, the questions 
were clear and unmistakable. 
Regrettably, we had a large amount of complications in both groups. All four women suffering 
urinary tract injuries had a complete follow-up and were thus included in the analysis of the study. 
One-third of the patients in either group had a fibroid uterus of 12 to 18 weeks’ gestation. In this 
respect, there was no difference between the groups. There was however a difference in number 
of patients with atypical hyperplasia or endometrial carcinoma, with eleven patients (29%) in 
the laparoscopic group and six patients (16%) in the abdominal group. Atypical hyperplasia and 
low stage endometrial carcinoma is not expected to have an influence on pelvic organ function. 
Therefore, the women with benign and malignant disease were included in the study. Because 
patients where a vaginal hysterectomy was feasible were excluded, as well as patients with a fibroid 
uterus beyond 18 weeks’ gestation, our data may not be applicable to those patients.
Conclusion
Worldwide, hysterectomy and pelvic organ dysfunction are two major health care issues. 
As far as the combination of the two is concerned, there is still a lot to explore in the field. This 
study consolidates that on the short-term both laparoscopic and abdominal hysterectomy has a 
positive effect on symptoms of urinary incontinence. At one year after surgery this effect seems 
even more pronounced in laparoscopic hysterectomy as compared with abdominal hysterectomy. 
The effects on bowel function and sexuality after laparoscopic hysterectomy are comparable to 
those after abdominal hysterectomy.
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Abstract
Background
Postoperative recovery is a considerable issue in studies comparing surgical techniques of similar 
effectiveness. In recent years there has been a shift towards patient-centered study outcomes 
such as quality of life questionnaires. The objective of this report was to provide a systematic 
review of the literature on postoperative recovery specific quality of life instruments and their 
measurement properties.
Methods
We searched the databases EMBASE.com, Cinahl, PsycINFO and PubMed for papers reporting 
on postoperative recovery specific quality of life instruments. A checklist was used to assess the 
revealed studies and instruments. Existing quality criteria were applied to the measurement 
properties to enable comparison of the instruments.
Results
The search strategy identified 620 studies, of which 18 studies reported on 12 different 
postoperative recovery specific quality of life instruments. None of the instruments had 
been validated completely in line with the eight quality criteria, which were used to assess the 
measurement properties. However, two instruments were clearly superior, which were the 
Postdischarge surgical recovery scale and the Quality of recovery-40.
Conclusions
There is no fully validated instrument available for the assessment of postoperative recovery. We 
advise to use the Postdischarge surgical recovery scale and the Quality of recovery-40 in future 
validation and application studies on short-term postoperative recovery.
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 Introduction
When comparing surgical procedures, the postoperative recovery has traditionally been 
referred to in terms of pain scores, hospital stay and return to normal activities. However, these 
outcomes are much dependent on external factors, i.e. local habits and social security matters. 
Thus, the application of quality of life instruments, measuring recovery in a patient-centered 
manner, has become more popular in recent times and has more and more been accepted as a 
solid primary outcome measure in scientific studies (1). A number of recovery specific quality 
of life instruments is available by now. Since the awareness of the need to use valid measure 
instruments has been enhanced, the choice for one of these instruments has become a major 
challenge. 
In 2007 Terwee et al. (2) have defined eight quality criteria on design and outcomes of studies 
describing the development and evaluation of quality of life instruments. These explicit criteria 
can be used to systematically assess the measurement properties of instruments, which facilitates 
the well-considered choice of the best measurement tool. 
At present, an overview of the instruments used for the measurement of recovery is lacking. 
The purpose of the present report was to provide a systematic review of the literature on 
postoperative recovery specific quality of life instruments and their measurement properties, in 
order to enable an informed choice for appropriate instruments in future studies. 
Methods
The databases EMBASE.com, PsycINFO, Cinahl and PubMed were searched until April 11, 
2006; April 21, 2006; May 1, 2006; and May 11, 2006 respectively. The number of search terms was 
extensive and the complete search strategy can be obtained from the corresponding author. Search 
terms were adapted for each database accordingly and generally referred to the different terms 
for ‘instrument’, ‘surgery’ and ‘recovery’. References of relevant retrieved studies were checked 
for additional studies. 
We included all studies reporting on instruments evaluating general postsurgical recovery. 
There were no language restrictions. Studies were excluded in case the instruments were site 
specific, i.e. more than 10% of the items were only applicable to a limited number of diseases or 
surgical procedures. Instruments evaluating postsurgical cognitive function or functional outcome, 
e.g. range of joint movement or reduction of epileptic strokes, were also excluded. Furthermore, 
instruments limited to recovery in the recovery rooms were excluded. To differentiate between 
recovery from surgery and resumption of quality of life, we excluded studies in which the quality 
of life instrument was applied less than twice in the first six weeks after surgery. 
All studies were scored independently by two of the authors (KK and HdV) and disagreement 
was resolved in consensus meetings. A checklist, based on the quality criteria for measurement 
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properties of health status instruments by Terwee et al. (2), was used. In each study data on 
the study design, i.e. population, sample size, characteristics of the instrument and points of 
measurements in time were documented. Furthermore, the availability of the questionnaire in 
the public domain as well as the respondent’s burden (minutes to completion) were assessed.
Data on the measurement properties of the retrieved instruments, i.e. content validity, internal 
consistency, criterion validity, construct validity, floor and ceiling effects, reproducibility (reliability 
and agreement), longitudinal validity or responsiveness and interpretability, were collected. The 
quality criteria as proposed by Terwee et al. were used to rate each of the measurement properties 
(2). Possible ratings were positive, indeterminate, negative and no information available. The 
conditions for these ratings are described below. All publications on a specific instrument were 
used for completion of the checklist. 
Content validity is the extent in which the items of the instrument cover the domain of interest. 
A positive rating was given in case a clear description of the measurement aim, the target population 
and the concepts being measured were given, as well as a description of the technique of the item 
selection in which, besides investigators or experts, the target population had to be involved. 
Internal consistency is a measure for the homogeneity in which the items measure the same 
underlying concept (construct). A positive rating was given in studies where a factor analysis had 
been performed on a sample size of at least seven times the number of items, with a minimum 
sample size of 100, and the Cronbach’s alphas per subscale were between 0.70 and 0.95.
Criterion validity is the degree to which scores on a particular instrument relate to a gold 
standard instrument and is not applicable in case such an instrument is not available. For a 
positive rating convincing arguments should be provided that the gold standard is gold and the 
correlation to this gold standard instrument should be a least 0.70.
Construct validity is the extent in which scores on an instrument correspond consistently 
to other measures and empirical findings. Hypotheses, defined prior to the study, on expected 
correlations to other instruments or expected score differences amongst defined groups should 
be tested. Since, the hypotheses had to be postulated before analysis of the data, we checked 
whether the hypotheses were already mentioned in the introduction or methods sections. For 
a positive rating specific hypotheses had to be formulated and at least 75% of the tested results 
had to be in accordance with these hypotheses. 
Floor and ceiling effects are present in case more than 15% of respondents to a instrument 
achieved the lowest or highest possible score respectively, which limits the ability to distinguish 
differences among these respondents as well as changes in one direction. For a positive rating 
these effects had to be absent in a study with a sample size of at least 50 respondents.
Reproducibility is the extent in which stable scores over time are obtained. Reliability and 
agreement can be distinguished (3). Reliability is the ability to distinguish separate persons 
despite measurement error (relative measurement error), whereas agreement is a measure for 
absolute measurement error (scores on repeated measures). For a positive rating for reliability 
the intraclass correlation coefficient (ICC) or weighted Cohen’s Kappa coefficient had to be at 
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least 0.70. For a positive rating for agreement, the minimally important change (MIC) had to be 
defined and had to be greater than the instruments smallest detectable change (SDC) or outside 
the limits of agreement in a Bland and Altman analysis. However, in case of other convincing 
arguments for acceptable agreement, the agreement was also rated as positive. 
Responsiveness is a measure for the ability of an instrument to detect a clinically important 
change of health status and is also referred to as longitudinal validity. Responsiveness can be assessed 
and expressed in multiple ways and a positive rating was given in case, in a sample size of at least 
50 subjects, the minimally important change (MIC) was greater than the instrument smallest 
detectable change (SDC) or was outside the limits of agreement in a Bland and Altman analysis. 
Positive rating were furthermore given, in case either the Guyatt’s responsiveness ratio was above 1.96 
or the area under the ROC-curve (AUC) for the diagnosis of an actual change was at least 0.70.
Interpretability is the extent in which qualitative meaning can be assigned to a score on an 
instrument. For a positive rating the mean scores with standard deviations had to be presented 
for at least four relevant subgroups of respondents as well as a presentation of the minimally 
important change (MIC).
Intermediate ratings were given in cases of a doubtful design, which was defined as follows: a 
sample size of less than 50 subjects; no clear description of measurement aim, target population, 
concepts being measured and item selection technique for content validity; no factor analysis 
for internal consistency; no convincing arguments for a gold standard instrument being gold 
for criterion validity; no hypotheses formulated for construct validity; no minimally important 
change defined and no convincing arguments for acceptable agreement for agreement; no mean 
scores with standard deviations provided for four subgroups and no minimally important change 
presented for interpretability. 
Negative ratings were given in case the target population had not been involved in the 
item selection and in cases of an adequate design but unsatisfactory results for a measurement 
property. For interpretability a negative rating was not applicable.
Results
The EMBASE.com-search revealed 175 studies. The PsycINFO revealed 83 studies, of which 
three studies had already been detected in the EMBASE.com-search. The Cinahl search revealed 
130 studies, of which one had already been detected in the previous databases. The PubMed 
search revealed 243 studies, of which seven had already been detected in the previous searches. 
Thus, a total of 621 studies were checked for eligibility, of which 480 studies were read by title and 
abstract only. Eighteen studies (4-21), published between 1970 and 2005, fulfilled the inclusion 
criteria, reporting on 12 different instruments. Two studies (4;22) were revealed by cross checking, 
of which one described the development and the other a translation of instruments, which both 
had been detected by the literature search.
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The Quality of recovery–40 (5-7) was a self-completed instrument containing 40 closed 
questions on recovery, of which seven questions were double-barreled. The items were answered 
on a 5-point Likert scale and were grouped into five subjects, i.e. emotional state, physical comfort, 
psychological support, physical independence and pain. The Quality of recovery score (8-10) was 
a short form of the Quality of Recovery-40 and was a self completed and telephone interview 
instrument containing nine closed questions on recovery. The items were answered on a 3-
point Likert scale and six out of nine questions were double-barreled. The Postdischarge surgical 
recovery scale (11) was a self completed instrument and consisted of 15 contrasting features, such 
as feeling alert versus feeling drowsy. These items on recovery, symptoms and functioning were 
answered on a 10-point semantic differential scale. According to factor analysis, the instrument 
was considered to be one scale. The Surgical recovery index (12) was a self-completed instrument 
with 24 closed questions on two subjects, i.e. pain and activity resumption. The Systemic 
symptom scale (13) was a Spanish instrument based on interviews. It measured symptoms and 
overall quality of life in 11 closed questions. The Biophysical health problems questionnaire 
(14) was a 27-item self completed Finnish instrument with closed questions on symptoms, 
functioning and wound healing. The Postoperative recovery scale (15) was a self completed 
instrument on symptoms, functioning and overall quality of life with a variable number of closed 
questions for pre-operative, hospitalized and recently discharged surgical patients (26, 21 and 
31 items respectively). The Home recovery log (16) was an instrument consisting of 11 items 
on pain, fatigue and activities. The Postoperative symptoms diary (17;18) was a self completed 
and telephone interview instrument and consisted of 16 closed questions, of which eight items 
were on symptoms and eight items were on symptom management. The Baseline and transition 
index (19) was tested under interview conditions and consisted of three closed and five open-
ended questions on postoperative functioning in relation to the pre-operative situation. The 
Inventory for postoperative recovery (20) was a French 25-item self completed or interview 
instrument with closed questions on symptoms and functioning. The Wolfer Davis recovery 
inventory (4;21) was a self completed instrument and consisted of eight closed questions on 
symptoms and functioning. 
The time taken to complete the instruments ranged from one to seven minutes.
All questionnaires included items on physical aspects of recovery. Items referring to pain were 
included in all instruments, except for the Baseline and transition index (4;21) and the Wolfer Davis 
recovery inventory (19). In three instruments there was clear consideration of emotional aspects 
(5-10;19), whereas one item on emotions was included in two further instruments (4;11;19).
In six studies the scores from measurements prior to surgery were presented (5-10;15;19). 
In three studies (4;9;13) the instruments had been completed by hospitalized patients only, 
whereas in the majority of studies the instruments had been completed both by hospitalized 
and recently discharged patients (5-8;10;14;15;19;21). In four studies only discharged patients 
had completed the instruments (11;12;17;18) and two studies did not provide information on 
this issue (16;20). 
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In three studies (11;14;16) it was not clear to which time period the items referred, whereas 
one study referred to variable time periods (12). This variability was due to retrospective nature 
of the data collection, which was also remarked as a limitation in that study. The items in the 
other studies referred to the past hours (8-10), today (4;17;18;20;21), the past day (5-7), the past 
week (13;15) or the past one or two weeks (19). 
Either a copy of the instruments or a link to a website where a copy could be obtained, 
was available on eight instruments (6;8;14;15;17;19-21). For the non-English instruments, these 
copies were in the original French language for the Inventory for postoperative recovery (20) 
and in English for the Finnish Biophysical health problems questionnaire (14). All other studies 
provided a list of the items’ subjects, although this list seemed incomplete in case of the Surgical 
recovery index (12). Unfortunately, a request to the corresponding author was not answered. 
Furthermore, a slightly modified German translation of the nine item Quality of recovery score 
was available (22).
The data on study design, such as population and sample size, as well as the measurement 
properties of eligible instruments are shown in Table 1 and 2. In Table 3 data on the quality of 
measurement properties as assessed by the eight existing criteria are shown.
Content validity was rated positive in six instruments (5-12;14;20), which is the highest 
number of positive ratings on any of the eight quality criteria. 
Only for the Postdischarge surgical recovery scale (11), data from factor analysis were presented 
and showed that the instrument consisted of a single scale with an acceptable Cronbach’s alpha 
(0.88 and 0.91 in two samples). Cronbach’s alpha has been presented in eight other instruments 
(5-10;12-14;16;17;21), which was either for the total scale or for subgroups of items on the same 
topic (e.g. pain), but in these cases prior factor analysis was lacking. 
Although one study presented criterion validity (13), these data were regarded as construct 
validity, since no gold standard instrument was available for recovery measurement. For seven 
instruments (6;8;11;13;18;19), at least one with a maximum of nine predefined hypotheses 
were presented for construct validity testing In three instruments (6;8;11) at least 75% of these 
hypotheses were confirmed.
The Postdischarge surgical recovery scale (11) was the only instrument with satisfactory 
evidence for the absence of floor and ceiling effects. For the nine-item Quality of recovery score 
(9), floor effects seemed to be absent in hospitalized patients in the first six days after surgery, but 
not in ambulatory patients. Although Talamini et al. (12) stated the absence of floor and ceiling 
effects, both the actual scores and a definition for this absence was lacking. As a consequence, we 
were not able to apply the quality criterion of the absence of 15% lowest or highest scores to the 
Surgical recovery index.
The Quality of recovery-40 and the Postoperative recovery scale were the only instruments 
revealing satisfactory proof of reliability (6;15). For the Postoperative recovery scale, this was the 
only satisfactory property on this scale. None of the instruments was rated positively for either 
agreement, responsiveness or interpretability.
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Table 1. Summary of the content validity and internal consistency of instruments measuring postoperative recovery.
 Content validity  Internal consistency
Instrument References Total sample  Population(s) Item selection Item reduction Reading skills Presentation  Cronbach’s
  studied    required factor analysis alpha  
        
Quality of recovery-40 Myles 2000;  Myles 2001;  465 surgery patients experts  correlation    no no 0.93 *
 Leslie 2003 (5-7)   investigators item-total score>0.30    
         
Quality of recovery score Myles 1999; Myles 2000; 6212 surgery patients experts  based on no no 0.57-0.90 *
 Wu 2005 (8-10)   investigators ranking importance    
Postdischarge surgical recovery  Kleinbeck 2000 (11) 230 short stay  patients experts based on internal no yes,  0.88-0.91 *
scale   surgery investigators consistency and validity  1 scale  
Surgical recovery index Talamini 2004 (12) 149 surgery patients experts – – no 0.91-0.97
    investigators     
Systemic  symptom scale Prieto 2004  220 stemcell  experts  – no no 0.59-0.69 *
  (13)  transplantation investigators     
Biophysical health problems  Susilahti 2004  (14) 107 short stay  patients experts – no no 0.51-0.86
questionnaire   surgery investigators     
Postoperative recovery scale Pace 2003  (15) 71 surgery – – no no –
Home recovery log Horvath 2003  (16) 91 ambulatory surgery – – – no 0.75-0.83 *
Postoperative symptoms diary Young 2000; Young 2001 (17;18) 252 surgery experts investigators – no no  0.73-0.78 *
           
Baseline and transition index McKenzie 1986 (19) 83 surgery,  patients experts?  – no no –
   internal medicine investigators?     
Inventory for postoperative  Grenier 1982 (20) 89 surgery patients experts  based on internal  no no 0.90-0.91 ** 
recovery    investigators consistency    
Wolfer Davis recovery inventory Wolfer 1970; Daly 1992 (4;21) 172 surgery experts investigators – no no 0.73-0.89 *
Item selection = persons involved in item selection; 
Item reduction = technique used for item reduction; 
Reading skills = level of reading skills required;
 – = no data available; 
 * = Cronbach’s alpha for total scale; 
 **  = split-half reliability.
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Table 2.  Summary of the construct validity, reproducibility, responsiveness and interpretability of instruments measuring  
postoperative recovery.
 Construct validity  Floor and ceiling effects Reproducibility reliability  Reproducibility agreement Responsiveness Interpretability 
Instrument Number of   Method and result  Method and result Points of measure-  Method and  Number of  MIC
 hypotheses  (time interval)  ment following  result subgroups 
 confirmed    intervention  (mean and SD)
        
Quality of recovery-40 5 out of 6          – ICC 0.92 (same day)  test-retest bias 7.1,  first 3 days  SRM 0.65  6 groups  –
   repeatability  1 and 3 months    
   coefficient 24 
Quality of recovery score 7 out of 9  ceiling in inpatients  Spearman 0.62          – first 6 days and        – 11 groups  –
  beyond day 6 and am (next day)  first 6 weeks   
  bulatory patients  
Postdischarge surgical  3 out of 3 no floor or ceiling          –         – day 2       – 2 groups –
recovery scale  effects
Surgical recovery index 1 out of 2 ceiling effect in 7 out          –         – variable, retrospective        – 2 groups –
  of 24 items   completion   
Systemic symptom scale 1 out of ?         – Spearman 0.61-0.80          – first weeks,  score changes in          – –
   (one week)  until discharge separate groups  
Biophysical health        –          –          –          – days 1 or 2 and 7        –          – –
problems questionnaire
Postoperative        –          – ICC 0.81 (2 weeks           – daily in hospital and         – 2 groups –
recovery scale   (before surgery))  at 2 weeks, 1,2,3,6   
     and 12 months   
Home recovery log       –          –          –          – first 6 days        – 1 groups –
Postoperative  0 out of 1          –          –          – 1-4 and 10 days        –          –* –
symptoms diary
Baseline and  1 out of 2          –          – subjective versus  1,2,4 and 6 weeks        –          – ** –
transition index    objective change;    
    interviewer agreement    
Inventory for        –          –          –          – first 2 days        –          – –
postoperative recovery 
Wolfer Davis        –          –          –          – first days until           – 6 groups – 
     two weeks   
recovery inventory         
ICC = intraclass correlation coefficient;  Spearman = Spearman correlation coefficient;  
SRM = standardized response mean;  MIC = minimal important change ; 
SD = standard deviation;  – = no data available; 
* = mean without SD presented for 2 groups;  ** = scores presented in percentage (incomplete).
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Discussion
This systematic review summarizes the characteristics and measurement properties of twelve 
available instruments measuring postoperative recovery. Eighteen studies using these instruments 
were systematically scored and the available data were rated on the basis of eight clearly defined 
quality criteria. Five out of these twelve instruments did not fulfill any of the quality criteria, 
whereas four other instruments obtained only one positive rating. The maximum number of 
positive ratings was four for the Postdischarge surgical recovery scale (11), three for the Quality 
of recovery -40 (5-7) and two for the Quality of recovery score (8-10). The Postdischarge surgical 
recovery scale (11) and the Quality of recovery–40 (5-7) showed especially superior content validity 
and construct validity, and did not reveal any negative ratings which would have disqualified the 
instrument. The validation, however, has not been completed for either instrument.
The Quality of recovery-40 (40 items) (5-7) performed better in fulfilling quality criteria as 
compared with the Quality of recovery score (9 items) (8-10), which is the short form instrument. 
At the cost of a small increase in completion time, the Quality of recovery-40 appeared to be more 
valid and consisted of less double-barreled questions as compared with the short form. 
The quality criterion, which was most frequently fulfilled, was the content validity in six 
instruments, showing that the target population had been involved in the selection of the items 
Table 3. Summary of the measurement quality of postoperative recovery instruments.
instrument Content  Internal  Construct  Floor and  Reproducibility  Reproducibility  Responsiveness Interpretability
 validity consistency validity ceiling effect reliability agreement   
Quality of recovery-40  + ?  + 0  + ? ? ?
Quality of recovery score  + ?  +  -  ? 0 0 ?
Postdischarge surgical recovery scale + + + + 0 0 0 ?
Surgical recovery index + ? ? ? 0 0 0 ?
Systemic symptom scale - ? ? 0 ? 0 ? 0
Biophysical health problems questionnaire + ? 0 0 0 0 0 0
Postoperative recovery scale 0 0 0 0 + 0 0 ?
 
Home recovery log 0 ? 0 0 0 0 0 ?
Postoperative symptoms diary  - ? ? 0 0 0 0 ?
Baseline and transition index ? 0 ? 0 0 ? 0 ?
Inventory for postoperative recovery  + ? 0 0 0 0 0 0
Wolfer Davis recovery inventory - ? 0 0 0 0 0 ?
+ = positive rating;  ? = indeterminate rating; - = negative rating;  0 = no information available
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used. This involvement is crucial to avoid missing relevant items as well as the selection of non-
relevant items (2). The number of items of the different instruments ranged from eight to 40 
and the maximum completion time was seven minutes, which seems acceptable (26). There 
was clearly more consideration for physical as compared with emotional aspects in the recovery 
instruments. Only three instruments questioned the patients clearly on their emotions, which 
might be a reflection of the focus of surgical departments.
Cronbach’s alpha is a measure for internal consistency and is known to be flattered when 
disregarding separate subscales as identified by factor analysis, especially in instruments with 
more than 19 items (23). Although a Cronbach’s alpha for either the total scale or for groups 
of items on a certain subject were presented for the majority of instruments, only one study 
presented a prior factor analysis (11). When designing the recovery scales, developers probably 
included all items of potential importance to postoperative recovery, and did not aim at the 
measurement of one single construct. In that case it results in a more clinimetric scale without 
the need for determination of Cronbach’s alpha  (24).
In this review, it was not possible to check extensively whether the hypotheses on construct 
validity testing had been postulated prior to the data analysis. Although this is no guarantee, we 
demanded the hypotheses to be described in the introduction or methods sections of the study 
and not in the results or discussion sections only. More challenging hypotheses give more support 
Table 3. Summary of the measurement quality of postoperative recovery instruments.
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 validity consistency validity ceiling effect reliability agreement   
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Inventory for postoperative recovery  + ? 0 0 0 0 0 0
Wolfer Davis recovery inventory - ? 0 0 0 0 0 ?
+ = positive rating;  ? = indeterminate rating; - = negative rating;  0 = no information available
for good construct validity in case of confirmation. However, the specificity of hypotheses is 
difficult to judge. No obligatory number of hypotheses has been defined in the quality criteria, 
but the number of hypotheses tested in the instruments with a positive rating for construct 
validity ranged from three to nine, which seems reasonable.
Correct timing of measurements in the recovery process is essential, since incorrect timing can 
lead to floor and ceiling effects, causing difficulties in the measurement of actual differences and 
changes among and within respondents (2). A question aiming at recovery following discharge, 
e.g. resumption of work, should not be answered by a hospitalized patient and vise versa. 
Likewise, the extensiveness of surgery is an important factor in the correct timing. Consequently, 
instruments on symptoms typically concerning patients in the early postoperative period, such 
as nausea, seem more appropriate in the first days after major surgery and during hospitalization 
(5-10;13;14;17;18;20;21), whereas instruments focusing on daily life activities such as caring for 
a household and working, seem more appropriate in the first days after minor surgery and in 
the weeks or month following major surgery (11;12;15;16;19). Furthermore, the definition of 
standardized time intervals may enhance the comparability of studies.
There were only two instruments revealing a positive rating for reliability, which is an 
important issue, since it is a prerequisite for good construct validity and responsiveness (25). 
Satisfactory data on test-retest reliability were mostly lacking, which is probably due to the 
fact that recovery is a very dynamic process. A time interval between two measurements in 
which the situation of the patient does not change, is probably hard to find. The criteria for 
agreement, responsiveness and interpretability were not rated positive for any of the instruments. 
Nevertheless, responsiveness is an important issue in the evaluation of postoperative recovery, 
since the change at the time of surgery and the changes during the dynamic process of recovery 
have to be assessed in a valid manner. The same holds true for the interpretability. Only on three 
instruments the mean scores (and spread) of more than two separate groups of patients were 
available (5-10;21) and none of the studies described the minimally important change, which 
reflects the smallest difference in score, which patients perceive as beneficial. 
The overview in Table 3 shows the measurement properties for which further validation is 
judged worthwhile. Properties rated as zero (i.e. no information available) or questionmarks (i.e. 
incomplete information or doubtful design), show issues, which need further assessment, whereas 
a negative rating disqualifies an instrument. The requirements for an instrument to comply with 
the eight strict quality criteria sets a high standard. However, these criteria are not unachievable 
and they can be a helpful guideline for future validation processes. For this reason, the present 
paper describes the criteria rather extensively. 
On eight out of twelve instruments, only one publication has been found in the literature 
search and the maximum number of publications per instrument was three.  The first paper, 
presenting a new instrument, usually describes the development and first steps in the validation. 
To obtain information on all measurement properties more studies are needed. For most recovery 
instruments further validation and consequent application in clinical studies was lacking. In view 
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of the enormous effort involved in the development process, this is rather surprising. Moreover, 
since the completion of questionnaires can place a load on patients, there is also an ethical 
obligation to avoid such aimless burden to postoperative patients. Using available instruments, 
more than developing new ones, would be helpful in solving this problem. This overview of 
available instruments, including a rating of their measurement properties, facilitates the choice 
of an appropriate measurement instrument. 
The two instruments that we recommend for future use and validation are both available to 
researchers, including a description of the scoring system. Although a copy of the Postdischarge 
surgical recovery scale was lacking, the subject of  the items was listed in the paper and the 
responses can be expressed on a 10-point semantic differential scale. 
Besides on quality of measurement properties, the choice on an instrument for a future study 
should be based on the intended research questions, the study group and practical considerations, 
such as respondent burden and ease of scoring. None of the studies reported either on an 
acceptable level of missing data or provided information on the way they had dealt with missing 
data, let alone gave guidelines on that subject. Furthermore, this quality may vary among different 
settings, populations and languages. Until now, the Postdischarge surgical recovery scale, for 
example, has only been applied to short stay surgical patients and may not be as valid in other 
populations (11). Therefore the recommendations from this review are preliminary and do not 
relieve researchers from careful selection of their instruments. Moreover, testing of measurement 
properties needs to be repeated when using a translated version, since careful translation is no 
guarantee for maintenance of the properties.
The interest in using patient-based instruments for clinical assessment and treatment 
monitoring of individual patients is growing. Instruments used for clinical assessment of 
individuals demand higher quality of the instruments as compared with group comparisons (27). 
At this stage, none of the reviewed instruments showed sufficient quality of the measurement 
properties to justify their use in the assessment of individual patients.
Postoperative recovery measurement is not in sharp contrast with the measurement of 
resumption of quality of life or declining symptoms and return to normal functioning after 
surgery. In the present study, we tried to make the distinction on the basis of the timing of 
the postoperative measurements, which had to be at least twice within the first six weeks after 
surgery. Furthermore, the instruments had to be applicable to a wide range of postoperative 
patients, and we did not review studies focusing exclusively on recovery in the recovery rooms. 
Consequently, our study does not give a systematic review of instruments used in the very short 
term (i.e. recovery rooms) and longer-term postoperative period (i.e. beyond six weeks) or of 
more disease specific instruments.
In conclusion, we summarized the measurement properties of twelve instruments measuring 
postoperative recovery, which enables an informed choice for the use by future researchers. 
Although none of the instruments was validated completely in line with all eight quality criteria, 
two instruments appeared to be clearly superior. We advise to apply the Postdischarge surgical 
83
Review on recovery specific quality of life instruments
recovery scale and the Quality of recovery-40 in future studies on postoperative recovery. Further 
validation of the instruments, with a focus on the responsiveness and the minimally important 
change, is required.
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Appendix: Search terms
Embase.com until 11th of April 2006 
(('rating scale'/exp OR 'scoring system'/exp OR 'clinical assessment tool' OR 'summated rating scale'/exp 
OR 'visual analog scale'/exp OR 'questionnaire'/exp OR 'named inventories questionnaires and rating 
scales'/exp) AND ‘Postoperative period’/exp AND (recovery OR convalescence OR Convalescence/exp 
OR reconvalescence OR recuperation OR return-to-normal-activities OR regain-of-health OR health-
status/de OR quality-of-life) AND human/exp NOT ('case report'/exp OR [cochrane review]/lim OR 
[controlled clinical trial]/lim OR [meta analysis]/lim OR [randomized controlled trial]/lim OR [systematic 
review]/lim OR [review]/lim OR [short survey]/lim OR [animal cell]/lim OR [animal experiment]/lim OR 
[animal model]/lim OR [animal tissue]/lim OR animal/exp)) AND ('psychometry'/exp OR 'correlation 
coefficient'/exp OR 'observer variation'/exp OR 'reliability'/exp OR 'reproducibility'/exp OR 'variance'/exp 
OR validity/exp OR 'instrument validation'/exp OR 'validation process'/exp OR 'Outcomes research'/exp 
OR 'accuracy'/exp OR 'intermethod comparison'/exp OR 'error'/exp OR 'sensitivity AND specificity'/exp) 
AND clinical-study/exp
Psycinfo until 21th of April 2006
kw=(postsurg* OR "post surg*" OR "after surg*" OR postoperat* OR "post operat*") OR de=surgery OR 
DE="surgical patients" OR DE="postsurgical complications"
AND
kw=(rating* OR scale* OR score* OR scoring OR assessment OR questionnaire* OR psychometr* 
OR correlat* OR observer OR reliab* OR reproduc* OR variance OR value OR valid* OR accura* OR 
intermethod OR error* OR sensitivity OR specificity) OR 
de=test validity >
AND
kw=(recover* OR convalescence OR reconvalescence OR recuperation OR "return to normal activities" 
OR "regain of health" OR "health status" OR "quality of life") OR DE=("quality of life" or "quality of 
work life")
AND 
de=Measurement+ OR cl=2200
OR de=("test interpretation" or "test standardization") OR DE=("test construction" or "content 
analysis test" or "difficulty level test" or "item analysis test" or "item content test" or "test bias" 
or "cultural test bias" or "test forms" or "test items" or "test reliability" or "test standardization" or 
"test validity")
Limits: human/inpatient/outpatient
Cinahl until 1st of May 2006
exp postoperative complications/ or exp "surgical recovery delay (saba ccc)"/ or exp postoperative 
period/
AND
exp Recovery/
AND
exp research measurement/ OR exp Outcome Assessment/ OR exp research methodology/
NOT 
exp Case Studies/
limit : to research
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PubMed until 11th of May 2006
Epidemiologic methods[mesh]
AND
measur*[ti] OR scale*[ti] OR subscale*[ti] OR rating*[ti] OR selfrating*[ti] OR rate[ti] OR rates[ti] 
OR selfrating*[ti] OR index[ti] OR indices[ti] OR score*[ti] OR scoring[ti] OR instrument[ti] OR 
instruments[ti] OR interview*[ti] OR questionnair*[ti] OR respondent*[ti] OR survey*[ti] OR inventory[ti] 
OR inventories[ti] OR assessment*[ti] OR assessing[ti] OR test[ti] OR tests[ti] OR testing[ti] OR self-
report*[ti] OR selfreport*[ti] 
AND
"Postoperative Period"[MeSH] OR "Postoperative Complications"[MeSH:noexp] OR "Pain, 
Postoperative"[MeSH]
AND
"Recovery of Function"[MeSH] OR "Convalescence"[MeSH] OR "Rehabilitation"[MeSH:NoExp] OR 
rehabilitation[sh] OR "Activities of Daily Living"[MeSH] OR "Disability Evaluation"[MeSH] OR "Quality 
of Life"[MeSH] OR recovery[ti] OR convalescence[ti] OR reconvalescence[ti] OR recuperation[ti] OR 
(return to normal activities) OR (regain of health) OR health-status/de OR (quality of life) 
AND
"Sensitivity and specificity"[MeSH Terms] OR "Reference values"[mesh] OR "Evaluation studies"[mesh] 
OR "Reproducibility of results"[mesh] OR "Quality control"[mesh] OR Validation studies[pt] OR "Observer 
variation"[mesh] OR "Treatment Outcome"[mesh] OR "Comparative study"[mesh] OR sensitive[tiab] OR 
sensitivity[tiab] OR specificity[tiab] OR accurate[tiab] OR accuracy[tiab] OR (golden standard[tiab]) OR 
(gold standard[tiab]) OR (reference test[tiab]) OR (index test[tiab]) OR valid*[tiab] OR verif*[tiab] OR 
evaluat*[tiab] OR (false[tiab] AND (positive[tiab] OR negative[tiab])) OR pretest[tiab] OR pre-test[tiab] 
OR posttest[tiab] OR post-test[tiab] OR (predictive value[tiab]) OR predict*[tiab] OR roc[tiab] OR 
likelyhood[tiab] OR likelihood[tiab] OR value*[tiab] OR cutoff[tiab] OR cut-off[tiab] OR repeatab*[tiab] 
OR reproducib*[tiab] OR efficacy[tiab] OR reliab*[tiab] OR odds[tiab] OR error*[tiab] OR suitab*[tiab] 
OR utility[tiab] OR useful*[tiab] OR significance[tiab] OR clinimetr*[tw] OR psychometr*[tw]
NOT
(animals[mesh] NOT humans[mesh]) 
NOT 
case reports[pt] OR review[pt] OR meta analysis[pt] OR clinical trial[pt] OR news[pt]
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Abstract
Objective
Generic health related quality of life questionnaires and recovery specific questionnaires have 
been used to measure recovery in surgical patients. The aim of the present study was to evaluate 
the clinimetric properties of three recovery instruments and to examine whether recovery specific 
instruments are useful.
Methods
The Quality of Recovery-40 (QoR-40), Recovery Index-10 (RI-10) and RAND-36 health survey 
were used to measure recovery in patients undergoing different types of hysterectomy in the first 
12 weeks after surgery. Construct validity was assessed by testing pre-defined hypotheses. The 
changes observed during the postoperative period were used as indicators for responsiveness. 
Results
One hundred and sixty-one women were included. Response rate and internal consistency were 
found satisfactory. The highest number of hypotheses used for construct validity assessment 
was confirmed in the RI-10. The RI-10 was more responsive as compared to the QoR-40 and 
RAND-36.
Conclusion
Since construct validity and responsiveness were highest in the RI-10, we conclude that this 
short recovery specific instrument is useful in studies evaluating postoperative recovery. We 
recommend the use of the RI-10, unless the immediate postoperative days are of interest in 
which the QoR-40 was valid.
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Introduction
Traditional evaluation of medical interventions considers clinical endpoints such as efficacy, 
effectiveness, mortality and occurrence of complications (1;2). In the last decade, there has been a 
shift from disease-orientated outcomes to patient orientated outcomes, such as patient preference 
and perceived health related quality of life. 
This issue is of eminent importance in the evaluation of minimally invasive surgery. Non-
invasive surgery as compared to conventional surgery is expected to obtain cure of the underlying 
disease at an equal effectiveness, however with less burden to the patient, and therefore quicker 
recovery after the operation and earlier resumption of daily activities and work. The evaluation 
of recovery from surgery requires instruments that specifically focus on recovery during the 
short-term postoperative period. 
Although many researchers have developed ad hoc questionnaires for the postoperative 
period and even performed validation studies, none have given an answer to the question whether 
there is a necessity to use these recovery specific instruments. There is a wide range of well 
validated generic health related quality of life instruments available, like the SF-36 and RAND-
36 health surveys, Nottingham Health Profile, Sickness Impact Profile and Euroqol 5D (3). A 
recovery specific quality of life instrument needs to show advantages over these widely known 
instruments before being recommended for use in clinical trials. Korijla et al. (4) advised to use 
the SF-36 health survey in the follow up of hysterectomy patients. However, they did not review 
studies that used this instrument or other recovery specific instruments. The SF-36 is identical 
to the RAND-36, which was used in the present study (5). Myles et al. have recently developed 
an instrument to measure quality of recovery (QoR-40) and tested the validity, reliability and 
responsiveness of the instrument in 160 patients after a wide range of surgical interventions. They 
concluded that the QoR-40 was a good objective measure of quality of recovery after anesthesia 
and surgery (6). 
We translated the QoR-40 in Dutch, and developed a recovery specific instrument, the 
Recovery Index-10 (RI-10). The objective of the study was to compare these instruments with the 
RAND-36 health survey and to study their performance for the evaluation of recovery following 
gynecologic interventions. 
Methods
Population
This clinimetric study was performed using the data from a randomized and parallel non-
randomized study comparing the surgical outcomes of different types of hysterectomy  (7;8). 
Patients were recruited from August 2002 until January 2005 in the Máxima Medical Centre, a 
large teaching hospital with 865 beds on two locations in the south of The Netherlands. Women 
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who underwent a hysterectomy with and without salpingo-oophorectomy for benign and 
malignant disease were asked to participate in the study. Patients who needed simultaneous 
interventions like vaginal repair or who were not fluently speaking Dutch were not eligible for the 
study. A vaginal hysterectomy was preferred unless there was suspicion of malignancy, the size of 
the uterus exceeded 12 weeks’ gestation or the descent of the uterine cervix under traction was not 
reaching until halfway the length of the vagina. In case patients did not meet these criteria, either 
a laparoscopic or abdominal hysterectomy was performed for a mobile uterus not exceeding 18 
weeks’ gestation and in case there was no suspicion of endometrial carcinoma other than FIGO 
stage I. In case informed consent was given, those patients in whom a vaginal hysterectomy was 
not possible and a laparoscopic hysterectomy was feasible were randomized to either laparoscopic 
or abdominal hysterectomy. In case of a uterus exceeding 18 weeks’ gestation and in case of 
suspicion of advanced cancer an abdominal hysterectomy was always preferred.
The patients were asked to complete the QoR-40, RI-10 and RAND-36 prior to surgery 
and postoperatively at five respectively eight points of measurement as shown in Table 1. The 
researchers did not assist the patients during completion of the questions. The questionnaires 
that were completed following discharge were returned by mail.
Instruments
The QoR-40 is a questionnaire containing 40 items on recovery, which consists of five 
subscales: emotional state, physical comfort, psychological support, physical independence and 
pain (9). A Dutch translation was used. Each item was answered on a five-point Likert scale, 
ranging from none of the time to all the time. The QoR-40 score was defined as the sum of the 
scores of all items. The QoR-40 score ranged from 40 to 200, in which 200 indicates a perfect 
recovery. The items referred to the past 24 hours and aimed at patients during hospital stay, but 
could be filled out at home as well. 
Furthermore, we developed the Recovery Index-10 (RI-10), a 10-items questionnaire 
measuring postoperative recovery on five-point Likert scales ranging from full disagreement to 
full agreement. Two gynecologists developed the RI-10 in 1996. At that time no other recovery 
instruments, like the QoR-40, were available. The instrument was considered to be one scale and 
Table1. Point of measurement of the three instruments.
 Baseline 1 dy 2 dy 3 dy 1 wk 2 wk 4 wk 6 wk 12 wk
QoR-40 X X X X X X X X X
RI-10     X X X X X
RAND-36 X    X X X X X
QoR-40 = Quality of Recovery-40, RI-10 = Recovery Index-10, 
RAND-36 = RAND-36 health survey,  X = measurement has been performed.
the score ranged from 10 to 50, where 50 indicates a perfect recovery. A translation of the RI-10 is 
shown in appendix-1. The items referred to the past week. Since most of the items in the RI-10 
referred to the postoperative situation, no baseline measurement was available. The items suited 
best for recently discharged patients, but could be filled out in hospital as well.
The RAND-36 health survey is a widely known generic health-related quality of life 
instrument. We used the validated Dutch version (10). This instrument measured subjective 
health status in eight subscales. The range per subscale was 0-100 and thus the total score ranged 
from 0 to 800, where 0 was the poorest quality of life and 800 the best imaginable. The version 
referring to the past four weeks was used in this study.
Statistical analysis
The response rate and number of missing items were identified. In case items were missing 
and more than half of the items of the particular subscale was missing, the score of that subscale 
as well as the total scale were regarded as missing. In case half or less of the items of the subscale 
was missing, the average of the available items was used to complete the missings and determine 
the total score. Only the total scores, i.e. not the scores on subscales, were used in the study.
Cronbach’s α was calculated at one week after surgery for each questionnaire to assess the 
internal consistency. The point of measurement at one week was used, as this was the first where 
data on all three instruments were available.
To assess the construct validity of the instruments in their use of post-operative recovery, hypothesis 
testing was used (11). The hypotheses were based on literature and defined prior to the study. 
The six hypotheses tested on the three instruments were:
1.  Patients younger than 45 years have a better recovery as compared to patients older than 60 
years (12-14). 
2. Patients with ASA score 1 do recover better as compared to patients with ASA 2 or more (15). 
3.  Patients with a total hospital stay of seven days or more have a worse recovery as compared to 
patients admitted for four days or less (9;13;16-18). 
4.  Patients with complications affecting recovery (i.e. all complications leading to readmission 
or re-operation, visceral lesions without re-admission or re-operation, neurological damage, 
exacerbation of pre-existing colitis, severe wound infection and pre-existing micturition 
problem) have a worse recovery as compared to patients without any complications (15-17).
5.  Vaginal hysterectomy patients have a better recovery as compared to abdominal hysterectomy 
patients (19). Patients with peroperative conversions from laparoscopic hysterectomy to 
abdominal hysterectomy laparotomy due to complications in the days following laparoscopic 
hysterectomy and peroperative conversions from vaginal hysterectomy to abdominal 
hysterectomy were excluded from this hypothesis. 
6.  Patients with a hemoglobin decrease of less than 0.5 mmol/l have a better recovery as compared 
to patients with a hemoglobin decrease of more than 1.5 mmol/l (20). Patients who had 
received a blood transfusion were excluded from this hypothesis. 
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Differences between the groups, as defined in each of the six hypotheses of construct validity, 
were tested for statistical significance using the test of Mann-Whitney. The instrument for which 
most hypotheses were holding true was considered as having the highest construct validity. 
Again the data at one week after surgery were used. As the instruments referred to different time 
periods, i.e. the past 24 hours, past week and past four weeks, the testing of the aspects of validity 
as mentioned above was repeated making use of the four-week data. 
Correlations among the three instruments at one week after surgery were calculated using 
Spearman’s correlation coefficient.
Each instrument was assessed at several points in time. We assumed that the postoperative 
patients recovered continuously during at least six weeks. The responsive period of the instrument 
can be defined as the time period in which the score shows a change over time. The range of the 
mean scores over time as a percentage of the instruments total range was used as an indicator 
of responsiveness. A linear mixed model was used to study the mean levels in the quality of life 
score over time (21). The dependent variable was the quality of life score. The independent class 
variables were patient and time in weeks after surgery. The intercept of each patient was treated 
as random variable in the model. This way, random differences between patients are allowed. The 
estimated mean levels per week with 95% confidence bands were visualized in figures.
Recovery following hysterectomy as measured by the three instruments
Difference in recovery over time on the three instruments was studied in the RCT comparing 
the data of patients randomized to laparoscopic versus abdominal hysterectomy, who were not 
threatened by malignancy. The recovery scores during the suggested responsive time period of 
each instrument were used. The treatment effect was analyzed on an intention to treat basis.
A linear mixed model was used to study the increase in the quality of life score over time in 
the treatment groups (21). The dependent variable was the quality of life score. The independent 
class variables were patient, time in weeks after surgery and treatment group (laparoscopic and 
abdominal hysterectomy). In case of the RAND-36 and QoR-40 the baseline level was added to 
the model as an independent regression variable. The intercept of each patient was treated as 
random variable in the model. Initially the interaction term between time and group was added 
to the model. However, this term did never reach the level of statistical significance and was 
removed from the final model. The estimated regression parameters with standard errors of each 
score are used to calculate the average level per week in each treatment group. These levels with 
confidence bands are further presented in figures.
All data were analyzed using SAS 10.0 software (SAS Institute, Inc., Chicago, IL) and SPSS 
13.0 software (SPSS, Inc., Chicago, IL). P-values below 0.05 were considered as statistically 
significant. 
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Results
We included a total of 161 hysterectomy patients in the clinimetric study. Twenty-one 
underwent vaginal hysterectomy, 76 abdominal hysterectomy and 64 laparoscopic hysterectomy. 
In the abdominal hysterectomy group, surgery had been started as vaginal hysterectomy twice 
and as laparoscopic hysterectomy in seven cases. Patient characteristics and indications for the 
intervention are shown in Table 2. 
Clinimetrics
The overall response rate was 94%, ranging from 100% for the first days after surgery to 84% 
twelve weeks after surgery. The percentage of missing items ranged per point of measurement from 
0.2 to 1.9% in the QoR-40, from 0.1 to 0.7% in the RI-10 and 0.1 to 0.6% in the RAND-36. 
Cronbach’s α at one week after surgery was 0.93 for the QoR-40, 0.81 for the RI-10 and 0.86 
for the RAND-36, showing good internal consistency.
Table 3 shows the results of the construct validity assessment as measured by testing six 
pre-defined hypotheses at one week after surgery on all three instruments. Two hypotheses were 
confirmed in the QoR-40, three in the RI-10 and one in the RAND-36. In the hypothesis on 
difference in recovery amongst age groups, the QoR-40 and RI-10 were unexpectedly showing a 
significant better recovery in the older age group. A prolonged hospital stay and the occurrence 
95
Instruments measuring postoperative recovery
Table 2. Patient characteristics.
 Total (n=161)
Age (yr) 49.1 ± 9.1
BMI (kg/m 2)  26.9 ± 5.7
Parity 1.8 ± 1.2
ASA score 1 [1-3]
Employed women 106 (66) 
Benign disease 127 (79)
Uterine weight (gr) 173 [30-1560] 
No complication 89 (55) 
Hb decrease (mmol/l) 1.1 ± 0.7
Hospitalization (dy) 5.8 ± 4.7
Readmissions 9 (6) 
Return to theatre 7 (4) 
BMI = body mass index; ASA score = physical status classification of the American Society of Anesthesiologists; 
Hb = hemoglobin; Hospitalisation (dy) = Hospitalisation incl readmissions in days.
Data shown as mean ± standard deviation, median [range] or absolute numbers (percentage).
of complications was significantly associated with a lower mean score in all questionnaires, 
although this difference was only borderline significant in the hypothesis on complications in 
the RAND-36. The results of the construct validity testing at four weeks after surgery were 
comparable to those at one week after surgery, although a slight reduction in the performance 
of the QoR-40 and a slight improvement in the performance of the RAND-36 has been found 
(data not shown). 
Correlation at one week after surgery was high amongst the two recovery specific instruments 
(r=0.63), and moderate amongst each recovery specific instruments and the RAND-36 (r=0.37-
0.38). 
Observed mean scores at baseline and observed and estimated mean scores in the postoperative 
period of the 161 patients are shown in Figures 1 a, b and c.
The range of the QoR-40 mean scores over time was 25% of the instruments total range, 
whereas the RI-10 scores ranged over 33% of the total range and the RAND-36 scores over 17% 
of the total range. Between two and twelve weeks after surgery the QoR-40 mean scores ranged 
over no more than 4% of the total range of the instrument, which shows that the QoR-40 was not 
responsive beyond two weeks after surgery. The RI-10 showed an increase and thus responsiveness 
during the entire twelve-week postoperative period, whereas the mean score on the RAND-36 
did not change in the first two weeks after surgery and was not responsive in this time period. 
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Table 3. The mean scores (standard error) of the three instruments at one week after surgery by the groups as defined 
in the six hypotheses.
 QoR-40 RI-10 RAND-36 
Hypothesis  Group n Mean (SE) p n Mean (SE) p n Mean (SE) p
1 Age < 45 years  48 165 (3.3) 0.02 49 24.0 (1.0) 0.00 49 407 (13.6) 0.53
 > 60 years 14 180 (4.1)  16 32.5 (1.7)  16 389 (26.9) 
2 ASA score ASA 1 90 173 (2.0) 0.09 94 27.3 (.7) 0.14 94 422 (10.0) 0.20
 ASA 2 + 3 58 167 (2.9)  60 25.5 (1.0)  61 401 (13.6) 
3 Hospital   ≤ 4 days 68 176 (2.3) 0.00 72 29.4 (.9) 0.00 72 446 (10.5) 0.00
   stay ≥ 7 days 26 159 (4.9)  25 23.3 (1.4)  26 379 (21.5) 
4 Complica- None 79 174 (2.0) 0.00 86 28.9 (.7) 0.00 86 421 (10.9) 0.07
   tions Major 16 151 (6.7)  15 20.3 (1.9)  16 370 (24.7) 
5 Treatment VH 19 166 (6.2) 0.95 20 27.1 (1.7) 0.05 20 421 (25.6) 0.37
 AH 59 167 (2.2)  62 23.6 (.8)  63 397 (13.0) 
6 Hb- <0.5 mmol/l  22 175 (4.4) 0.07 23 27.1 (1.3) 0.25 23 421 (22.2) 0.38
   decrease >1.5 mmol/l 32 163 (4.5)  32 24.6 (1.5)  32 394 (20.5) 
QoR-40 = Quality of Recovery-40, RI-10 = Recovery Index-10, RAND-36 = RAND-36 health survey, n = number op patients, 
SE = standard error, p =  p-value for difference among groups using the test of Mann-Whitney, 
ASA score = physical status classification of the American Society of Anesthesiologists, 
VH = vaginal hysterectomy, AH = abdominal hysterectomy, Hb = Hemoglobin.
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Figure 1 a,b,c. Observed scores and estimated mean scores with 95% confidence bands in 161 hysterectomy 
patients, using a linear mixed model. 
RAND-36 = RAND-36 health survey, QoR-40 = Quality of Recovery-40, RI-10 = Recovery Index-10. Closed symbols = observed 
mean score with the vertical bar indicating one standard error, solid line = the line that joins the estimated mean scores, 
dotted lines = 95% confidence bands. 
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Figure 2
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Figure 2 a,b,c. Estimated mean scores with 95% confidence bands by treatment group, using a linear mixed 
model.
RAND-36 = RAND-36 health survey, QoR-40 = Quality of Recovery-40, RI-10 = Recovery Index-10, AH = abdominal hysterectomy, 
LH = laparoscopic hysterectomy. Thick solid line = line that joins the estimated mean scores in LH group, dotted line = 95% confidence 
bands. Thick broken line = line that joins the estimated mean scores in AH group, dotted line = 95% confidence bands. 
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Recovery following hysterectomy: results on the three instruments
Fifty-nine patients with benign indications for surgery had been randomized to either 
laparoscopic (n=27) or abdominal hysterectomy (n=32). There was a statistically significant 
treatment effect of 11.7 (3.9) units in the QoR-40 and 5.72 (1.45) units in the RI-10 both favoring 
laparoscopic hysterectomy (Table 4). Figures 2 a,b and c show the estimated mean scores with 
95% confidence bands by treatment group. 
Discussion
This is, to our knowledge, the first study comparing postoperative recovery as measured by 
specific and generic instruments. The study was conducted to examine whether the application 
of a recovery specific quality of life instrument was more valid as compared to a generic health 
related quality of life instrument for the assessment of postoperative recovery. In other words, the 
objective of the study was to evaluate whether there is a need for recovery specific questionnaires. 
The QoR-40, RI-10 and RAND-36 showed good internal consistency. The three instruments 
showed comparable construct validity with the best performance in the RI-10. Moreover, the 
RI-10 showed the best responsiveness with an increase during the entire 12 weeks postoperative 
period, as well as the greatest score range over time in relation to the instruments score range. 
Table 4. Evaluation of three recovery questionnaires in randomized laparoscopic and abdominal hysterectomy 
patients, using a linear mixed model.
 QoR-40 p RI-10 p RAND-36 p
Score range 40 - 200 - 10 - 50 - 0 - 800 -
Postoperative    1day – 2 weeks - 1week – 12 weeks  - 2 weeks – 12 weeks -
time period  
Treatment effect * 11.7 (3.9)  < 0.01 5.72 (1.45)  < 0.01 42.3 (26.1) 0.11
Baseline effect 0.1 (0.1)  0.21 - - 0.2 (0.1)  0.01
Time effect ** 10.8 (1.6) < 0.01 1.35 (0.08) < 0.01 13.8 (1.4) < 0.01
SDw 13.4 - 4.40 - 75.7 -
SDb 11.8 - 5.13 - 87.0 -
QoR-40 = Quality of Recovery-40, RI-10 = Recovery Index-10, RAND-36 = RAND-36 health survey, p = p-value for difference 
using a linear mixed model, treatment effect = estimated increase in score (standard error) by treatment group, baseline effect = 
estimated increase in score (standard error) by unit increase in baseline score, time effect = estimated increase in score (standard 
error) per week, SDw = standard deviation within patients, SDb = standard deviation between patients, - = not applicable. 
Notes: *Treatment effect favors LH, **In the model different increments between the points of measurement were allowed, 
but for the ease of presentation the average increase per week was presented.
At the start of this research project in 1996, there was no valid recovery specific instrument 
available to measure recovery from laparoscopy versus open surgery in gynecology. The number 
of items was an important issue in the development of the RI-10, as to cause as less trouble as 
possible to patients in their recovery period. Consequently, this instrument may be advantageous 
due to its limited number of questions. However, the validation process has only been performed 
for the Dutch language until now. A limitation of the questionnaire is that a baseline measurement 
is lacking, since most of the questions refer to the postoperative situation. Furthermore, the target 
population was not involved in the development and no item reduction techniques were applied, 
as has been recommended (22). 
The QoR-40 has shown to be a valid and reliable tool for measurement of recovery in a 
wide range of surgical patients. In a cardiac surgical population, a poor QoR-40 score on day 3 
was moderately correlated to a poor quality of life as measured by SF-36 at 3 month after the 
operation (17). Although Leslie et al. (16) have shown that the questionnaire did not discriminate 
between the recovery of cranial and spinal surgical patients, the conclusion of their study was that 
the QoR-40 had shown to be valid and reliable in a neurosurgical population as well. The mean 
score on day 1 in the adult cardiac surgical population as describes by Myles et al. (17) and the 
neurosurgical population as describes by Leslie et al. (16) was 163 and 160 respectively. Whereas 
baseline scores were comparable, our hysterectomy patients have a lower QoR-40 score with a 
mean score of 143 on day 1. Unfortunately, the QoR-40 has not been translated in accordance 
with prevailing rules of back and forward translations, but the Cronbach’s α were comparable 
to those in the English version (17).
Although the RAND-36 is a more extensive instrument and was less responsive as compared 
to the RI-10, it has the advantage of being a more widely known questionnaire with well-validated 
subscales. In this study the total score of the instruments have been used for validation. Whether 
one of the eight subscales of the RAND-36 has better clinimetric properties for the measurement 
of postoperative recovery has not been studied.
Cronbach’s α has been calculated for the three instruments and found satisfactory. However, 
in instruments focusing on evaluation of health status, responsiveness is more important than 
internal consistency (23;24). As recovery in the first weeks after surgery is expected to be a very 
dynamic process, we did not check for test-retest reliability in the present study. 
It has been stated that at least 75% of pre-defined hypotheses should hold true on statistical 
testing to conclude that there is good validity (22). The instrument coming closest at one week 
after surgery was the RI-10 where three out of six hypotheses (50%) were confirmed. In the 
present study we were looking for the instrument where most hypotheses would hold true as 
compared to the others. This led to the formulation of quite challenging hypotheses, which 
were less likely to be confirmed in our population. This was probably the case for the difference 
between women with an ASA score 1 and women with an ASA score of at least 2, where none 
of the questionnaires could identify a difference between the groups. Since there were only six 
patients with an ASA score 3, we were practically testing for a difference between ASA score 1 
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and 2. From a clinical point of view a difference in recovery among these groups is not very likely. 
Lack of contrast was probably also the case for the hypothesis on hemoglobin decrease, as these 
two groups do not seem to be differing enough in relation to the sensitivity of the instruments 
used. 
Although it has previously been shown that older patients have lower quality of life scores 
and poorer recovery (12-14), we were not able to confirm this in our population. In the RI-10 
and QoR-40 the patients aged above 60 years had a significantly better recovery as compared to 
the women of less than 45 years of age. Moreover, as compared to the groups as defined in other 
hypotheses, the patient group aged above 60 years had a remarkable high quality of life score. 
This was in the exact opposite direction as defined in the hypothesis. Possibly, this difference 
in recovery was due to a difference in indications for surgery, since eleven women (65%) in the 
older age group were operated for endometrial carcinoma and another five women (29%) for 
atypical hyperplasia of the endometrium, which is a potentially malignant condition. Another 
possible explanation is that the older patients have corrected for their age their selves, and thus 
did not experience any mismatch between expectations and actual recovery. 
Surprisingly, the hypothesis comparing vaginal and abdominal hysterectomy was only 
confirmed in the RI-10. Since it is widely accepted that vaginal hysterectomy is the first choice 
approach to hysterectomy, we would have expected to find differences in the other instruments 
as well (19).
The three instruments refer to different time periods after surgery, since the QoR-40 is 
referring to the past 24 hours, the RI-10 is referring to the past week and the RAND-36 is referring 
to the past four weeks. Furthermore, the questionnaires refer to different situations in the recovery 
process, i.e. in hospital for the QoR-40 and at home for RI-10 and RAND-36. This may have had 
an influence on the comparability of the instruments and might also be the explanation for the 
absence of change in the first two weeks in the RAND-36 and the weak correlation between the 
recovery specific instruments and the RAND-36 at one week after surgery. Furthermore, we did 
not apply the RI-10 and RAND-36 in the first days after surgery as we did for the QoR-40. The 
QoR-40 showed great changes in quality of life in these days. Whether this would also have been 
the case for the RI-10 and RAND-36 is less likely, although not proven at this stage. In retrospect, 
it would probably have been more appropriate to distribute all three questionnaires in the first 
days after surgery and to use the so-called acute-version of the RAND-36 referring to the past 
week (25). The pattern of score changes over time, imply that it is appropriate to use the QoR-40 
on a daily basis in the first days after surgery and stop the application two weeks after surgery. 
Since the RAND-36 score does not change in the first two weeks after surgery, it is appropriate 
to await the application until this time point. The RI-10 can be applied for at least twelve weeks 
postoperatively as a change in score was seen along this time period. 
Application of the instruments in the RCT, showed a statistically significant treatment 
effect in favor of the laparoscopic hysterectomy in the two recovery specific instruments. As 
this analysis was an evaluation over time, this is another indication for better responsiveness of 
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these instruments. The curve of the QoR-40 scores does not fit to a linear or parabolic model, 
which makes interpretation of the results over time more difficult. The decrease in mean score 
at one week after surgery might be caused by the discharge from hospital, as the laparoscopic 
hysterectomy patients returned home at a mean of 4.2 days and the abdominal hysterectomy 
patients at a mean of 5.4 days after surgery. Possibly, there are more or less two separate QoR-40 
curves, i.e. one for hospitalized and one for discharged patients, which was not further evaluated 
in the present study. 
In conclusion, the QoR-40, RI-10 and RAND-36 showed comparable internal consistency. 
With regard to construct validity, the RI-10 appeared to perform best and was more responsive as 
compared to the QoR-40 and RAND-36. Therefore we recommend the use of the short recovery 
specific questionnaire RI-10 in studies on postoperative recovery. However, in studies where the 
main interest is in hospitalized patients in their first postoperative days, the QoR-40 has likewise 
shown to be valid. 
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Vragenlijst Kwaliteit van Herstel Patientnummer:
Studienummer:
Volgnummer:
Geachte mevrouw,
om inzicht te krijgen in het herstel na de operatie die u heeft ondergaan, vragen wij u deze vragenlijst in te
vullen.
Geeft u daarvoor alstublieft bij elke vraag het antwoord dat het beste weergeeft hoe u zich de laatste 24
uur voelde. Dit gebeurt op een schaal van 1 tot 5. Boven de getallen staat de betekenis van de getallen. 
Datum:
Hoe heeft u zich de laatste 24 uur gevoeld?
Welbevinden
helemaal niet waar helemaal waar
Ik kan gemakkelijk ademhalen . . . . . . . . . . . . . . . . . . . 1 2 3 4 5
Ik heb goed geslapen . . . . . . . . . . . . . . . . . . . . . . . . . . 1 2 3 4 5
Het eten heeft me gesmaakt. . . . . . . . . . . . . . . . . . . . . 1 2 3 4 5
Ik voel me uitgerust . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 2 3 4 5
Gevoelens
helemaal niet waar helemaal waar
Ik voel me over het algemeen goed . . . . . . . . . . . . . . . 1 2 3 4 5
Ik heb de situatie / mezelf in de hand . . . . . . . . . . . . . . 1 2 3 4 5
Ik voel me op mijn gemak. . . . . . . . . . . . . . . . . . . . . . . 1 2 3 4 5
Zelfredzaamheid
helemaal niet waar helemaal waar
Ik kan goed een gesprek voeren. . . . . . . . . . . . . . . . . . 1 2 3 4 5
Ik kan mezelf wassen en tandenpoetsen. . . . . . . . . . . . 1 2 3 4 5
Ik kan mezelf verzorgen . . . . . . . . . . . . . . . . . . . . . . . . 1 2 3 4 5
Ik kan schrijven . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 2 3 4 5
Ik kan werken / werkzaamheden thuis verrichten . . . . . 1 2 3 4 5
Voorbeeld:
helemaal niet waar helemaal waar
Ik kan gemakkelijk ademhalen . . . . . . . . . . . . . . . . . . . 1 2 3 4 5
Als u de laatste 24 uur steeds gemakkelijk kon ademhalen, omcirkelt u de 5. 
Appendix 1. Quality of recovery - 40
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Hoe heeft u zich de laatste 24 uur gevoeld?
Steun
helemaal niet waar helemaal waar
Het is mogelijk in het ziekenhuis met artsen en. . . . . . . 1 2 3 4 5
verpleegkundigen te spreken
Het is mogelijk met familie en vrienden te spreken . . . . 1 2 3 4 5
Ik word gesteund door de artsen in het ziekenhuis . . . . 1 2 3 4 5
Ik word gesteund door de verpleegkundigen . . . . . . . . . 1 2 3 4 5
in het ziekenhuis
Ik word gesteund door familie en vrienden . . . . . . . . . . 1 2 3 4 5
Ik begrijp uitleg en adviezen . . . . . . . . . . . . . . . . . . . . . 1 2 3 4 5
Welbevinden
helemaal niet waar helemaal waar
Ik heb last van misselijkheid . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb overgegeven . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik moet kokhalzen . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik voel me rusteloos . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb last van trillen of beven . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb last van rillerigheid . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb het te koud. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb last van duizeligheid. . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Gevoelens
helemaal niet waar helemaal waar
Ik heb naar gedroomd . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik voel me angstig . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik ben boos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik voel me somber . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik voel me alleen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb moeite om in slaap te komen . . . . . . . . . . . . . . . 5 4 3 2 1
Ik voel me verward . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Pijn en klachten
helemaal niet waar helemaal waar
Ik heb matige pijn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb ernstige pijn . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb hoofdpijn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb spierpijn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb rugpijn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb een pijnlijke mond . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
Ik heb een pijnlijke keel . . . . . . . . . . . . . . . . . . . . . . . . 5 4 3 2 1
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Vragenlijst: Herstel na operatie
Recovery index-10
De volgende vragen hebben betrekking op hoe u zich de afgelopen week heeft
gevoeld.
Er zijn geen foute antwoorden mogelijk. U kunt per vraag maar één cijfer aankruisen of omcircelen.
De antwoorden staan op een vijfpuntenschaal. Als u het helemaal eens bent met de uitspraak
omcirceld u een 1, als u het een beetje eens bent een 2, etc. Als u het er helemaal mee oneens bent
omcircelt u een 5.
      Helemaal       Helemaal
Hoe heeft u zich de afgelopen week gevoeld?        eens        oneens
1. Ik ben snel moe 1 2 3 4 5
2. Overdag moet ik regelmatig rusten 1 2 3 4 5
3. Ook als ik niets doe heb ik regelmatig last
 van buikpijn 1 2 3 4 5
4. Zelfs lichte inspanning (b.v. koffie zetten) kan
 ik nauwelijks doen 1 2 3 4 5
5. Ik voel me volledig hersteld na de operatie 1 2 3 4 5
6. Ik kan mijn normale dagelijkse bezigheden
 in huis helemaal doen 1 2 3 4 5
7. Sinds de operatie heb ik moeite met slapen 1 2 3 4 5
8. De operatie en het herstel daarna zijn minder
 goed verlopen dan ik mij had voorgesteld 1 2 3 4 5
9. Ik heb in het algemeen veel pijn gehad na
 de operatie 1 2 3 4 5
10. De klachten waarvoor ik ben geopereeerd zijn
 volledig verdwenen 1 2 3 4 5
Appendix 2. Recovery index - 10
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RAND 36
Toelichting
In deze vragenlijst wordt naar uw gezondheid gevraagd.
Wilt U elke vraag beantwoorden door het juiste hokje aan te kruisen. Wanneer U twijfelt over het
antwoord op een vraag, probeer dan het antwoord te geven dat het meest van toepassing is.
1. Wat vindt u, over het algemeen genomen, van uw gezondheid?
uitstekend �
zeer goed �
goed �
matig �
slecht �
2. In vergelijking met een jaar geleden, hoe zou u nu uw gezondheid in het algemeen
beoordelen?
Veel beter dan een jaar geleden �
Iets beter dan een jaar geleden �
Ongeveer hetzelfde als een jaar geleden �
Iets slechter dan een jaar geleden �
Veel slechter dan een jaar geleden �
3. De volgende vragen gaan over dagelijkse bezigheden.
Wordt u door uw gezondheid op dit moment beperkt bij deze bezigheden? Zo ja, in welke
mate?
ja,
ernstig
beperkt
ja, een
beetje
beperkt
nee, hele-
maal niet
beperkt
a. Forse inspanning
zoals hardlopen, zware voor-
werpen tillen, inspannend sporten
� � �
b. Matige inspanning
zoals het verplaatsen van een
tafel, stofzuigen, fietsen
� � �
c. Tillen of boodschappen dragen � � �
d. Een paar trappen oplopen � � �
e. Eén trap oplopen � � �
f. Buigen knielen of bukken � � �
g. Meer dan een kilometer lopen � � �
h. Een have kilometer lopen � � �
i. Honderd meter lopen � � �
j. Uzelf wassen of aankleden � � �
Appendix 3. RAND - 36 health survey
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4. Had u, ten gevolge van uw lichamelijke gezondheid de afgelopen 4 weken één van de
volgende problemen bij uw werk of andere dagelijkse bezigheden?
ja nee
a. U heeft minder tijd kunnen besteden aan werk
of andere bezigheden
� �
b. U heeft minder bereikt dan u zou willen � �
c. U was beperkt in het soort werk of het soort
bezigheden
� �
d. U had moeite met het werk of andere bezig-
heden (het kostte u b.v. extra inspanning)
� �
5. Had u, ten gevolge van een emotioneel probleem (bijvoorbeeld doordat u zich depressief of
angstig voelde), de afgelopen 4 weken één van de volgende problemen bij uw werk of andere
dagelijkse bezigheden?
ja nee
a. U heeft minder tijd kunnen besteden aan werk
of andere bezigheden
� �
b. U heeft minder bereikt dan u zou willen � �
c. U heeft het werk of andere bezigheden niet zo
zorgvuldig gedaan als u gewend bent
� �
6. In hoeverre heeft uw lichamelijke gezondheid of hebben van emotionele problemen u de
afgelopen 4 weken belemmerd in uw normale sociale bezigheden met gezin, vrienden, buren
of anderen?
helemaal niet �
enigszins �
nogal �
veel �
heel erg veel �
7. Hoeveel pijn had u de afgelopen 4 weken?
geen �
heel licht �
licht �
nogal �
ernstig �
heel ernstig �
8. In welke mate heeft pijn u de afgelopen vier weken belemmerd bij uw normale
 werkzaamheden (zowel werk buitenshuis als huishoudelijk werk)?
helemaal niet �
een klein beetje �
nogal �
veel �
heel erg veel �
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9. Deze vragen gaan over hoe u zich de afgelopen 4 weken heeft gevoeld. Wilt U bij elke vraag
het antwoord aankruisen dat het beste aansluit bij hoe U zich heeft gevoeld.
Hoe vaak gedurende de afgelopen 4 weken:
Voort-
durend
meestal vaak soms zelden nooit
a. voelde u zich levenslustig? � � � � � �
b. voelde u zich erg zenuwachtig? � � � � � �
c. zat u zo erg in de put dat niets u
kon opvrolijken?
� � � � � �
d. voelde u zich kalm en rustig? � � � � � �
e. voelde u zich erg energiek? � � � � � �
f. voelde u zich neerslachtig en
somber?
� � � � � �
g. voelde u zich uitgeblust? � � � � � �
h. voelde u zich gelukkig? � � � � � �
i. voelde u zich moe? � � � � � �
10. Hoe vaak hebben uw lichamelijke gezondheid of emotionele problemen gedurende de
afgelopen 4 weken uw sociale activiteiten (zoals bezoek aan vrienden of naaste familieleden)
belemmerd?
voordurend �
meestal �
soms �
zelden �
nooit �
11. Wilt U het antwoord kiezen dat het beste weergeeft hoe juist of onjuist u elke van de
volgende uitspraken voor uzelf vindt.
volkomen
juist
groten-
deels
juist
weet
ik
niet
groten-
deels
onjuist
volkomen
onjuist
a. Ik lijk gemakkelijker ziek te worden dan
andere mensen.
� � � � �
b. Ik ben net zo gezond als andere mensen
die ik ken.
� � � � �
c. Ik verwacht dat mijn gezondheid achteruit
zal gaan.
� � � � �
d. Mijn gezondheid is uitstekend. � � � � �
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Abstract
Objective
Laparoscopic hysterectomy and abdominal hysterectomy are alternative approaches for 
hysterectomy in women with a moderately enlarged uterus. This study was performed to elicit 
women’s preferences on the subject.
Study design
Patients scheduled for hysterectomy and nurses were assessed in individual, structured interviews 
and a questionnaire identical to the interview respectively. Specific advantages and disadvantages 
of laparoscopic and abdominal hysterectomy were explained. In the interview we assessed patients’ 
preferences for laparoscopic or abdominal hysterectomy. We asked for the maximum acceptable 
risk of major complications and the maximum acceptable risk of conversion from laparoscopic 
hysterectomy to abdominal hysterectomy. 
Results
We interviewed 43 patients and 39 nurses. Eighty-four percent of patients and 74 percent of 
nurses preferred laparoscopic hysterectomy over abdominal hysterectomy. The avoidance of 
complications was indicated as the most important influencing factor. More than half of the 
women perceived 1% as the maximum acceptable major complication rate. 
Conclusions
Women prefer laparoscopic hysterectomy over abdominal hysterectomy. The actual major 
complication rate in hysterectomy is perceived as high. 
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Introduction
Laparoscopic hysterectomy has been introduced in 1989 as an alternative to abdominal 
hysterectomy (1). Since then, both approaches have been compared in more than 30 randomised 
controlled trials. A meta-analysis of these trials demonstrated that laparoscopic hysterectomy was 
associated with less operative blood-loss, less post-operative pain and less infectious morbidity, 
as well as a shorter hospital stay and more rapid return to normal activities. On the other hand, 
longer operating times and more urinary tract injuries have been reported for laparoscopic 
hysterectomy (2;3), which seem partly due to the learning curve (4;5). 
The introduction of laparoscopy in gynaecology develops at a slow pace. In 2002, only 4% of 
hysterectomies in the Netherlands was performed laparoscopically (6). The Council for Public 
Health and Health Care (Raad voor de Volksgezondheid en Zorg), an independent body that 
advises the Dutch government, supports the implementation of minimal access surgery in health 
care (7). Some gynaecologists are enthusiastic about the new technique and judge that the patients 
are better off with a quick recovery. Other gynaecologists, however, are reserved due to the higher 
major complication rate. 
Although the choice for laparoscopic or abdominal hysterectomy can only be made after 
a weighing of the pros and cons of the procedure. At present, patients have not been involved 
systematically in the decision for the introduction of laparoscopic hysterectomy. The assessment 
of patient weighing of advantages and disadvantages could indicate the need for individualised 
treatment-decisions if patients make different trade-offs. On the other hand, if a large majority 
of patients clearly favours laparoscopic or abdominal hysterectomy, this could either stimulate 
the implementation of laparoscopic hysterectomy, or lead to an abandoning of the procedure.
Nowadays, the choice for a treatment option is more based on shared decision-making 
as compared with the past, although it is known that doctors still underestimate the patients’ 
desire for the involvement in the decision-making (8). A recent survey in Scotland showed that 
half of the women with benign menstrual problems scheduled for either vaginal, abdominal or 
laparoscopic hysterectomy had not been informed on advantages and disadvantages of treatment 
options other than hysterectomy (9). Moreover, half of these women had not been informed 
on advantages and disadvantages of the different approaches to hysterectomy, and one in every 
five women did not even know which approach to hysterectomy was planned in her individual 
case (10). 
Although both laparoscopic and abdominal hysterectomy are viable options in women 
with a moderately enlarged uterus, the preference of women has, to our knowledge, not been 
assessed systematically. The aim of the present paper was to investigate women’s preferences 
for laparoscopic or abdominal hysterectomy, as well as the main factors underlying these 
preferences.
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Material and Methods
We studied both patients scheduled for hysterectomy as well as nurses. Patients were recruited 
at the Máxima Medical Center between January 2005 and April 2007. The Máxima Medical 
Center is a teaching hospital with 865 beds on two locations in the south of The Netherlands. 
The gynaecology department of the Máxima Medical Center is experienced in minimally invasive 
surgery, and the first laparoscopic hysterectomy was performed in 1992. 
Patients scheduled for hysterectomy for benign disease in whom vaginal surgery was not 
suitable, but in whom laparoscopic hysterectomy and/or abdominal hysterectomy were feasible, 
were included in the study. A laparoscopic hysterectomy and/or abdominal hysterectomy was 
indicated in case the size of the uterus was not beyond 18 weeks’ gestation. In case the uterus was 
larger than 18 weeks’ gestation, the patient was always scheduled for abdominal hysterectomy. The 
inclusion was not consecutive, but occurred arbitrarily depending on the presence of members 
of the study group and the availability of the research nurse who performed the interviews. 
Exclusion criteria were inability to speak Dutch and an expected endometrial carcinoma of stage 
II or higher. The study was exempt from Institutional Review Board approval.
Nurses were recruited from the departments for paediatrics, obstetrics, general surgery 
and internal medicine at the Radboud University Medical Centre, Nijmegen, The Netherlands. 
Inclusion criteria were being female, and not being involved in the care of hysterectomy patients. 
The nurses were asked to imagine that they were scheduled to undergo hysterectomy. 
The patient group was assessed through a structured face-to-face interview taken by one 
research nurse. These interviews lasted for approximately one hour. Patients were invited for 
a second interview approximately six weeks after the procedure. The nurses completed the 
questionnaires without assistance of the researchers and returned them by mail.
The interview or questionnaire was introduced with the (hypothetical) situation that vaginal 
hysterectomy was not feasible, and that there were two alternative approaches to hysterectomy, 
of which none was superior; both having specific advantages and disadvantages. 
The first two questions addressed the attitude of women to the decision-making process in 
general, including the amount of information the woman desired to receive on specific advantages 
and disadvantages of treatments, as well as the desired involvement in decision-making. 
Subsequently, global information was provided on laparoscopic and abdominal hysterectomy, 
without explication of exact rates or figures. In short, abdominal hysterectomy was described 
as a procedure requiring an abdominal incision, associated with less major complications 
(e.g. injury to adjacent organs and major blood loss), and more minor complications (e.g. 
infections and wound healing problems). Laparoscopic hysterectomy was presented as a minimal 
access procedure, with a risk of conversion to laparotomy. However, a successful laparoscopic 
hysterectomy would result in a quicker recovery. Subsequently, women were asked for the first 
time whether they would prefer laparoscopic or abdominal hysterectomy.
In the next part of the interview, the two approaches to hysterectomy and their advantages 
and disadvantages were explained in detail in a text of 600 words of which a summary is shown in 
Table 1. The presented complication rates, conversion rates, duration of hospital stay and duration 
of recovery were based on a recent randomized controlled trial from the local department (11), a 
meta-analysis on the subject (3), two prospective studies (4;12) and three retrospective case series 
(5;13;14) including over 10,000 laparoscopic hysterectomies. The figures and rates presented were 
mainly applicable to experienced surgeons beyond their learning curve.
When women indicated that they had read and understood the supplied detailed information, 
they were asked again to indicate a preference for laparoscopic or abdominal hysterectomy. 
Subsequently, the preference was assessed for the hypothetical situation of equal complication 
rates for both approaches to hysterectomy and no risk of conversion in laparoscopic hysterectomy. 
Women were furthermore asked whether they would accept a two-fold increased major 
complication rate in laparoscopic hysterectomy as compared with abdominal hysterectomy 
and whether they thought a possible conversion from laparoscopic hysterectomy to abdominal 
hysterectomy to be acceptable. Subsequently, women were asked to indicate the highest 
complication rate in laparoscopic hysterectomy and the highest conversion rate from laparoscopic 
hysterectomy to abdominal hysterectomy, that they still considered being acceptable.
Finally, the importance of individual advantages and disadvantages of laparoscopic and abdominal 
hysterectomy was rated on a five-point Likert scale (very unimportant until very important) for the 
following factors: avoidance of complications, avoidance of conversions, restriction of operation 
times, limitation of the recovery period and the avoidance of abdominal scars. 
Statistical analysis
Normally distributed data were presented as mean and standard deviations, whereas skewed 
distributed data were presented as medians with a range. In case of dichotomous variables, data 
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Table 1. Detailed information on differences between laparoscopic and abdominal hysterectomy.
 LH AH
Type of anesthesia General General
Removal uterus, cervix and ovaries Identical to AH Identical to LH
Incision 4 small incisions Low transverse incision
Risk of conversion during surgery from LH to AH  10%  None
Operation time (minutes) 130 90
Major complications More frequent as in AH Less frequent as in LH
Injury to adjacent organs 1% 0.5%
Minor complications Less frequent as in AH More frequent as in LH
Hospital stay (days) 3 - 4  4 - 6
Pain in first 3 weeks after surgery Less painful as in AH More painful as in LH
Return normal activities (weeks) 3 - 6 5 – 8 
LH = laparoscopic hysterectomy; AH = abdominal hysterectomy.
were presented as absolute numbers with percentages. Differences between groups (patients 
versus nurses, laparoscopic hysterectomy versus abdominal hysterectomy and preoperative versus 
postoperative assessment) were tested with t-tests and non-parametric Wilcoxon-Mann-Whitney 
tests as appropriate. Chi-square tests were used for dichotomous data. 
Thresholds for risk of complications and conversions were visually presented in cumulative 
distribution curves, reflecting the overall willingness to accept risks. 
Data were analysed in SPSS 13.0 software (SPSS, Inc., Chicago, IL). P-values < 0.05 were 
considered to indicate statistical significance.
Results 
We interviewed 43 patients, of whom 32 were scheduled for laparoscopic hysterectomy and 
11 for abdominal hysterectomy. These groups are referred to as the laparoscopic hysterectomy 
group and abdominal hysterectomy group, respectively. The mean age was 46.6 (standard 
deviation 8.0) years in the laparoscopic hysterectomy group and 44.6 (standard deviation 5.4) 
years in the abdominal hysterectomy group. Five women, who were scheduled for abdominal 
hysterectomy, did not have an actual choice for laparoscopic hysterectomy, due to an enlarged 
uterus or endometriosis. One of the laparoscopic procedures was converted to an abdominal 
hysterectomy during the procedure, due to a bleeding that could not be controlled by laparoscopy. 
Twenty-six women (81%) in the laparoscopic hysterectomy group and ten women (91%) in the 
abdominal hysterectomy group returned for the post-operative interview. 
Thirty-nine nurses completed the questionnaire, of whom six (15%) had undergone prior 
hysterectomy. The mean age of the nurses was 41.8 (standard deviation 10.5) years.
There was no difference in the desired amount of information on advantages and disadvantages 
of treatment options and the desired involvement in the decision-making between patients and 
nurses (Table 2). Overall, 81% of women preferred laparoscopic hysterectomy (Table 2). There 
was no difference in treatment preferences between the nurses and the patients (p=0.38). 
At the post-operative interview, none of the women scheduled for laparoscopic hysterectomy 
had changed her preference for laparoscopic hysterectomy, whereas two women (18%), who 
had been scheduled and had undergone abdominal hysterectomy, changed their post-operative 
preference. One woman changed her preference from laparoscopic hysterectomy to abdominal 
hysterectomy, whereas the other switched from abdominal to laparoscopic hysterectomy.
Figure 1 shows the percentage of women in the laparoscopic hysterectomy group, abdominal 
hysterectomy group and nurses group who accepted a certain risk of major complications in 
hysterectomy. The median acceptable risk was 1.0% in the laparoscopic hysterectomy group, 
and 0.5% in the abdominal hysterectomy group and the nurses group. These percentages were 
significantly higher in the laparoscopic hysterectomy group versus the abdominal hysterectomy 
group (p=0.001) and in the patients versus the nurses (p=0.004). A major complication rate 
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of 7.2%, such as reported in laparoscopic hysterectomy in the large eVALuate study, when 
disregarding the intraoperative conversions (15), was unacceptable to 96% of women. 
Figure 2 shows the percentage of women in the laparoscopic hysterectomy group, abdominal 
hysterectomy group and nurses group who accepted a certain risk of conversion from laparoscopic 
hysterectomy to abdominal hysterectomy during surgery. The median acceptable conversion rate 
from laparoscopic hysterectomy to abdominal hysterectomy was 55%, 20% and 10% in the 
laparoscopic hysterectomy group, abdominal hysterectomy group and nurses group respectively. 
The difference between the laparoscopic hysterectomy group and abdominal hysterectomy group 
was not statistically significant (p=0.096), whereas the patients accepted a significantly higher 
conversion rate as compared to the nurses (p<0.001). A conversion rate from laparoscopic to 
Table 2. Women’s preferences.
  Patients  Patients  Nurses Test for 
  scheduled scheduled  differences
  for LH  for AH  
  (n=32)  (n=11) (n=39) 
Desired information  1 [1-8] * 1 [1-3] * 1 [1-10] * a: p = 0.24
     b: p = 0.76
Desired involvement  4 [1-9] * 3 [1-6] * 3 [1-10] * a: p = 0.65
     b: p = 0.67
Preferred approach  LH 32 (100)  4 (36)  29 (74)  a: p < 0.01
(after global information) ? 0 1 (9) 1 (3) b: p = 0.56 
 AH 0 6 (55) 9 (23)  
Preferred approach  LH 32 (100)  5 (45)  29 (76 ‡)  a: p < 0.01
(after detailed information) ? 0 0 1 (3) b: p = 0.38
 AH 0 6 (55) 8 (21) 
Preferred approach  LH 32 (100)  7 (64)  33 (92 ‡ )  a: p < 0.01
(equal complications  ? 0 2 (18) 2 (6) b: p = 0.90
and no conversions) AH 0 2 (18) 1 (3) 
Accepts doubled  Yes 28 (88) 3 (27) 17 (44) a: p < 0.01
major complication Maybe 2 (6) 4 (36) 16 (41) b: p = 0.04
rate in LH No 2 (6) 4 (36) 6 (15)  
Accepts conversion in  Yes 32 (100) 7 (64) 31 (79) a: p < 0.01
LH in case needed Maybe 0 1 (9) 5 (13) b: p = 0.18
 No 0 3 (27) 3 (8)  
AH = abdominal hysterectomy; LH = laparoscopic hysterectomy; Test for differences: a = LH vs AH; 
b = patients vs nurses; p = p-value for difference between groups using Chi-square tests; n.s. = difference not statistically 
significant; desired information = desired amount of information on advantages and disadvantages of treatment options on 
a 1 to 10 visual analogue scale, where 1 represents most information; desired involvement = desired level of involvement in 
medical decision -making on a 1 to 10 visual analogue scale, where 1 represents most involvement; ? = no preference.
Data shown as * median [range], absolute numbers (percentage). ‡ note: data from one and three nurses are missing 
respectively.
abdominal hysterectomy of 4%, such as reported in the eVALuate study (15), was unacceptable 
to 9% of women. 
In Figure 3, the importance of treatment characteristics for women in the laparoscopic 
hysterectomy group, abdominal hysterectomy group and nurses group are presented as 100% 
stack bars. The avoidance of complications was ranked more important by the patients than by 
the nurses (p=0.015). The limitation of the recovery period was ranked more important in the 
laparoscopic hysterectomy group than in the abdominal hysterectomy group (p=0.002). Other 
comparisons were not significantly different.
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Figure 1. Women's acceptance of the risk of major complications.
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Figure 2. Women's acceptance of the risk of a conversion during surgery from laparoscopic to abdominal 
hysterectomy.
Comment
This paper presents a study on women’s preferences for laparoscopic or abdominal hysterectomy 
and the main treatment related factors influencing their preference. We found that 81% of the 
women preferred laparoscopic hysterectomy, in spite of disadvantages such as a higher risk of major 
complications in the laparoscopic approach. However, 4% of the women preferred abdominal 
hysterectomy even in case of a hypothetical situation of equal complication rates and no risk 
of conversion to laparoscopic hysterectomy. These preferences did not change following a more 
detailed explanation of the two procedures or after experiencing hysterectomy in the near past. 
The main factor influencing the women’s treatment preference was the avoidance of 
complications. More than half of the patients and three-quarters of the nurses experienced 1% 
as the maximum acceptable risk of major complications in hysterectomy, and none of the patients 
in the abdominal hysterectomy group accepted a major complication risk over 2%. 
Considerable effort has been spent to obtain valid estimates for the figures and percentages 
on the differences between laparoscopic and abdominal hysterectomy in the detailed information 
of the interview. A difficulty in this respect, however, was that the meta-analysis of randomised 
controlled trials on laparoscopic versus abdominal hysterectomy (3) reported a much higher 
complication rate as compared with large prospective (4;12) and retrospective case series 
(5;13;14). This discrepancy might be explained by differences in learning curve in the various 
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Figure 3. Treatment characteristics.
studies (2;3;16-19). In the meta-analysis on hysterectomy, the cumulative risk of injury to urinary 
tract, bowels and blood vessels was 4.4% and 2.7% in laparoscopic and abdominal hysterectomy, 
respectively (3). This complication rate in laparoscopic hysterectomy was in agreement with the 
4.6% injury rate to urinary tract or bowels as occurring during the learning curve of laparoscopic 
hysterectomy in a large prospective Finnish study (4). In the present study, less than 5% of women 
perceived this high complication rates as acceptable (Figure 1). Since more and more surgeons 
will be thoroughly trained in laparoscopic hysterectomy, we have presented the complication 
rates as achieved by experienced surgeons in the present study (i.e. 0.5% and 1% urinary tract 
injuries in abdominal and laparoscopic hysterectomy respectively). Consequently, the treatment 
preferences presented are mainly applicable to a wide range of surgeons who have finished their 
learning curve in laparoscopic hysterectomy.
The fact that women scheduled for hysterectomy considered a 1% probability of major 
complications as their maximum acceptable risk also indicates that other alternatives for 
hysterectomy should be considered prior to surgery. In a recent preference study among women 
suffering from dysfunctional uterine bleeding, we found that a majority of the patients scheduled 
for an endometrial ablation or a levonorgestrel-releasing IUD were inclined to take a risk of 50% 
likelihood of treatment failure to avoid a hysterectomy (20).
The risk of conversion in laparoscopic hysterectomy was less important to the women in the 
decision-making on approach to hysterectomy (Figures 3). There was, however, a minority of 
women who did not accept the risk of conversion and would prefer abdominal hysterectomy to 
avoid this uncertainty. 
We have used face-to-face interviews to assess patients’ preferences. Both strength and 
limitation of these personal interviews is the flexible nature (21). It allows tailoring information 
and explication to the need of the individual patient, whereas interviewers’ influences make the 
technique prone to bias, and need to be minimised. Since the results from the questionnaires 
used in the nurses group were largely in line with the results from the interviews in the patients, 
this suggests absence of major bias in this respect.
Half of the women in the abdominal hysterectomy group did not have an actual choice 
for laparoscopic hysterectomy and all other patients had already made a personal decision on 
the desired approach to hysterectomy at the time of the first interview. Women could feel free 
to state their preference without consequences for their personal situation. It can be difficult, 
however, for women to reconsider the choices they have just made facing their own doctor. This 
might have caused some opportunistic answers in line with the planned approach, e.g. caused 
by a psychological mechanism called cognitive dissonance reduction (22). This might be the 
reason for (part of) the lower acceptance of complications and conversions, and the fact that the 
less importance was ascribed to the speed of recovery in the abdominal hysterectomy group as 
compared with the laparoscopic hysterectomy group. Another explanation for this phenomenon 
might be selection bias, as women with a lower acceptance of complications and conversions had 
opted already for abdominal hysterectomy.
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We have included a group of nurses in the study, since, by virtue of their profession, we 
expected them to be more experienced in judging complex issues, such as complication rates, 
conversion rates, and post-operative recovery. Since treatment preferences in the nurses group 
were largely in line with the patients group, this consolidates our findings. The maximum 
acceptable rates of complications and conversions, however, were lower among nurses as among 
patients. Since the nurses did not experience the necessity for hysterectomy and are professionally 
involved in patients having complications, this might be the explanation for the difference in 
willingness to accept these adverse events.  
Advantages and disadvantages of all feasible approaches to hysterectomy need to be discussed 
with each woman scheduled for hysterectomy, which may include the proposal of a laparoscopic 
hysterectomy as performed by a colleague. The fact that a recent study showed that half of the 
women was not informed on the pros and cons of different approaches and one in every five 
women did not even know which approach to hysterectomy was planned (10), indicates that 
there is a need for improvement in this perspective. 
The evident preference for laparoscopic hysterectomy reported by patients in this study is 
conflicting with the slow implementation of laparoscopic hysterectomy in clinical practice. There 
is a strong call for laparoscopic hysterectomy from society to be heard and measures to stimulate 
the further implementation of laparoscopic hysterectomy are needed. This can be either by 
expansion of laparoscopic training to gynaecologists or the centralisation of laparoscopic 
hysterectomies in laparoscopic centres. 
In conclusion, the majority of women prefers laparoscopic hysterectomy over abdominal 
hysterectomy, and accepts the risk of conversion to laparotomy. The complications, however, are 
a major issue of concern, and the actual major complication rate in hysterectomy is perceived 
as high.
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Discussion9
This thesis describes various aspects of the three approaches to hysterectomy with emphasis on the 
measurement of quality of life and recovery following laparoscopic and abdominal hysterectomy. 
The first chapters provide an overview of the available literature on hysterectomy. Since 
disadvantages from vaginal hysterectomy as compared with laparoscopic and abdominal 
hysterectomy have not been reported, there is a general consensus that vaginal hysterectomy is 
the first choice approach in women with no suspicion of gynaecological malignancy (1). Due 
to the limitation of access, however, the vaginal approach is impossible in women with more 
than moderately enlarged uteri. In these women, a decision for either laparoscopic or abdominal 
hysterectomy needs to be made. Laparoscopic hysterectomy is associated with a reduction in 
blood loss, infections, post-operative pain, hospital stay and time to resume normal activities, 
at the expense of longer surgical procedures and more urinary tract injuries as compared with 
abdominal hysterectomy. Although larger size uteri can be removed by laparoscopic approach as 
compared with the vaginal approach, the laparoscopic access is equally limited by uterine size. In 
abdominal hysterectomy, there is no uterine size limitation and this approach is applied where 
vaginal and laparoscopic hysterectomy is not feasible. 
Laparoscopic hysterectomy has been introduced as an alternative for abdominal hysterectomy 
in 1989 by Reich (2). His introduction has given an impetus to research on the comparison 
of various approaches to hysterectomy, and more than 30 randomized controlled studies on 
laparoscopic versus abdominal hysterectomy have been published since. The main question on 
the relative complication rates in women undergoing hysterectomy by vaginal, laparoscopic and 
abdominal approach has now been answered by meta-analysis of these studies, which has shown 
a more than 2-fold increase in urinary tract lesions in laparoscopic hysterectomy as compared 
with abdominal hysterectomy (1). In spite of the large number of randomized controlled trials, 
however, the effects of the many other factors influencing complication rates remain obscure. It is 
still not known, for example, whether one of the subcategories of laparoscopic hysterectomy, such 
as laparoscopic assisted vaginal hysterectomy (LAVH) or total laparoscopic hysterectomy (TLH), 
is safer as compared with the others. It is equally not demonstrated as yet, how uterine size and the 
surgeons’ experience influence complication rates. Due to the low major complication rate and 
the many influencing factors, large sample sizes are needed to allow various subgroup analyses. It 
is not very likely that more randomized controlled trials of a sample size comparable to the large 
eVALuate study (i.e. 1,346 women) (3) will be conducted in the near future. This emphasizes 
the importance of detailed descriptions of studies on new surgical procedures, since the detailed 
documentation of outcomes for which each individual study was underpowered, allows to draw 
conclusions in a subsequent meta-analysis (1). The sample size in our randomized controlled 
study was too small for proper analysis of complications (Chapters 4). Unfortunately, due to 
an accumulation of complications during the study period, there was a high complication rate.
A prospective observational study by Makinen et al. has shown that, with increasing 
experience in laparoscopic hysterectomy, the urinary tract injury rate decreases to a rate similar 
to abdominal hysterectomy (4). This is in agreement with results from large case series with 
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experienced surgeons, including over 6,000 laparoscopic hysterectomies (5-8). The urinary tract 
injury rate as reported in the meta-analysis of randomized controlled trials is comparable to the 
rate in surgeons during the learning curve in observational studies (1;4;6). Only few randomized 
controlled studies, however, have reported on the surgeons’ experience or on experience in dealing 
with serious complications (Chapter 2). In the studies where experience of the surgeons has 
been reported, it has mainly been reported in terms of the numbers of previous laparoscopic 
hysterectomies, which is only one of the markers for competence (9). The learning curve of a 
surgeon without any laparoscopic experience will differ from the learning curve of a surgeon 
who is used to a wide range of other laparoscopic procedures. Analyses of complication rates 
are even more challenging with the assessment of the learning curve position of gynaecologists 
in training, supervised by a gynaecologist, both with a variable amount of experience. In the 
randomized controlled trial presented in this thesis, most abdominal procedures were performed 
by gynaecologists in training, whereas most laparoscopic hysterectomies were performed by 
gynaecologists. Although the gynaecologists had performed more than 100 procedures, it is not 
surprising, that the gynaecologists in training and the gynaecologists were equally involved in 
the urinary tract injuries in these procedures (Chapter 4). Obtaining more data on complication 
rates in relation to surgical experience level is an important, though complicated subject for future 
research, which would provide more insight in the need for future centralization of complex 
laparoscopic procedures.
Although the implementation of laparoscopic hysterectomy in clinical practice is slow (10), 
the procedure has not been abandoned since the publication of the meta-analysis with the report 
of higher urinary tract injury rates (11). Reasons for the laparoscopic hysterectomy to stay, 
may include the strong call from society for minimally invasive procedures (12), the patients’ 
unawareness or acceptation of the risks (13), and the surgeons’ believe of doing better than 
average and finding it hard to abandon the challenging procedure (14). It is not known which 
of these elements is the decisive factor. There is probably a wide believe among patients and 
doctors that a shorter recovery associated with laparoscopic hysterectomy can compensate for 
the extra complication risks. 
The main objective of this thesis was to assess the post-operative recovery in hysterectomy 
patients. Post-operative recovery is the process of convalescence after surgery and involves physical 
and mental aspects. After successful recovery the patient will feel comfortable, free of symptoms 
such as pain and nausea, experience normal nutrition, micturition and defecation, and is able 
to fulfil normal activities. Recovery should be measured in an unbiased manner, which excludes 
the duration of hospital stay and time taken to resume work as measurement tools. Although 
these periods are related to recovery, they are influenced by local habits and protocols, and it is 
of more interest to know when the patient feels ready to go home and ready to resume normal 
activities. Consequently, patients’ involvement in recovery assessment is essential, and in recent 
years, emphasis has been put on patient-reported post-operative quality of life measurement (15), 
where recovery is reflected in the time taken till resumption of preoperative quality of life.
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In our studies, a modest advantage in favour of laparoscopic hysterectomy as compared 
with abdominal hysterectomy was found in three quality of life questionnaires (RAND-36, RI-
10 and QoR-40) in the first twelve weeks after surgery (Chapters 4 and 7). Although clinicians 
would probably expect a more pronounced difference in recovery, the evidence in favour of 
laparoscopic hysterectomy is apparent, and in agreement with quality of life outcomes from 
other studies (Chapter 3). 
Both generic health-related quality of life questionnaires and recovery specific quality of 
life questionnaires can be used as instruments for recovery assessment. The generic health-
related instruments, such as RAND-36, have the advantage of being used more frequently as 
compared with recovery specific instruments, so that more data from other studies are available 
for comparison. Recovery specific instruments, however, are more valid for recovery measurement 
as compared with the RAND-36 (Chapter 7). The dilemma here is either more comparability 
or more validity, which can easily be solved by applying both types of instruments in future 
studies.
Unsatisfactory measurement properties of the instruments used, can lead to non-valid 
outcomes, which should be prevented at all times. Available recovery specific instruments with 
good measurement properties are the Postdischarge surgical recovery scale, the Quality of 
recovery-40 and the Recovery index-10 (Chapter 6 and 7). The latter two instruments are available 
in a Dutch version. The validation of none of the three instruments has been completed, and 
further validation is awaited with special regards to responsiveness and the minimally important 
change.
If the data from the Recovery index-10 (Chapter 7) had already been published at the time 
of our systematic review on available recovery specific instruments (Chapter 6), the instrument 
would have been included. This hampers the comparability of the Recovery index-10 to the 
other recovery instruments. When the eight quality criteria for measurement properties (16) 
are applied to the RI-10, it results in positive ratings for internal consistency and floor/ceiling 
effects, intermediate ratings for responsiveness and interpretability and negative ratings for 
content validity and construct validity, whereas no information is available for agreement and 
reliability. The two negative ratings are due to the lack of target population involvement and 
also to the fact that only two-thirds, instead of three-quarters, of predefined hypotheses held 
true on construct validity testing in hysterectomy patients. In our validation study (Chapter 
7), however, the construct validity of the Recovery index-10 proofed superior to the Quality of 
recovery-40 and this instrument was rated positive for construct validity in the review (Chapter 
6). This positive rating was based on the results of the original validation study of the Quality of 
Recovery-40 (17). As a consequence, it is not justified to disqualify the Recovery index-10 as a 
recovery specific instrument at this stage and a further validation study is needed.
The items in recovery instruments should correspond with the surgical procedure and the 
time period studied. Problems with mobility and emotional factors for example, are more likely 
in orthopaedic surgery and life-threatening diseases respectively. In addition, depending on the 
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extent of surgery and the time passed since surgery, there is a shift in the main topics with 
regards to recovery. Concerns about nausea, for example, are more prominent in the first days 
after surgery, whereas return to work plays a role at the end of the recovery period. With regards 
to the two Dutch recovery instruments, the application of the Quality of recovery-40 is more 
appropriate during hospitalization, whereas the Recovery index-10 is more suitable in recently 
discharged patients. The English version of the Quality of recovery-40 has shown to be valid in 
a wide range of surgical procedures (17), whereas the Recovery index-10 has only been studied 
in hysterectomy patients up until now.
In the study on women’s preference for either approach to hysterectomy (Chapter 8), it is 
shown that over 80% of women would choose laparoscopic hysterectomy when counselled for 
abdominal and laparoscopic hysterectomy. Although 75% of women stated that the avoidance of 
complications is "very important", the majority of women accepted a doubled  major complication 
rate in laparoscopic hysterectomy as compared with abdominal hysterectomy. A shorter recovery 
period was ranked as "very important" in only 50% of women. Apparently, complication rates 
in laparoscopic hysterectomy are perceived within acceptable limits and the controversy on 
complications versus recovery in abdominal and laparoscopic hysterectomy is settled in favour 
of laparoscopic hysterectomy.
It is assumed that laparoscopic hysterectomy is feasible in 25% of hysterectomies, although 
this rate will be reciprocal with the local vaginal hysterectomy rate. Since over 80% of patients 
would choose laparoscopic hysterectomy when offered and only 4% of hysterectomies in the 
Netherlands in 2002 were performed by laparoscopic approach (10), only a limited number 
of Dutch gynaecologists seem to offer this approach. In view of the patients’ preference for the 
laparoscopic procedure, either more gynaecologists need to become familiar with laparoscopic 
hysterectomy or a referral system with centralization of the procedure is needed. 
It is only since recently, that a causal relationship between hysterectomy and pelvic organ 
dysfunction has been refuted (18). Until now, however, little is known on the relative safety in 
this respect of either approach to hysterectomy. In our randomized controlled trial (Chapter 5), 
significantly less urinary problems have been found one year after surgery following laparoscopic 
hysterectomy as compared with abdominal hysterectomy. The reason for this remains hypothetical, 
but is possibly due to a less traumatic dissection of the bladder in laparoscopic hysterectomy. A 
potential difference in pelvic organ function following laparoscopic and abdominal hysterectomy 
is an important factor, since dysfunctions have a large and long-lasting impact on the patients’ 
quality of life (19). Consequently, further investigation of urinary dysfunctions associated with 
hysterectomy is needed.
Increasing costs of medical care are a matter of political concern, since these costs are 
increasing relatively fast. Cost-utility analyses can be used to weigh benefits and costs of new 
techniques, and the assessment of costs for an additional quality adjusted life year has been 
mentioned as an appropriate outcome in this respect (20). In a cost-utility analysis of laparoscopic 
hysterectomy versus abdominal hysterectomy, no significant difference has been reported at the 
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end of one-year follow-up (21). In this cost-utility analysis, a generic health-related quality of life 
instrument was used to assess differences in quality of life. Since recovery specific instruments 
have superior properties for the assessment of these differences, a cost-utility analysis using a 
recovery specific instrument would be an interesting topic for future research. Differences in both 
quality of life as well as costs for the hysterectomy are visible on the short term, i.e. within the 
first three months after surgery (Chapter 3, 4 and 7). As a consequence, the cost-utility analysis 
can be performed in a study with this short follow-up, which avoids neutralization of the cost 
and quality of life differences when spread out over a year.  
The three levels of decision-making in health care are decisions on resource utilisation, 
decisions for groups of patients and decisions for individual patients (22). As this thesis 
demonstrates, laparoscopic hysterectomy, particularly when performed by experienced surgeons, 
has shown to be a good alternative on all these three levels. It has even shown to be superior to 
abdominal hysterectomy on a considerable number of outcomes. This implies that laparoscopic 
hysterectomy deserves to be widely implemented in clinical practice.
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Conclusions
When performing hysterectomy, vaginal hysterectomy is the first choice approach. When vaginal 
hysterectomy is not feasible, the individual choice for laparoscopic or abdominal hysterectomy should 
be balanced against the available evidence of benefits and hazards of the procedures, individual 
patients’ characteristics, patients’ and doctors’ preferences, and surgical skills (Chapter 2). 
Laparoscopic hysterectomy is associated with higher post-operative quality of life scores 
and enhanced post-operative recovery in the first twelve weeks after surgery as compared with 
abdominal hysterectomy (Chapters 3, 4 and 7).
Laparoscopic hysterectomy is associated with a better pelvic organ function one year after 
surgery as compared with abdominal hysterectomy (Chapter 5).
Recovery specific instruments assess post-operative recovery more validly as compared with 
a generic health-related instrument (Chapter 7).
Available English-version recovery specific instruments with superior measurement properties 
are the Postdischarge surgical recovery scale and the Quality of recovery-40 (Chapter 6 and 7).
Available Dutch-version recovery specific instruments with superior measurement properties 
are the Quality of recovery-40 and the Recovery index-10 (Chapter 6 and 7). 
Women prefer laparoscopic hysterectomy to abdominal hysterectomy (Chapter 8).
Topics for future research
Further exploration of the impact of surgical experience level, uterine size and subcategory 
of laparoscopic hysterectomy on complication rates in hysterectomy.
Further exploration of the influences of surgical approach to hysterectomy on urinary 
symptoms.
Further validation of recovery specific instruments (Postdischarge surgical recovery scale, 
Recovery index-10 and Quality of recovery-40).
Cost-utility analysis of approaches to hysterectomy using a recovery specific instrument and 
short-term follow-up (i.e. three months).
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Summary10
Summary 
In Chapter 2, the available evidence on effectiveness, costs and cost-effectiveness of various 
hysterectomy techniques was compared. 
Effectiveness
When technically feasible, vaginal hysterectomy is preferred over laparoscopic and abdominal 
hysterectomy. In case vaginal hysterectomy is not feasible, laparoscopic hysterectomy results in 
less operative blood-loss, less pain and less infectious morbidity, as well as a shorter hospital stay 
and more rapid return to normal activities as compared with abdominal hysterectomy. However, 
these benefits, need to be weighed against a longer operating time and a higher risk of urinary 
tract injuries in laparoscopic hysterectomy. 
Costs
In the various randomised controlled studies on costs of different treatment options for 
menorrhagia, medical treatment, treatment with the levonorgestrel-IUD and endometrial 
ablation, were associated with lower costs as compared with randomisation for hysterectomy. 
Furthermore, the vaginal approach is the hysterectomy technique associated with the lowest 
costs. In studies on hospital costs in abdominal hysterectomy, these costs were either equal or 
lower, as compared with costs in laparoscopic hysterectomy. In case of differences among the 
hospital costs in the two techniques, these were neutralised by differences in societal costs, such 
as productivity loss. 
Cost-effectiveness
A cost-utility analysis at one-year follow-up favoured randomisation for treatment with the 
levonorgestrel-IUD as compared with hysterectomy. In women undergoing hysterectomy, vaginal 
hysterectomy is cost-effective as compared with laparoscopic hysterectomy and is likely to be 
cost-effective as compared with abdominal hysterectomy. The difference in cost-effectiveness 
between laparoscopic and abdominal hysterectomy is more balanced, especially when avoiding 
the use of disposable instruments.  
The objective of the study in Chapter 3 was to investigate the results from randomised studies 
reporting on quality of life following laparoscopic hysterectomy as compared with abdominal 
hysterectomy. The studies were assessed for the methods in which they reported on postoperative 
quality of life as an outcome measure. We identified, thirty papers, published between 1994 and 
2004. Only seven studies, incorporating data on 1,450 patients, reported on quality of life. In the 
four studies using validated instruments, eight different validated quality of life questionnaires 
were used. Two of these studies reported significant differences in quality of life in the first six 
weeks, favouring laparoscopic hysterectomy. 
In Chapter 4, quality of life after total laparoscopic hysterectomy versus total abdominal 
hysterectomy was compared in a randomised controlled trial. Fifty-nine patients scheduled for 
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hysterectomy for a benign condition, in whom a vaginal hysterectomy was not possible and 
laparoscopic hysterectomy was feasible, were included. The primary outcome of the study was 
quality of life as measured by the RAND-36, whereas secondary outcomes were hospital stay 
and complications. Laparoscopic hysterectomy performed better as compared with abdominal 
hysterectomy, on all scales of the RAND-36, although these differences were only statistically 
significant in the scale for vitality. Overall complication rate (22% versus 53% of patients) and 
hospital stay (four versus five days) significantly favoured laparoscopic hysterectomy.
In Chapter 5, pelvic organ function was studied in seventy-six randomised hysterectomy 
patients. In contrast with Chapter 4, the women with both endometrial carcinoma and benign 
indications for hysterectomy, were included in the study. Data on the incidence of urinary 
incontinence and sexual problems were collected before and after surgery. Furthermore, the 
women completed the Urogenital Distress Inventory (UDI), Incontinence Impact Questionnaire 
(IIQ), Defaecatory Distress Inventory (DDI) and the Questionnaire for screening Sexual 
Dysfunctions (QSD) one year after surgery. This study showed that the incidence of urinary 
incontinence at three month after surgery decreased equally in both groups as compared with 
baseline. Furthermore, de novo urinary incontinence and sexual problems were rare. One year 
after surgery, a significant treatment effect favouring laparoscopic hysterectomy was found in 
the UDI and IIQ, whereas no differences were found in the DDI and QSD. 
Chapter 6 provides a systematic review of the literature on postoperative recovery specific quality 
of life instruments and their measurement properties. Existing quality criteria were applied to the 
measurement properties of 12 instruments detected by an extensive literature search. None of the 
instruments had been validated completely in line with the quality criteria. However, two instruments 
were superior, which were the Postdischarge surgical recovery scale and the Quality of recovery-40. 
We advise to use these two instruments in future studies on short-term postoperative recovery.
The aim of the study from Chapter 7, was to evaluate the relative quality of measurement 
properties of the Quality of Recovery-40 (QoR-40), Recovery Index-10 (RI-10) and RAND-36 
health survey for the assessment of postoperative recovery. One hundred and sixty-one women 
completed the three questionnaires at several time points in the first 12 weeks after surgery. Both 
response rate and internal consistency were found satisfactory for all instruments. Construct 
validity was highest in the RI-10. Furthermore, the RI-10 showed the most marked change 
over time and was more responsive as compared to the QoR-40 and RAND-36. However, in 
hospitalised patients in their first days after surgery, validity and responsiveness of the QoR-40 
were satisfactory as well. In conclusion, the RI-10, which is a recovery specific instrument, was 
most validly assessing postoperative recovery, although application of the QoR-40 is likewise 
appropriate in hospitalised patients in their first days after surgery
In Chapter 8, women’s preference for laparoscopic or abdominal hysterectomy was assessed in 
standardised interviews and questionnaires. After explanation of the advantages and disadvantages 
of the two procedures, more than 80% of women preferred laparoscopic hysterectomy. Although 
the avoidance of complications was indicated as the most important treatment characteristic, 
only 15% of women regarded a two-fold increased risk of major complications in laparoscopic 
hysterectomy as unacceptable. More than half of the women perceived 1% as the maximum 
acceptable major complication rate. This rate can only be achieved by experienced surgeons. 
The slow implementation of laparoscopic hysterectomy in clinical practice is in contrast with 
women’s preference for this approach.
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11 Samenvatting
In hoofdstuk 2, werden de beschikbare gegevens over effectiviteit, kosten en kosteneffectiviteit 
van de verschillende technieken van hysterectomie (baarmoederverwijdering) met elkaar 
vergeleken. 
Effectiviteit
Indien technisch mogelijk, is de vaginale hysterectomie te prefereren boven de laparoscopische 
en abdominale hysterectomie. Indien een vaginale hysterectomie niet mogelijk is, dan gaat de 
laparoscopische hysterectomie gepaard met voordelen van minder peroperatief bloedverlies, 
minder pijn, minder infecties, evenals een kortere opname duur en sneller hervatten van de 
dagelijkse bezigheden ten opzichte van de abdominale hysterectomie. Deze voordelen moeten 
echter afgewogen worden tegen een langere operatieduur en meer risico op laesies aan de 
urinewegen bij de laparoscopische hysterectomie. 
Kosten
In verschillende gerandomiseerde studies waarin de kosten van verschillende opties voor de 
behandeling van menorragie werd vergeleken, gingen medicamenteuze behandeling, behandeling 
met het levonorgestrel-spiraal en ablatie van het endometrium gepaard met lagere kosten in 
vergelijking met hysterectomie. In geval van hysterectomie, is de vaginale hysterectomie de 
techniek met de laagste kosten. In studies naar de hoogte van ziekenhuiskosten bij abdominale 
hysterectomie, waren deze lager of gelijk in vergelijking met de kosten bij laparoscopische 
hysterectomie. Indien de ziekenhuiskosten verschilden, werd dit verschil opgeheven door een 
verschil in maatschappelijke kosten, zoals kosten van productiviteitsverlies. 
Kosteneffectiviteit
In een kostenutiliteitsstudie met een follow-up van een jaar, werd een voordeel gevonden 
van randomisatie voor het levonorgestrel-spiraal in vergelijking met randomisatie voor 
hysterectomie. De vaginale hysterectomie is kosteneffectief in vergelijking met de laparoscopische 
hysterectomie en waarschijnlijk ook in vergelijking met de abdominale hysterectomie. Het verschil 
in kosteneffectiviteit tussen de laparoscopische hysterectomie en de abdominale hysterectomie is 
kleiner, vooral indien het gebruik van materiaal voor éénmalig gebruik wordt vermeden. 
Het doel van de studie in hoofdstuk 3 was om de resultaten van gerandomiseerde studies 
over kwaliteit van leven na laparoscopische en abdominale hysterectomie te evalueren. Van deze 
studies werd de methode in kaart gebracht die werd toegepast om de kwaliteit van leven te meten. 
We identificeerden dertig studies, gepubliceerd tussen 1994 and 2004. Slechts zeven studies, met 
data van 1450 patiënten, rapporteerden over kwaliteit van leven. In de vier studies die gebruik 
maakten van gevalideerde meetinstrumenten, werden acht verschillende gevalideerde kwaliteit 
van leven vragenlijsten toegepast. Twee van deze studies rapporteerden een significant verschil 
en wel een betere kwaliteit van leven in de eerste zes weken na laparoscopische hysterectomie in 
vergelijking met abdominale hysterectomie. 
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In hoofdstuk 4 werd de kwaliteit van leven na totale laparoscopische hysterectomie in 
vergelijking met de abdominale hysterectomie in een gerandomiseerd onderzoek geëvalueerd. 
Negenenvijftig patiënten, gepland voor hysterectomie omwille van een goedaardige aandoening, 
waarbij een vaginale hysterectomie niet mogelijk was en een laparoscopische hysterectomie 
haalbaar leek, werden geïncludeerd. De primaire uitkomstmaat van de studie was kwaliteit 
van leven zoals gemeten met behulp van de vragenlijst RAND-36. De opnameduur en het 
complicatiepercentage waren de secundaire uitkomstmaten. Er was een significant betere kwaliteit 
van leven na de laparoscopische hysterectomie in vergelijking met abdominale hysterectomie 
in het RAND-36 domein Vitaliteit. De laparoscopische hysterectomie ging tevens gepaard 
met een betere kwaliteit van leven in alle overige domeinen, maar deze verschillen waren niet 
statistisch significant. Het totale complicatiepercentage (22% versus 53% van de vrouwen) en de 
opnameduur (vier versus vijf dagen) toonden een significant voordeel van de laparoscopische 
hysterectomie. 
In hoofdstuk 5, werden problemen van urine incontinentie, verzakking, defaecatie en 
seksualiteit onder zesenzeventig gerandomiseerde vrouwen bestudeerd. In tegenstelling tot 
hoofdstuk 4, werden de vrouwen met zowel goedaardige als ook kwaadaardige aandoeningen 
geïncludeerd. De gegevens over het voorkomen van urine incontinentie en problemen met 
seksualiteit voor en na operatie werden opgenomen en de vrouwen vulden een jaar na de operatie 
de urogenitale klachtenlijst (UKL), incontinentie impact lijst (IIL), defaecatie klachtenlijst (DKL) 
en de vragenlijst voor het signaleren van seksuele dysfuncties (VSD) in. In deze studie toonden 
wij aan, dat de incidentie van urine incontinentie drie maanden na de operatie even veel gedaald 
was in de twee groepen ten opzichte van voor de operatie. Verder kwamen nieuwe klachten van 
urine incontinentie en seksuele problemen nauwelijks voor. Een jaar na de operatie werd een 
significant behandelingseffect in het voordeel van de laparoscopische hysterectomie gezien in de 
UKL en IIL, terwijl er geen verschillen in de DKL en VSD werden gevonden.
Hoofdstuk 6 geeft een systematisch overzicht van de literatuur over meetinstrumenten naar 
postoperatief herstel en hun meeteigenschappen. Bestaande kwaliteitscriteria werden toegepast 
op de meeteigenschappen van 12 instrumenten, die gevonden werden bij een uitgebreid literatuur 
onderzoek. Geen van de instrumenten was geheel in de lijn van de kwaliteitscriteria gevalideerd. 
Er waren echter twee instrumenten superieur: de Postdischarge surgical recovery scale and 
de Quality of recovery-40. Wij adviseren om één van deze twee instrumenten te gebruiken in 
toekomstige studies naar het postoperatieve herstel op de korte termijn. 
Het doel van de studie beschreven in hoofdstuk 7 was het evalueren van de relatieve kwaliteit 
van de meeteigenschappen van de Quality of Recovery-40 (QoR-40), Recovery Index-10 (RI-10) 
and RAND-36 voor wat betreft de postoperatieve herstelmeting. Honderdéénenzestig vrouwen 
vulden de drie vragenlijsten op meerdere tijdstippen gedurende de eerste twaalf weken na de 
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operatie in. Zowel het response percentage als ook de interne consistentie waren tevredenstellend. 
Construct validiteit was het hoogste voor de RI-10. Verder toonde de RI-10 de meest uitgebreide 
verandering van score door de tijd en was meer responsief dan de QoR-40 and RAND-36. Voor 
patiënten in het ziekenhuis in de eerste dagen na operatie, waren de validiteit en responsiviteit 
van de QoR-40 eveneens goed.
De conclusie was dat de RI-10, een herstelspecifiek instrument, het meest valide het postoperatieve 
herstel meet. Ook de QoR-40 is goed toepasbaar bij patiënten in het ziekenhuis in de eerste dagen 
na operatie.
In hoofdstuk 8 werd de preferentie van vrouwen voor de laparoscopische of abdominale 
hysterectomie gemeten met behulp van interviews en vragenlijsten. Na uitleg over de voor en 
nadelen van de twee ingrepen, prefereerde meer dan 80% van de vrouwen de laparoscopische 
hysterectomie. Hoewel het vermijden van complicaties het meest belangrijk werd gevonden, 
was een verdubbeling van het risico op grote complicaties bij de laparoscopische hysterectomie 
maar voor 15% van de vrouwen onacceptabel. Voor meer dan de helft van de vrouwen was 
1% het maximaal aanvaardbare complicatie risico. Dit percentage kan alleen behaald worden 
door ervaren operateurs. De trage implementatie van de laparoscopische hysterectomie staat in 
contrast met de voorkeur van vrouwen voor deze ingreep.
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